0001104659-19-027657.txt : 20190508 0001104659-19-027657.hdr.sgml : 20190508 20190508070235 ACCESSION NUMBER: 0001104659-19-027657 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190508 DATE AS OF CHANGE: 20190508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRADIMED CORP CENTRAL INDEX KEY: 0001325618 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 731408526 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36534 FILM NUMBER: 19805122 BUSINESS ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 BUSINESS PHONE: 4076778022 MAIL ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 10-Q 1 a19-7721_110q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2019

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No.: 001-36534

IRADIMED CORPORATION

(Exact name of Registrant as specified in its charter)

Delaware		73-1408526
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification Number

1025 Willa Springs Drive
Winter Springs, Florida		32708
(Address of principal executive offices)		(Zip Code)

(407) 677-8022

(Registrant’s telephone number, including area code)

N/A

(Former Name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:		Trading Symbol		Name of each exchange on which registered:
Common stock, par value $0.0001		IRMD		NASDAQ Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

Large accelerated filer o		Accelerated filer o

Non-accelerated filer o		Smaller reporting company x
		Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes x No o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

The registrant had 11,157,222 shares of common stock, par value $0.0001 per share, outstanding as of April 30, 2019.

Table of Contents

IRADIMED CORPORATION

Table of Contents

			Page
Part I	Financial Information

	Item 1	Condensed Financial Statements	2

		(a) Condensed Balance Sheets as of March 31, 2019 (Unaudited) and December 31, 2018	2

		(b) Condensed Statements of Operations for the Three Months Ended March 31, 2019 and 2018 (Unaudited)	3

		(c) Condensed Statements of Comprehensive Income for the Three Months Ended March 31, 2019 and 2018 (Unaudited)	4

		(d) Condensed Statements of Stockholders’ Equity for the Three Months Ended March 31, 2019 and 2018 (Unaudited)	5

		(e) Condensed Statements of Cash Flows for the Three Months Ended March 31, 2019 and 2018 (Unaudited)	6

		(f) Notes to Unaudited Condensed Financial Statements	7

	Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17

	Item 3	Quantitative and Qualitative Disclosures About Market Risk	23

	Item 4	Controls and Procedures	24

Part II	Other Information

	Item 1	Legal Proceedings	25

	Item 1A	Risk Factors	25

	Item 2	Unregistered Sale of Equity Securities and Use of Proceeds	42

	Item 3	Default Upon Senior Securities	42

	Item 4	Mine Safety Disclosures	42

	Item 5	Other Information	42

	Item 6.	Exhibits	43

Signatures			44

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Condensed Financial Statements

IRADIMED CORPORATION

CONDENSED BALANCE SHEETS

	March 31, 2019			December 31, 2018
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	29,684,457		$	28,027,688
Accounts receivable, net of allowance for doubtful accounts of $63,894 as of March 31, 2019 and $42,443 as of December 31, 2018	5,328,550			4,209,992
Investments	5,746,888			6,349,915
Inventory, net	4,231,504			4,059,443
Prepaid expenses and other current assets	783,170			526,787
Prepaid income taxes	1,665,986			1,367,892
Total current assets	47,440,555			44,541,717
Property and equipment, net	1,902,045			1,869,561
Intangible assets, net	819,752			832,519
Operating lease right-of-use asset	3,127,278			—
Deferred income taxes, net	1,017,049			1,088,702
Other assets	106,536			109,759
Total assets	$	54,413,215		$	48,442,258
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	1,180,598		$	772,470
Accrued payroll and benefits	1,423,967			1,802,321
Other accrued taxes	86,168			133,000
Warranty reserve	74,183			74,524
Deferred revenue	1,902,175			1,798,784
Current portion of operating lease liability	230,271			—
Other current liability	108,421			108,421
Total current liabilities	5,005,783			4,689,520
Deferred revenue	1,864,348			1,807,005
Operating lease liability, less current portion	2,897,007			—
Total liabilities	9,767,138			6,496,525
Stockholders’ equity:
Common stock; $0.0001 par value; 31,500,000 shares authorized; 11,144,196 shares issued and outstanding as of March 31, 2019 and 10,989,111 shares issued and outstanding as of December 31, 2018	1,114			1,099
Additional paid-in capital	16,133,905			15,317,335
Retained earnings	28,515,056			26,669,491
Accumulated other comprehensive loss	(3,998		)	(42,192		)
Total stockholders’ equity	44,646,077			41,945,733
Total liabilities and stockholders’ equity	$	54,413,215		$	48,442,258

See accompanying notes to unaudited condensed financial statements.

Table of Contents

IRADIMED CORPORATION

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	For the Three Months Ended March 31,
	2019			2018
Revenue	$	8,437,593		$	7,108,151
Cost of revenue	2,047,827			1,691,535
Gross profit	6,389,766			5,416,616
Operating expenses:
General and administrative	2,412,696			2,303,532
Sales and marketing	2,110,652			1,645,936
Research and development	352,573			379,826
Total operating expenses	4,875,921			4,329,294
Income from operations	1,513,845			1,087,322
Other income, net	92,574			40,072
Income before provision for income taxes	1,606,419			1,127,394
Provision for income tax (benefit) expense	(239,146		)	286,198
Net income	$	1,845,565		$	841,196
Net income per share:
Basic	$	0.17		$	0.08
Diluted	$	0.15		$	0.07
Weighted average shares outstanding:
Basic	11,029,639			10,608,387
Diluted	12,227,696			11,879,889

See accompanying notes to unaudited condensed financial statements.

Table of Contents

IRADIMED CORPORATION

CONDENSED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

	For the Three Months Ended March 31,
	2019		2018
Net income	$	1,845,565	$	841,196
Other comprehensive income (loss):
Change in fair value of available-for-sale securities, net of tax expense (benefit) of $11,656 and $(14,128), respectively	35,317		(42,651		)
Realized loss on available-for-sale securities reclassified to net income, net of tax (benefit) expense of $(949) and $86, respectively	2,877		(429		)
Other comprehensive income (loss)	38,194		(43,080		)
Comprehensive income	$	1,883,759	$	798,116

See accompanying notes to unaudited condensed financial statements.

Table of Contents

IRADIMED CORPORATION

CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

For the Three Months Ended March 31, 2019:

	Common Stock			Additional Paid-in			Retained		Accumulated Other Comprehensive			Stockholders’
	Shares	Amount		Capital			Earnings		Loss			Equity
Balances, December 31, 2018	10,989,111	$	1,099	$	15,317,335		$	26,669,491	$	(42,192	)	$	41,945,733
Net income	—	—		—			1,845,565		—			1,845,565
Other comprehensive income	—	—		—			—		38,194			38,194
Stock-based compensation	—	—		382,353			—		—			382,353
Net share settlement of restricted stock units	4,322	—		(22,507		)	—		—			(22,507		)
Exercise of stock options	150,763	15		456,724			—		—			456,739
Balances, March 31, 2019	11,144,196	$	1,114	$	16,133,905		$	28,515,056	$	(3,998	)	$	44,646,077

For the Three Months Ended March 31, 2018:

	Common Stock			Additional Paid-in			Retained		Accumulated Other Comprehensive			Stockholders’
	Shares	Amount		Capital			Earnings		Loss			Equity
Balances, December 31, 2017	10,596,566	$	1,060	$	12,623,181		$	20,355,545	$	(48,909	)	$	32,930,877
Net income	—	—		—			841,196		—			841,196
Other comprehensive loss	—	—		—			—		(43,080		)	(43,080		)
Stock-based compensation	—	—		416,327			—		—			416,327
Net share settlement of restricted stock units	3,163	—		(4,376		)	—		—			(4,376		)
Exercise of stock options	22,313	2		95,922			—		—			95,924
Cumulative effect from adoption of accounting standard update	—	—		—			10,496		(10,496		)	—
Balances, March 31, 2018	10,622,042	$	1,062	$	13,131,054		$	21,207,237	$	(102,485	)	$	34,236,868

See accompanying notes to unaudited condensed financial statements.

Table of Contents

IRADIMED CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended March 31,
	2019			2018
Operating activities:
Net income	$	1,845,565		$	841,196
Adjustments to reconcile net income to net cash provided by operating activities:
Change in allowance for doubtful accounts	21,450			8,842
Change in provision for excess and obsolete inventory	120,529			61,011
Depreciation and amortization	387,081			427,747
Stock-based compensation	382,353			416,327
Deferred income taxes, net	59,048			(123,689		)
Loss (gain) on maturities of investments	3,826			(550		)
Changes in operating assets and liabilities:
Accounts receivable	(1,140,008		)	490,147
Inventory	(333,546		)	(155,234		)
Prepaid expenses and other current assets	(665,862		)	(254,051		)
Other assets	(4,891		)	(18,185		)
Accounts payable	375,202			(80,631		)
Accrued payroll and benefits	(378,354		)	(331,790		)
Other accrued taxes	(46,832		)	(75,365		)
Warranty reserve	(341		)	10,414
Deferred revenue	338,078			(42,344		)
Prepaid income taxes, net of accrued income taxes	(298,094		)	410,045
Net cash provided by operating activities	665,204			1,583,890
Investing activities:
Proceeds from maturity of investments	650,000			250,000
Purchases of property and equipment	(82,943		)	(37,983		)
Capitalized intangible assets	(9,724		)	(298		)
Net cash provided by investing activities	557,333			211,719
Financing activities:
Proceeds from exercises of stock options and underwriters’ warrants	456,739			95,924
Taxes paid related to the net share settlement of equity awards	(22,507		)	(4,376		)
Net cash provided by financing activities	434,232			91,548
Net increase in cash and cash equivalents	1,656,769			1,887,157
Cash and cash equivalents, beginning of period	28,027,688			18,205,976
Cash and cash equivalents, end of period	$	29,684,457		$	20,093,133
Supplemental disclosure of cash flow information:
Right-of-use asset recognized in exchange for new lease obligation	$	3,182,724		$	—
Operating and short-term lease payments recorded within cash flow from operating activities	$	106,659		$	101,505

See accompanying notes to unaudited condensed financial statements.

Table of Contents

IRADIMED CORPORATION

Notes to Unaudited Condensed Financial Statements

1 — Basis of Presentation

The accompanying interim condensed financial statements of IRADIMED CORPORATION (“IRADIMED”, the “Company”, “we”, “our”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally presented in annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The interim financial information is unaudited, but reflects all normal adjustments that are, in the opinion of management, necessary for the fair presentation of our financial position, results of operations and cash flows for the interim periods presented. Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019.

These accompanying interim condensed financial statements should be read with the financial statements and related footnotes to financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018. The accounting policies followed in the preparation of these interim condensed financial statements, except as described in Note 1, are consistent in all material respects with those described in Note 1 of our Form 10-K.

We operate in one reportable segment which is the development, manufacture and sale of MRI compatible medical devices, related accessories, disposables and services for use by hospitals and acute care facilities during MRI procedures.

FDA Warning Letter

The FDA conducted a routine inspection of our prior facility between April 7 and April 16, 2014. This was the first FDA inspection of our facility since the voluntary product recall in August 2012 of certain infusion sets and the voluntary recall in July 2013 of our DERS software. The FDA issued a Form 483 on April 16, 2014 that identified eight observations. Most of the observations related to procedural and documentation issues associated with the design, development, validation testing and documentation of software used in certain of our products. Other observations were related to the design validation of pump labeling, design analysis of tube stretching, procedures for post-market design review, and control and procedures related to handling certain reported complaints. We submitted responses to the Form 483 in May 2014 and June 2014 in which we described our proposed corrective and preventative actions to address each of the FDA’s observations.

On September 2, 2014, we received a warning letter from the FDA relating to this inspection (the “Warning Letter”). The Warning Letter states that the FDA accepted as adequate several of our responses to Form 483 observations, identified two responses whose accuracy will be determined in the next scheduled inspection of our facility and identified issues for which our response was determined to be inadequate. The issues identified as inadequate concern our procedures for validating device design primarily related to software quality assurance.

Also, the Warning Letter raised a new issue. The Warning Letter states that modifications made to software on our previously cleared infusion pumps, the MRidium 3860 and MRidium 3850, were “significant” and required submission of new premarket notifications under Section 510(k) (a “510(k) submission”) of the FDC Act. These modifications had been made over time. We believed they were insignificant and did not require premarket notification submissions. However, the FDA indicated that the modifications of the software for the MRidium 3860 and the software for the MRidium 3850 were “significant” modifications because they could significantly affect the safety or effectiveness of these devices. As a result, the Warning Letter states that the products being sold by us are “adulterated” and “misbranded” under the FDC Act. The Warning Letter also indicates that the MRidium 3860+ infusion pump requires separate FDA clearance from the MRidium 3860 and MRidium 3850.

The Warning Letter requested that we immediately cease activities that result in the misbranding or adulteration of the MRidium 3860 MRI infusion pump, MRidium 3850 MRI infusion pump, and the MRidium 3860+ MRI infusion pump, including the commercial distribution of the devices. We immediately complied with the Warning Letter and ceased sale and distribution of the identified products in the United States.

On September 4, 2014, we submitted to the FDA our initial response to the Warning Letter and on September 17, 2014 we sent an additional response that included supplemental information related to the Form 483 inspection observations for which the FDA considered our initial responses inadequate.

Table of Contents

On December 22, 2014, under FDA enforcement discretion, we announced that we resumed domestic distribution of our MRI compatible MRidium 3860+ MRI IV infusion pump systems, without the DERS option. On January 28, 2015, under FDA enforcement discretion, we announced that we resumed domestic distribution of our DERS option. On December 9, 2015, we met with the FDA to review responses to the agency’s additional information letter.

Between July 11 and July 18, 2016, the FDA conducted a routine inspection of our facility. This was the first FDA inspection of our facility since the receipt of the Warning Letter. During this inspection, the updated documents and actions implemented in response to the Warning Letter findings were reviewed, and the FDA determined that no further actions were necessary.

On December 15, 2016, we received FDA 510(k) clearance for our MRidium 3860+ MRI IV infusion pump system, including the DERS software feature. As of March 31, 2019, the Warning Letter remains open.

CE Mark for 3880 Patient Vital Signs Monitoring System

On January 16, 2019, we were notified by the U.K. Notified Body, UL International Ltd. (“UL”) that their recent technical file review of our 3880 MRI compatible patient vital signs monitoring system could not be completed as aspects of clinical evaluation reporting, as required by newly issued guidance from the European Union, was not acceptable, resulting in a technical non-conformity. Accordingly, UL issued a temporary EC Certificate that excludes our 3880 patient vital signs monitoring system. This temporary EC Certificate extends through July 27, 2019. We immediately suspended shipments of our 3880 patient vital signs monitor to all markets requiring a CE Mark. We are addressing the technical non-conformity, but there can be no assurance that these efforts will be successful.

Certain Significant Risks and Uncertainties

We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses. As of March 31, 2019, one domestic customer accounted for approximately 16.2% of accounts receivable.

Recent Accounting Pronouncements

Accounting Pronouncements Implemented in 2019

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842). This update requires lessees to recognize, on the balance sheet, assets and liabilities for the rights and obligations created by all leases not considered short-term leases. For short-term leases, lessees may elect an accounting policy by class of underlying assets under which right-of-use assets and lease liabilities are not recognized and lease payments are generally recognized as expense over the lease term on a straight-line basis.

We adopted this update on January 1, 2019 and, as part of that process, made the following elections:

· We elected to use the hindsight practical expedient.

· We elected the package of practical expedients in transition for leases that commenced prior to January 1, 2019 whereby contracts were not reassessed or reclassified from their previous assessment as of December 31, 2018.

· In March 2018, the FASB approved an optional transition method that allows companies to use the effective date as the date of initial application on transition. We elected this transition method, and as a result, did not adjust comparative period financial information or make the newly required lease disclosures for periods before the effective date.

· We elected to make the accounting policy election for short-term leases resulting in lease payments being recorded as an expense on a straight-line basis over the lease term.

· We elected to not separate lease and nonlease components, for all leases.

· We did not elect the land easement practical expedient.

Table of Contents

The impact of Topic 842 on our Balance Sheet beginning January 1, 2019 was through the recognition of an operating lease right-of-use asset and operating lease liability. Amounts recognized at January 1, 2109 for operating leases were as follows:

	January 1, 2019
Operating lease right-of-use asset	$	3,182,724
Current portion of operating lease liability	$	226,852
Operating lease liability, less current portion	$	2,955,872

There was no impact to our Condensed Statements of Operations, Condensed Statements of Cash Flows or beginning retained earnings related to the adoption of Topic 842.

Recently Issued Accounting Pronouncements to be Implemented

In August 2018, the FASB issued ASU 2018-03, Fair Value Measurement (Topic 820). This update modifies disclosure requirements related to fair value measurements. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Implementation on a prospective or retrospective basis varies by specific disclosure requirement. Early adoption is permitted. The ASU also allows for early adoption of any removed or modified disclosures upon issuance of this ASU, while delaying adoption of the additional disclosures until their effective date. We do not expect the adoption of this guidance will have a material impact upon our footnote disclosures.

In June 2016, the FASB issued 2016-03, Financial Instruments — Credit Losses (Topic 326). This update requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. In addition, for available-for-sale debt securities, this ASU replaces the other-than-temporary impairment model and requires the recognition of an allowance for reductions in a security’s fair value attributable to declines in credit quality, instead of a direct writedown of the security, when a valuation decline is determined to be other-than-temporary. The ASU requires a cumulative-effect adjustment to retained earnings as of the beginning of the reporting period of adoption. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019 and for interim periods therein. Companies may choose to adopt this ASU as of its fiscal year beginning after December 15, 2018. We did not early adopt this standard. We do not believe this ASU will have a material impact on our financial condition or statements of operations.

2 — Revenue Recognition

Disaggregation of Revenue

We disaggregate revenue from contracts with customers by geographic region and revenue type as we believe it best depicts the nature, amount, timing and uncertainty of our revenue and cash flow.

Revenue information by geographic region is as follows:

	Three Months Ended March 31,
	2019		2018
	(unaudited)
United States	$	7,073,735	$	5,977,107
International	1,363,858		1,131,044
Total revenue	$	8,437,593	$	7,108,151

Table of Contents

Revenue information by type is as follows:

	Three Months Ended March 31,
	2019		2018
	(unaudited)
Devices:
MRI compatible IV infusion pump system	$	4,192,754	$	3,625,622
MRI compatible patient vital signs monitoring systems	1,766,608		1,203,856
Total Devices revenue	5,959,362		4,829,478
Disposables and services	2,036,674		1,939,091
Amortization of extended warranty agreements	441,557		339,582
Total revenue	$	8,437,593	$	7,108,151

Contract Liabilities

Our contract liabilities consist of:

	March 31, 2019		December 31, 2018
	(unaudited)
Advance payments from customers	$	51,991	$	180,425
Shipments in-transit	177,344		9,582
Extended warranty agreements	3,537,188		3,415,782
Total	$	3,766,523	$	3,605,789

Changes in the contract liabilities during the periods presented are as follows:

	Deferred Revenue
Contract liabilities, December 31, 2018	$	3,605,789
Increases due to cash received from customers	813,298
Decreases due to recognition of revenue	(652,564		)
Contract liabilities, March 31, 2019	$	3,766,523

	Deferred Revenue
Contract liabilities, December 31, 2017	$	3,621,256
Increases due to cash received from customers	549,032
Decreases due to recognition of revenue	(591,376		)
Contract liabilities, March 31, 2018	$	3,578,912

Capitalized Contract Costs

Our capitalized contract costs consist of:

	March 31, 2019		December 31, 2018
	(unaudited)
Capitalized contract costs	$	186,140	$	181,248

Expense for the three months ended March 31, 2019 and 2018 related to the amortization of capitalized contract costs were immaterial to our financial statements.

Table of Contents

3 — Basic and Diluted Net Income per Share

Basic net income per share is based upon the weighted-average number of common shares outstanding during the period. Diluted net income per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. The underwriters’ warrants, stock options and restricted stock units granted by us represent the only dilutive effect reflected in diluted weighted-average shares outstanding.

The following table presents the computation of basic and diluted net income per share:

	Three Months Ended March 31,
	2019		2018
	(unaudited)
Net income	$	1,845,565	$	841,196
Weighted-average shares outstanding — Basic	11,029,639		10,608,387
Effect of dilutive securities:
Underwriters’ warrants	99,814		53,434
Stock options	996,303		1,155,708
Restricted stock units	101,940		62,360
Weighted-average shares outstanding — Diluted	12,227,696		11,879,889
Basic net income per share	$	0.17	$	0.08
Diluted net income per share	$	0.15	$	0.07

Stock options and warrants to purchase shares of our common stock and restricted stock units excluded from the calculation of diluted net income per share because the effect would have been anti-dilutive are as follows:

	Three Months Ended March 31,
	2019	2018
	(unaudited)
Anti-dilutive stock options, restricted stock units and warrants	7,123	64,382

4 — Inventory

Inventory consists of:

	March 31, 2019			December 31, 2018
	(unaudited)
Raw materials	$	3,570,874		$	3,408,158
Work in process	252,829			305,562
Finished goods	652,878			557,566
Inventory before allowance for excess and obsolete	4,476,581			4,271,286
Allowance for excess and obsolete	(245,077		)	(211,843		)
Total	$	4,231,504		$	4,059,443

5 — Property and Equipment

Property and equipment consist of:

	March 31, 2019			December 31, 2018
	(unaudited)
Computer software and hardware	$	593,347		$	555,292
Furniture and fixtures	978,152			901,415
Leasehold improvements	209,226			202,026
Machinery and equipment	2,193,486			2,184,015
Tooling in-process	83,625			58,263
	4,057,836			3,901,011
Accumulated depreciation	(2,155,791		)	(2,031,450		)
Total	$	1,902,045		$	1,869,561

Table of Contents

Depreciation expense of property and equipment was $124,341 and $109,371 for the three months ended March 31, 2019 and 2018, respectively.

Property and equipment, net, information by geographic region is as follows:

	March 31, 2019		December 31, 2018
	(unaudited)
United States	$	1,474,529	$	1,439,545
International	427,516		430,016
Total property and equipment, net	$	1,902,045	$	1,869,561

Long-lived assets held outside of the United States consist principally of tooling and machinery and equipment, which are components of property and equipment, net.

6 — Intangible Assets

The following table summarizes the components of intangible asset balances:

	March 31, 2019			December 31, 2018
	(unaudited)
Patents — in use	$	304,270		$	304,270
Patents — in process	76,990			73,164
Internally developed software — in use	867,569			867,569
Internally developed software — in process	19,621			13,723
Trademarks	23,017			23,017
	1,291,467			1,281,743
Accumulated amortization	(471,715		)	(449,224		)
Total	$	819,752		$	832,519

Amortization expense of intangible assets was $22,491 and $21,860 for the three months ended March 31, 2019 and 2018, respectively.

Expected annual amortization expense for the remaining portion of 2019 and the next five years related to intangible assets is as follows (excludes in process intangible assets):

Nine months ending December 31, 2019	$	67,472
2020	89,963
2021	89,963
2022	89,392
2023	88,740
2024	88,439

Table of Contents

7 — Investments

Our investments consist of corporate bonds that we have classified as available-for-sale and are summarized in the following tables:

	March 31, 2019
	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Corporate bonds:
U.S. corporations	$	4,833,819	$	1,100	$	14,367	$	4,820,552
International corporations	918,417		7,919		—		926,336
Total	$	5,752,236	$	9,019	$	14,367	$	5,746,888

	December 31, 2018
	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Corporate bonds:
U.S. corporations	$	5,487,645	$	—	$	58,309	$	5,429,336
International corporations	918,417		2,162		—		920,579
Total	$	6,406,062	$	2,162	$	58,309	$	6,349,915

Unrealized losses from the above investments for all periods presented are attributable to changes in interest rates. We do not believe any of these unrealized losses represent other-than-temporary impairments based on our evaluation of available evidence as of March 31, 2019.

8 — Fair Value Measurements

The fair value of our assets and liabilities subject to recurring fair value measurements are as follows:

	Fair Value at March 31, 2019
	Fair Value		Quoted Prices in Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Corporate bonds:
U.S. corporations	$	4,820,552	$	—	$	4,820,552	$	—
International corporations	926,336		—		926,336		—
Total	$	5,746,888	$	—	$	5,746,888	$	—

	Fair Value at December 31, 2018
	Fair Value		Quoted Prices in Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Corporate bonds:
U.S. corporations	$	5,429,336	$	—	$	5,429,336	$	—
International corporations	920,579		—		920,579		—
Total	$	6,349,915	$	—	$	6,349,915	$	—

Our corporate bonds are valued by a third-party custodian at closing prices from secondary exchanges or pricing vendors on the valuation date.

There were no transfers into or out of any Levels during the three months ended March 31, 2019 or the year ended December 31, 2018.

Table of Contents

9 — Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2019 and 2018 are as follows:

	Unrealized (Losses) Gains on Available-For-Sale Securities
Balance at December 31, 2018	$	(42,192	)
Gains on available-for-sale securities, net	35,317
Reclassification realized in net earnings	2,877
Balance at March 31, 2019	$	(3,998	)

Balance at December 31, 2017	$	(48,909	)
Losses on available-for-sale securities, net	(42,651		)
Reclassification realized in net earnings	(429		)
Cumulative effect from adoption of accounting standard update	(10,496		)
Balance at March 31, 2018	$	(102,485	)

10 — Stock-Based Compensation

Stock-based compensation was recognized as follows in the Condensed Statements of Operations:

	Three Months Ended March 31,
	2019		2018
	(unaudited)
Cost of revenue	$	62,524	$	68,259
General and administrative	219,705		226,771
Sales and marketing	82,131		83,616
Research and development	17,993		37,681
Total	$	382,353	$	416,327

As of March 31, 2019, we had $35,611 of unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted-average period of 0.6 years. As of March 31, 2019, we had $2,870,751 of unrecognized compensation cost related to unvested restricted stock units, which is expected to be recognized over a weighted-average period of 2.6 years.

The following table presents a summary of our stock-based compensation activity for the three months ended March 31, 2019 (shares):

	Stock Options		Restricted Stock Units
Outstanding beginning of period	1,129,463		226,501
Awards granted	—		3,592
Awards exercised/vested	(150,763	)	(5,200	)
Awards canceled	(750	)	(11,270	)
Outstanding end of period	977,950		213,623

11 — Income Taxes

For the three months ended March 31, 2019, we recorded a provision for income tax benefit of $(239,146). Our effective tax rate was (14.9) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation, partially offset by U.S. state tax expense.

For the three months ended March 31, 2018, we recorded a provision for income tax expense of $286,198. Our effective tax rate was 25.4 percent and differed from the U.S. Federal statutory rate primarily due to research and development credits, partially offset by U.S. state tax expense.

Table of Contents

As of March 31, 2019 and December 31, 2018, we had not identified or accrued for any uncertain tax positions. We are currently unaware of any uncertain tax positions that could result in significant payments, accruals or other material deviations in this estimate over the next 12 months. We believe that our tax positions comply in all material respects with applicable tax law. However, tax law is subject to interpretation, and interpretations by taxing authorities could be different from ours, which could result in the imposition of additional taxes and penalties.

We file tax returns in the United States Federal jurisdiction and many U.S. state jurisdictions. The Company is subject to income tax examinations for our United States Federal and certain U.S. state income taxes for 2015 and subsequent years and various other U.S. state income taxes for 2014 and subsequent years.

12 — Leases

Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate, unless the rate implicit in the lease is readily determinable. Lease assets also include any upfront lease payments made and exclude lease incentives. Lease terms include options to extend or terminate leases when it is reasonably certain that those options will be exercised.

Variable lease payments are expensed as incurred and include annual rent adjustments based on the consumer price index. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.

Lease agreements with lease and nonlease components are combined as a single lease component. The depreciable life of lease assets and leasehold improvements is limited by the expected lease term.

We have only one material lease contract outstanding. In January 2014, we entered into a non-cancelable operating lease, commencing July 1, 2014, for our manufacturing and headquarters facility in Winter Springs, Florida owned by Susi, LLC, an entity controlled by our President and CEO, Roger Susi. Pursuant to the terms of our lease for this property, the monthly base rent is $34,133, adjusted annually for changes in the consumer price index. Under the terms of the lease, we are responsible for property taxes, insurance and maintenance expenses. The initial term of the lease expires on May 31, 2019. Unless advance written notice of termination is timely provided, the lease will automatically renew for two successive terms of five years each beginning in 2019 and again in 2024, and thereafter, will be renewed for successive terms of one year each. For purposes of Topic 842, we concluded that we will exercise both of the five year options, resulting in a remaining lease term of 10.2 years as of March 31, 2019. This lease agreement does not contain any residual value guarantee or material restrictive convenants.

Operating lease cost recognized for the three months ended March 31, 2019 is follows in the Condensed Statements of Operations:

Cost of revenue	$	46,535
General and administrative	46,044
Sales and marketing	2,605
Research and development	7,215
Total	$	102,399

Lease costs for short-term leases were immaterial for the three months ended March 31, 2019.

Maturity of Operating Lease Liability as of March 31, 2019 is as follows:

Nine months ending December 31, 2019	$	307,197
2020	409,596
2021	409,596
2022	409,596
2023	409,596
Thereafter	2,218,646
Total lease payments	4,164,227
Imputed interest	(1,036,949		)
Present value of lease liability	$	3,127,278

Table of Contents

We used a discount rate of 6.0% to determine the present value of the operating lease liability on January 1, 2019.

Undiscounted future minimum lease payments under noncancelable operating leases as of December 31, 2018 as determined prior to the adoption of ASC 842 are as follows:

2019	$	170,664
2020	—
2021	—
2022	—
2023	—
Thereafter	—
Total minimum lease payments	$	170,664

13 — Commitments and Contingencies

Purchase commitments. We had various purchase orders for goods or services totaling $2,920,468 and $2,674,691 as of March 31, 2019 and December 31, 2018, respectively. No amounts related to these purchase orders have been recognized in our balance sheet.

Legal matters. We may from time to time become party to various legal proceedings or claims that arise in the ordinary course of business.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis of Financial Condition (“MD&A”) supplements the MD&A in the Company’s Annual Report filed on Form 10-K. The MD&A should be read in conjunction with the Risk Factors section of this Quarterly Report, our condensed financial statements and accompanying footnotes, the discussion of certain risks and uncertainties contained in Part II, Item 1A of this Quarterly Report, the Form 10-K and the cautionary information regarding forward-looking statements at the end of this section.

Some of the statements contained in this MD&A and elsewhere in this Quarterly Report are forward-looking statements that involve substantial risks and uncertainties. All statements other than historical facts contained in this report, including statements regarding our future financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “may,” “will,” “continue,” “should,” “plan,” “predict,” “potential” and other similar expressions. We have based these forward-looking statements on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Our actual results could differ materially from those anticipated in these forward-looking statements, which are subject to a number of risks, uncertainties and assumptions including, but not limited to the risks discussed in the Risk Factor section of this Quarterly Report.

Our Business

We develop, manufacture, market and distribute Magnetic Resonance Imaging (“MRI”) compatible medical devices and accessories, disposables and services relating to them.

We are a leader in the development of innovative magnetic resonance imaging (“MRI”) compatible medical devices. We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, uniquely-designed non-ferrous parts and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe and dependable fluid delivery before, during and after an MRI scan, which is important to critically-ill patients who cannot be removed from their vital medications, and children and infants who must generally be sedated to remain immobile during an MRI scan.

Each IV infusion pump system consists of an MRidium® MRI compatible IV infusion pump, non-magnetic mobile stand, proprietary disposable IV tubing sets and many of these systems include additional optional upgrade accessories.

Our 3880 MRI compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features to safely and accurately monitor a patient’s vital signs during various MRI procedures. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss, which means it can operate virtually anywhere in the MRI scanner room. The IRADIMED 3880 has a compact, lightweight design allowing it to travel with the patient from their critical care unit, to the MRI and back, resulting in increased patient safety through uninterrupted vital signs monitoring and decreasing the amount of time critically ill patients are away from critical care units. The features of the IRADIMED 3880 include: wireless ECG with dynamic gradient filtering; wireless SpO2 using Masimo® algorithms; non-magnetic respiratory CO2; non-invasive blood pressure; invasive blood pressure; patient temperature, and; optional advanced multi-gas anesthetic agent unit featuring continuous Minimum Alveolar Concentration measurements. The IRADIMED 3880 MRI compatible patient vital signs monitoring system has an easy-to-use design and allows for the effective communication of patient vital signs information to clinicians.

We generate revenue from the one-time sale of MRI compatible medical devices and accessories, ongoing service contracts and the sale of disposable products used with our devices. The principal customers for our MRI compatible products include hospitals and acute care facilities, both in the United States and internationally.

We sell our MRI compatible products through our direct sales force in the U.S. and independent distributors internationally. We also enter into agreements with healthcare supply contracting companies in the U.S., which enable us to sell and distribute our MRidium MRI compatible IV infusion pump systems to their member hospitals. Under these agreements, we are required to pay these group purchasing organizations (“GPOs”) a fee of three percent of the sales of our products to their member hospitals. Our current GPO contracts effectively give us the ability to sell to more than approximately 95 percent of all U.S. hospitals and acute care facilities. Historical selling cycles for our devices vary and are typically three to six months in duration.

Table of Contents

FDA Warning Letter

On November 25, 2014, we announced that we filed the 510(k) submission related to our MRidium 3860+ MRI IV infusion pumps and on December 12, 2014 we were notified that our 510(k) submission had been formally accepted for review by the FDA. On December 22, 2014, under FDA enforcement discretion, we announced that we resumed domestic distribution of our MRI compatible MRidium 3860+ MRI IV infusion pump systems, without the DERS option. On January 28, 2015, under FDA enforcement discretion, we announced that we resumed domestic distribution of our DERS option. On December 9, 2015, we met with the FDA to review responses to the agency’s additional information letter.

On December 15, 2016, we received FDA 510(k) clearance for our MRidium 3860+ MRI IV infusion pump system, including the DERS software feature. As of March 31, 2019, the Warning Letter remains open.

CE Mark for 3880 Patient Vital Signs Monitoring System

Table of Contents

Financial Highlights and Outlook

Our revenue increased $1.3 million, or 18.7 percent, to $8.4 million for the first quarter ended March 31, 2019, compared to $7.1 million for the first quarter last year. Net income was $1.8 million, or $0.15 per diluted share in the first quarter ended March 31, 2019, compared to net income of $0.8 million, or $0.07 per diluted share in the first quarter last year.

For the remainder of 2019, we expect our revenues to increase when compared to same period in 2018 due to higher sales of our medical devices and related accessories, disposables and services through the continued execution of our critical care strategy and headcount growth of our sales team. We intend to continue targeting hospitals and acute care facilities that have yet to adopt our MRI compatible IV pump and patient monitoring solutions and penetrating the Intensive Care Unit, Emergency Room and other critical care locations within hospitals where there is a high probability that interventional radiology procedures will need to be performed on patients.

We expect higher full year 2019 operating expenses compared to 2018 due primarily to higher sales and marketing expenses.

Application of Critical Accounting Policies

We prepare our financial statements in conformity with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and use assumptions that affect the reported amounts of assets, liabilities and related disclosures at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

We believe that the following critical accounting policies require the use of significant estimates, assumptions, and judgments.

· Revenue recognition

· Accounts receivable and allowance for doubtful accounts

· Inventory carried at the lower of cost or net realizable value

· Stock-based compensation

· Income taxes

These critical accounting policies are described in more detail in our Annual Report filed on Form 10-K, under Management’s Discussion and Analysis and Results of Operations. Except as disclosed in Note 1 to the unaudited condensed financial statements contained herein related to the adoption of recent accounting pronouncements, there have been no changes to these policies during the three months ended March 31, 2019.

The use of different estimates, assumptions, and judgments could have a material effect on the reported amounts of assets, liabilities and related disclosures as of the date of the financial statements and revenue and expenses during the reporting period.

Table of Contents

Results of Operations

The following table sets forth selected statements of operations data as a percentage of total revenue for the periods indicated. Our historical operating results are not necessarily indicative of the results for any future period.

	Percent of Revenue Three Months Ended March 31,
	2019		2018
Revenue	100.0	%	100.0	%
Cost of revenue	24.3		23.8
Gross profit	75.7		76.2
Operating expenses:
General and administrative	28.6		32.4
Sales and marketing	25.0		23.2
Research and development	4.2		5.3
Total operating expenses	57.8		60.9
Income from operations	17.9		15.3
Other income, net	1.1		0.6
Income before provision for income taxes	19.0		15.9
Provision for income tax (benefit) expense	(2.8	)	4.0
Net income	21.9	%	11.8	%

Three Months Ended March 31, 2019 and 2018

Revenue by Geographic Region

	Three Months Ended March 31,
	2019		2018		Change
United States	$	7,073,735	$	5,977,107	18.3	%
International	1,363,858		1,131,044		20.6	%
Total revenue	$	8,437,593	$	7,108,151	18.7	%

Revenue by Type

	Three Months Ended March 31,
	2019		2018		Change
Devices:
IV infusion pump system	$	4,192,754	$	3,625,622	15.6	%
Patient monitoring systems	1,766,608		1,203,856		46.7	%
Total Devices revenue	5,959,362		4,829,478		23.4	%
Disposables and services	2,036,674		1,939,091		5.0	%
Amortization of extended maintenance contracts	441,557		339,582		30.0	%
Total revenue	$	8,437,593	$	7,108,151	18.7	%

For the three months ended March 31, 2019, revenue increased $1.3 million, or 18.7 percent, to $8.4 million from $7.1 million for the same period in 2018.

The average selling price of our MRI compatible IV infusion pump system during the three months ended March 31, 2019 was approximately $35,800, compared to $33,300 for the same period in 2018. The increase in ASP relates to a favorable geographic and product sales mix when compared to the same period in 2018.

The average selling price of our MRI compatible patient vital signs monitoring system during the three months ended March 31, 2019 was approximately $37,400, compared to $36,300 for the same period in 2018. The increase in ASP primarily relates to favorable product sales mix when compared to the same period in 2018.

Table of Contents

Revenue from sales in the U.S. increased $1.1 million, or 18.3 percent, to $7.1 million from $6.0 million for the same period in 2018. Revenue from sales internationally increased $0.3 million, or 20.6 percent, to $1.4 million for the three months ended March 31, 2019, from $1.1 million for the same period in 2018. Domestic sales accounted for 83.8 percent of revenue in the first quarter 2019, compared to 84.1 percent in the first quarter 2018.

Revenue from sales of devices increased $1.2 million, or 23.4 percent, to $6.0 million from $4.8 million for the same period in 2018. Revenue from sales of our disposables and services increased $0.1 million, or 5.0 percent, to $2.0 million from $1.9 million for the same period in 2018. Revenue from the amortization of extended maintenance contracts increased $0.1 million, or 30.0%, to $0.4 million from $0.3 million for the same period in 2018.

Cost of Revenue and Gross Profit

	Three Months Ended March 31,
	2019			2018
Revenue	$	8,437,593		$	7,108,151
Cost of revenue	2,047,827			1,691,535
Gross profit	$	6,389,766		$	5,416,616
Gross profit percentage	75.7		%	76.2		%

For the three months ended March 31, 2019, cost of revenue increased $0.3 million, or 21.1 percent, to $2.0 million from $1.7 million for the same period in 2018. Gross profit increased $1.0 million, or 18.0 percent, to $6.4 million for the first quarter 2019 from $5.4 million for the same period in 2018. The increase in cost of revenue and gross profit is primarily attributable to higher sales.

Gross profit margin was 75.7 percent for first quarter 2019, compared to 76.2 percent for the first quarter 2018. This decrease is primarily due to unfavorable inventory costing adjustments, partially offset by higher average selling prices of devices.

Operating Expenses

	Three Months Ended March 31,
	2019			2018
General and administrative	$	2,412,696		$	2,303,532
Percentage of revenue	28.6		%	32.4		%
Sales and marketing	$	2,110,652		$	1,645,936
Percentage of revenue	25.0		%	23.2		%
Research and development	$	352,573		$	379,826
Percentage of revenue	4.2		%	5.3		%

General and Administrative

For the three months ended March 31, 2019, general and administrative expense increased $0.1 million, or 4.7 percent, to $2.4 million from $2.3 million for the same period last year. This increase is primarily due to higher corporate franchise taxes and higher legal and professional expenses, partially offset by lower regulatory expenses.

Sales and Marketing

For the three months ended March 31, 2019, sales and marketing expense increased $0.5 million, or 28.2 percent, to $2.1 million from $1.6 million for the same period last year. This increase is primarily the result of higher payroll due to higher headcount and higher sales commissions due to higher sales.

Research and Development

For the three months ended March 31, 2019 and 2018, research and development expense was consistent at $0.4 million.

Other Income, Net

Other income, net consists of interest income, foreign currency gains and losses, and other miscellaneous income. For the three months ended March 31, 2019 and 2018, we reported other income of approximately $93,000 and $40,000, respectively. This increase is primarily due to higher interest income.

Table of Contents

Income Taxes

Liquidity and Capital Resources

Our principal sources of liquidity have historically been our cash and cash equivalents balances, our investments, cash flow from operations and access to the financial markets. Our principal uses of cash are operating expenses, working capital requirements, capital expenditures and share repurchases.

As of March 31, 2019, we had cash, cash equivalents and investments of $35.4 million, stockholders’ equity of $44.6 million, and working capital of $42.4 million. As of December 31, 2018, we had cash and cash equivalents and investments of $34.4 million, stockholders’ equity of $41.9 million, and working capital of $39.9 million.

We believe that our current cash, cash equivalents and any cash generated from operations will be sufficient to meet our ongoing operating requirements for at least the next 12 months. We do not anticipate requiring additional capital; however, if required or desirable, we may seek to obtain a credit facility, raise debt or issue additional equity in the private or public markets.

	Three Months Ended March 31,
	2019		2018
Net cash provided by operating activities	$	665,204	$	1,583,890
Net cash provided by investing activities	557,333		211,719
Net cash provided by financing activities	434,232		91,548

For the three months ended March 31, 2019, cash provided by operating activities decreased $0.9 million to $0.7 million, compared to $1.6 million for the same period in 2018. This decrease was primarily the result of lower cash inflows from accounts receivable, partially offset by higher net income and deferred revenue.

Cash provided by investing activities increased $0.4 million to $0.6 million for the three months ended March 31, 2019, compared to $0.2 million for the same period in 2018. This increase primarily relates to higher maturities of investments in the three months ended March 31, 2019 compared to the same period in 2018.

Cash provided by financing activities increased $0.3 million to $0.4 million for the three months ended March 31, 2019, compared to $0.1 million for the same period in 2018. This increase primarily relates to cash received from the exercise of stock options.

We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses. As of March 31, 2019, one domestic customer accounted for approximately 16.2% of accounts receivable.

Our manufacturing and headquarters facility has been leased from Susi, LLC, an entity controlled by our President and CEO, Roger Susi. Pursuant to the terms of our lease, the monthly base rent is $34,133, adjusted annually for changes in the consumer price index.

Table of Contents

Off-Balance Sheet Arrangements

Under our amended and restated bylaws, we have agreed to indemnify our officers and directors for certain events or occurrences arising as a result of the officer or director serving in such capacity. We have a director and officer liability insurance policy that limits our exposure under these indemnifications and enables us to recover a portion of any future loss arising out of them. In addition, in the normal course of business, we enter into contracts that contain indemnification clauses whereby the Company indemnifies our customers against damages associated with product failures. We have obtained liability insurance providing coverage that limits our exposure for these indemnified matters. Based on our historical experience and the estimated probability of future loss, we have determined that the estimated fair value of these indemnities is not material to our financial position or results of operations and have not recorded a liability for these agreements as of March 31, 2019. We had no other off-balance sheet arrangements during the three months ended March 31, 2019 or for the year ended December 31, 2018 that had, or are reasonably likely to have, a material effect on our financial condition, results of operations, or liquidity.

Contractual Obligations

There have been no material changes outside the ordinary course of business to our contractual obligations and commercial commitments since December 31, 2018.

Recent Accounting Pronouncements

See Note 1 to the unaudited condensed financial statements contained herein for a full description of recent accounting pronouncements including the respective expected dates of adoption and status of evaluation of expected effects on results of our operations and financial condition.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Foreign Currency Exchange Risk

We have foreign currency risks related to our revenue and operating expenses denominated in currencies other than the U.S. Dollar, principally the Japanese yen (“Yen”). The volatility of the Yen depends on many factors that we cannot forecast with reliable accuracy. We have experienced and will continue to experience fluctuations in our net income because of transaction gains (losses) related to revaluing Yen denominated accounts payable balances. In the event our Yen denominated accounts payable or expenses increase, our operating results may be affected by fluctuations in the Yen exchange rate. If the U.S. Dollar uniformly increased or decreased in strength by 10% relative to the Yen, our net income would have correspondingly increased or decreased by an immaterial amount for the three months ended March 31, 2019 and 2018.

Interest Rate Risk

When able, we invest excess cash in bank money-market funds, corporate debt securities or discrete short-term investments. The fair value of our cash equivalents and short-term investments is sensitive to changes in the general level of interest rates in the U.S., and the fair value of these investments will decline if market interest rates increase. As of March 31, 2019, we had $5.7 million in corporate bonds, with $3.0 million maturing in less than 1 year, $2.2 million maturing between 1 and 3 years and $0.5 million maturing between 3 and 5 years. These corporate bonds have fixed interest rates and semi-annual interest payment dates. If market interest rates were to change by 100 basis points from levels at March 31, 2019, we expect the corresponding change in fair value of our investments would be approximately $71,000. This is based on sensitivity analyses performed on our financial position as of March 31, 2019. Actual results may differ as our analysis of the effects of changes in interest rates does not account for, among other things, sales of securities prior to maturity and repurchase of replacement securities, the change in mix or quality of the investments in the portfolio, and changes in the relationship between short-term and long-term interest rates.

Table of Contents

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

We may from time to time become party to various legal proceedings or claims that arise in the ordinary course of business. Our management reviews these matters if and when they arise and believes that the resolution of any such matters currently known will not have a material effect on our results of operations or financial position.

Item 1A. Risk Factors

Risks Relating to Our Business and Financial Condition

Our financial performance is significantly dependent on a single product, and disruptions in our ability to sell this product may have a material adverse effect on our business.

Our current revenue and profitability is significantly dependent on the sale of the MRidium 3860+ MRI compatible IV infusion pump system (a Class II medical device) and the ongoing sale of disposable tubing sets and related services. Sales of the MRidium 3860+ MRI compatible IV infusion pump system have historically comprised a substantial majority of our net revenue. Although we have recently launched our marketing efforts for our new 3880 MRI compatible patient vital signs monitor in the U.S., our near-term revenue and profitability will be dependent upon our ability to successfully market and sell the MRidium 3860+ MRI compatible IV infusion pump system.

In the past, the FDA issued us a Warning Letter that impacted our ability to commercially distribute our MRidium 3860+ MRI compatible IV infusion pump system. Although we have resumed commercial distribution of the MRidium 3860+ MRI compatible IV infusion pump system, the Warning Letter remains open and there can be no guarantee that the FDA will not take similar action in the future. The FDA could require us to cease shipment of our products, notify health professionals and others that the devices present unreasonable risk or substantial harm to public health, order a recall, repair, replacement, or refund of the devices, detain or seize adulterated or misbranded medical devices, or ban the medical devices. The FDA may also issue further warning letters or untitled letters, refuse future requests for 510(k) submission or premarket approval, revoke existing 510(k) clearances or premarket approvals previously granted, impose operating restrictions, enjoin and restrain certain violations of applicable law pertaining to medical devices and assess civil or criminal penalties against our officers, employees, or us.

Our products could be rendered obsolete or economically impractical by numerous factors, many of which are beyond our control, including but not limited to:

· entrance of new competitors into our markets;

· technological advancements of MRI scanners;

· technological developments such as new imaging modalities which render MRI procedures obsolete or reduce the instances where MRI imaging is utilized;

· loss of key relationships with suppliers, group purchasing organizations, or end-user customers;

· manufacturing or supply interruptions;

· product liability claims;

· our reputation and product market acceptance;

· loss of existing regulatory approvals or the imposition of new requirements to maintain such approvals; and

· product recalls or safety alerts.

Any major factor adversely affecting the sale of our products or services would cause our revenues to decline and have a material adverse impact on our business, financial condition and our common stock.

Table of Contents

We have been subject to securities class action litigation and derivative litigation and we may be subject to similar or other litigation in the future.

In the past, following adverse action by the FDA or volatility in our stock price, securities class action litigation has been brought against us. There can be no assurance that we will not face other securities litigation in the future. With respect to any litigation, our insurance may not reimburse us or may not be sufficient to reimburse us for the expenses or losses we may suffer in contesting and concluding such lawsuits. A decision adverse to our interests on these actions or resulting from these matters could result in the payment of substantial damages and could have a material adverse effect on our business, financial condition and our common stock. Regardless of the outcome, these claims may result in injury to our reputation, significant costs, diversion of management’s attention and resources, and loss of revenue.

There is no assurance that our internal and external sources of liquidity will at all times be sufficient for our cash requirements.

We must have sufficient sources of liquidity to fund our working capital requirements, our capital improvement plans, and execute on our strategic initiatives. Our decline in operating results during 2017 limited our generation of capital resources and that situation could return if we are unable to continue to increase revenues or adjust our costs appropriately to changes in revenue. Further, future new product launches may demand increased working capital before any long-term return is realized from increased revenue. Our ability to achieve our business and cash flow plans is based on a number of assumptions which involve significant judgments and estimates of future performance, borrowing capacity and credit availability, which cannot at all times be assured. Accordingly, there is no assurance that cash flows from operations and other internal and external sources of liquidity will at all times be sufficient for our cash requirements. If necessary, we may need to consider actions and steps to improve our cash position and mitigate any potential liquidity shortfall, such as modifying our business plan, pursuing additional financing to the extent available, reducing capital expenditures, pursuing and evaluating other alternatives and opportunities to obtain additional sources of liquidity and other potential actions to reduce costs. There can be no assurance that any of these actions would be successful, sufficient or available on favorable terms. Any inability to generate or obtain sufficient levels of liquidity to meet our cash requirements at the level and times needed could have a material adverse impact on our business and financial position.

Our continued success depends on the integrity of our supply chain, including multiple single-source suppliers, the disruption of which could negatively impact our business.

Many of the component parts of our products are obtained through supply agreements with third parties. Some of these parts require our partners to engage in complex manufacturing processes and involve long lead times or delivery periods. Considering our dependence on third-party suppliers, several of which are single-source suppliers, we are subject to inherent uncertainties and risks related to their ability to produce or deliver parts on a timely basis, to comply with product safety and other regulatory requirements and to provide quality parts to us at a reasonable price.

For example, we are dependent upon a single vendor for the ultrasonic motor at the core of our MRidium MRI compatible IV infusion pump. If this vendor fails to meet our volume requirements, which we anticipate will increase over time, or if the vendor becomes unable or unwilling to continue supplying motors to us, this would impact our ability to supply our pumps to customers until a replacement source is secured. Our executed agreement with this vendor provides that the price at which we purchase products from the vendor is determined by agreement from time to time or should material costs change. Although we have had a long history of stable pricing with this supplier, this provision may make it difficult for us to continue to receive motors from this vendor on favorable terms or at all if we do not agree on pricing in the future. In such event, it could materially and adversely affect our commercial activities, operating results and financial condition.

In the near term, we do not anticipate finding alternative sources for our primary suppliers, including single source suppliers. Therefore, if our primary suppliers become unable or unwilling to manufacture or deliver materials, or manufacture or deliver such materials later than anticipated, we could experience protracted delays or interruptions in the supply of materials which would ultimately delay our manufacture of products for commercial sale, which could materially and adversely affect our development programs, commercial activities, operating results and financial condition.

Additionally, any failure by us to forecast demand for, or to maintain an adequate supply of raw materials, parts, or finished products, could result in an interruption in the supply of certain products and a decline in our sales.

Table of Contents

We rely on third-party suppliers for certain of our raw materials and components.

We rely on unaffiliated third-party suppliers for certain raw materials and components necessary for the manufacturing and operation of our products. Certain of those raw materials and components are proprietary products of those unaffiliated third-party suppliers and are specifically cited in our applications with regulatory agencies so that they must be obtained from that specific sole source or sources and could not be obtained from another supplier unless and until an appropriate application amendment is approved by the regulatory agency. For example, the non-magnetic ultrasonic motor which drives our MRI compatible IV infusion pump is sole-sourced from a major multinational Japanese manufacturing company.

Among the reasons we may be unable to obtain these raw materials and components include, but are not limited to:

· a supplier’s inability or unwillingness to continue supplying raw materials and/or components;

· regulatory requirements or action by regulatory agencies or others, including changes in international trade treaties and/or tariffs;

· adverse financial or other strategic developments at or affecting the supplier, including bankruptcy;

· unexpected demand for or shortage of raw materials or components;

· failure of the supplier to comply with quality standards which results in quality and product failures, product contamination and/or recall;

· discovery of previously unknown or undetected imperfections in raw materials or components;

· labor disputes or shortages, including from the effects of health emergencies and natural disasters; and

· political instability and actual or anticipated military or political conflicts.

These events could negatively impact our ability to satisfy demand for our products, which could have a material adverse effect on our product use and sales and our business and results of operations. We may experience these or other shortages in the future resulting in delayed shipments, supply constraints, contract disputes and/or stock-outs of our products.

The manufacture of our products requires strict adherence to regulatory requirements governing medical devices and if we or our suppliers encounter problems our business could suffer.

The manufacture of our products must comply with strict regulatory requirements governing Class II medical devices in the U.S. and other regulatory requirements in foreign locations. Problems may arise during manufacturing, quality control, storage or distribution of our products for a variety of reasons, including equipment malfunction, failure to follow specific protocols and procedures, manufacturing quality concerns, or problems with raw materials, electromechanical, software and other components, supplier issues, and natural disasters. If problems arise during production, the affected products may have to be discarded. Manufacturing problems or delays could also lead to increased costs, lost sales, damage to customer relations, failure to supply penalties, time and expense spent investigating the cause and, depending on the cause, similar losses with respect to other batches of products. If problems are not discovered before the product is released to the market, voluntary recalls, corrective actions or product liability related costs may also be incurred. Should we encounter difficulties in the manufacture of our products or be subject to a product recall, our business could suffer materially.

Our markets are very competitive and we sell certain of our products in a mature market.

The market for our 3880 MRI compatible patient vital signs monitoring system is well-developed and sales growth for our monitor could be slow. Our vital signs monitoring system could face difficult competition, including competitors offering lower prices, which could have an adverse effect on our revenue and margins. Our competitors may have certain advantages, which include the ability to devote greater resources to the development, promotion, and sale of their products. Consequently, we may need to increase our efforts, and related expenses for research and development, marketing, and selling to maintain or improve our position. We may not realize the per unit revenue we have planned for and expect. Continued sales to our existing customers is expected to be significant to our revenue in the future, and if our existing customers do not continue to purchase from us, our revenue may decline.

Table of Contents

We manufacture and store our products at a single facility in Florida.

We manufacture and store our products at a single facility in Winter Springs, Florida. If by reason of fire, hurricane or other natural disaster, or for any other reason, the facility is destroyed or seriously damaged or our access to it is limited, our ability to provide products to our customers would be seriously interrupted or impaired and our operating results and financial condition would be materially and negatively affected.

Our inability to collect on our accounts receivables held by customers may have an adverse effect on our business operations and financial condition.

We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses. From time to time, we have had, and may in the future have, accounts receivables from one or more customers that accounted for 10 percent or more of our gross accounts receivable. As a result, we may be exposed to a certain level of concentration of credit risk. If a major customer experiences financial difficulties, the effect on us could be material and have an adverse effect on our business, financial condition and results of operations.

If we fail to maintain relationships with Group Purchasing Organizations, sales of our products could decline.

Our ability to sell our products to U.S. hospitals, acute care facilities and outpatient imaging centers depends in part on our relationships with Group Purchasing Organizations (“GPOs”). Many existing and potential customers for our products are members of GPOs. GPOs negotiate pricing arrangements and contracts, which are sometimes exclusive, with medical supply manufacturers and distributors, and these negotiated prices are made available to a GPO’s affiliated hospitals and other members. We pay the GPOs an administrative fee in the form of a percentage of the volume of products sold to their affiliated hospitals and other members. If we are not an approved provider selected by a GPO, affiliated hospitals and other members may be less likely to purchase our products. Should a GPO negotiate a sole source or bundling contract covering a future or current competitor’s products, we may be precluded from making sales of our competing products to members of that GPO for the duration of the contractual arrangement. For example, even if we have an existing contract with a GPO for sales of our MRidium 3860+ MRI compatible IV infusion pump, we may encounter difficulties in selling, or be unable to sell, our 3880 MRI compatible patient vital signs monitoring system to that GPO’s affiliated hospitals and other members, which may result in a longer sales cycle or an inability to sell. Our failure to renew contracts with GPOs may cause us to lose market share and could have a material adverse effect on our sales, financial condition and results of operations. In the future, if another competitive supplier emerges, and we fail to keep our relationships and develop new relationships with GPOs, our competitive position would likely suffer.

Cost-containment efforts of our customers and purchasing groups could adversely affect our sales and profitability.

Our MRI compatible medical devices are considered capital equipment by many potential customers, and hence changes in the budgets of healthcare organizations and the timing of spending under these budgets and conflicting spending priorities can have a significant effect on the demand for our products and related services. Any decrease in expenditures by these healthcare facilities could decrease demand for our products and related services and reduce our revenue. Additionally, changes to reimbursement policies by third-party payors could also decrease demand for our products and related services and reduce our revenue.

Any failure in our efforts to educate clinicians, anesthesiologists, radiologists, and hospital administrators regarding the advantages of our products could significantly limit our product sales.

We believe our future success will require us to educate a sufficient number of clinicians, anesthesiologists, radiologists, hospital administrators and other purchasing decision-makers about our products and the costs and benefits of our products. If we fail to demonstrate the safety, reliability and economic benefits of our products to hospitals and acute medical facilities, our products may not be adopted and our expected and actual sales would suffer.

The lengthy sales cycle for medical devices could delay our sales.

The decision-making process of customers is often complex and time-consuming. Based on our experience, we believe the period between initial discussions with customers regarding our products and a customer’s purchase of our products is typically three to six months. Sales cycles can also be delayed because of capital budgeting procedures. Moreover, even if one or two units are sold to a hospital, we believe that it will take additional time and experience with our products before other medical professionals routinely use them for other procedures and in other departments of the hospital. Such time would delay potential sales of additional units and disposable products or additional optional accessories to that medical facility or hospital. These delays could have an adverse effect on our business, financial condition and results of operations.

Table of Contents

Because we rely on distributors to sell our products outside of the U.S., our revenues could decline if our existing distributors do not continue to purchase products from us or if our relationship with any of these distributors is terminated.

We rely on distributors for all our sales outside the U.S. and hence do not have direct control over foreign sales activities. These distributors also assist us with regulatory approvals and the education of physicians and government agencies. Our revenues outside the U.S. have historically represented approximately one-tenth to one-third of our net revenues. If our existing international distributors fail to sell our products or sell at lower levels than we anticipate, we could experience a decline in revenues or fail to meet our forecasts. We cannot be certain that we will be able to attract new international distributors nor retain existing ones that market our products effectively or provide timely and cost-effective customer support and service. None of our existing distributors are obligated to continue selling our products.

If we do not successfully develop and commercialize enhanced products or new products that remain competitive, we could lose revenue opportunities and customers, and our ability to achieve growth would be impaired.

The medical device industry is characterized by rapid product development and technological advances, which places our products at risk of obsolescence. Our long-term success depends upon the development and successful commercialization of new products, new or improved technologies and additional applications for MRI compatible infusion, therapeutic, diagnostic and safety products and services. The research and development process is time-consuming and costly and may not result in products or applications that we can successfully commercialize. If we do not successfully adapt our technology, products and applications, we could lose revenue opportunities and customers. In addition, we may not be able to improve our products or develop new products or technologies quickly enough to maintain a competitive position in our markets and continue to grow our business.

We are highly dependent on our founder, CEO, President, Chairman and controlling shareholder, Roger Susi.

We believe that Mr. Susi will play a significant role in our continued success and in the development of new products. Our current and future operations could be adversely impacted if we were to lose his services. Accordingly, our success will be dependent on appropriately managing the risks related to executing a succession plan for Mr. Susi on a timely basis.

If we fail to attract and retain the talent required for our business, our business could be materially harmed.

Competition for highly skilled personnel is often intense in the medical device industry, including in the MRI compatible medical device segment. If our current employees with experience in the MRI compatible device industry leave our company, we may have difficulty finding replacements with an equivalent amount of experience and skill, which could harm our operations. Our future success will also depend in part on our ability to identify, hire and retain additional personnel, including skilled engineers to develop new products, and executives to oversee our marketing, sales, customer support and production staff. We may not be successful in attracting, integrating or retaining qualified personnel to meet our current growth plans or future needs. Our productivity may be adversely affected if we do not integrate and train our new employees quickly and effectively.

We may also have difficulty finding and retaining qualified Board members. Any failure to do so could be perceived negatively and could adversely affect our business.

Also, to the extent we hire personnel from competitors, we may be subject to allegations that we have improperly solicited, or that they have divulged proprietary or other confidential information, or that their former employers own their inventions or work product.

We may be unable to scale our operations successfully.

We are working to expand our size and scale via more penetration of existing markets and the launch of new complementary products. This growth, if it occurs as planned, will place significant demands on our management and manufacturing capacity, as well as our financial, administrative and other resources. We cannot guarantee that any of the personnel, systems, procedures and controls we put in place will be adequate to support the manufacture and distribution of our products. Our operating results will depend substantially on the ability of our officers and key employees to manage changing business conditions and to implement and improve our financial and administrative systems and manage other resources. If we are unable to respond to and manage changing business conditions, or the scale of our products, services and operations, then the quality of our services, our ability to retain key personnel and our business could be harmed.

Table of Contents

We engage in related party transactions, which result in a conflict of interest involving our management.

We have engaged in the past, and continue to engage, in related party transactions, particularly between our company and Roger Susi and his affiliates. The only significant ongoing related party transaction is the lease agreement between our company and Susi, LLC, an affiliate of Roger Susi, with respect to our sole production and headquarters facility in Winter Springs, Florida. Related party transactions present difficult conflicts of interest, could result in disadvantages to our company and may impair investor confidence, which could materially and adversely affect us. Related party transactions could also cause us to become materially dependent on related parties in the ongoing conduct of our business, and related parties may be motivated by personal interests to pursue courses of action that are not necessarily in the best interests of our company and our stockholders.

Any acquisitions of technologies, products and businesses, may be difficult to integrate, could adversely affect our relationships with key customers, and/or could result in significant charges to earnings.

We plan to periodically review potential acquisitions of technologies, products and businesses that are complementary to our products and that could accelerate our growth. However, our company has never completed an acquisition and there can be no assurance that we will be successful in finding any acquisitions in the future. The process of identifying, executing and realizing attractive returns on acquisitions involves a high degree of uncertainty. Acquisitions typically entail many risks and could result in difficulties in integrating operations, personnel, technologies and products. If we are not able to successfully integrate our acquisitions, we may not obtain the advantages and synergies that the acquisitions were intended to create, which may have a material adverse effect on our business, results of operations, financial condition and cash flows, our ability to develop and introduce new products and the market price of our stock.

The environment in which we operate makes it increasingly difficult to accurately forecast our business performance.

Significant changes and volatility in most aspects of the current business environment, including financial markets, consumer behavior, speed of technological, regulatory and competitive changes, make it increasingly difficult for us to predict our revenues and earnings into the future. Our quarterly sales and profits depend substantially on the volume and timing of orders fulfilled during the quarter, and such orders are difficult to forecast. Product demand is dependent upon the capital spending budgets of our customers and prospects as well as government funding policies, and matters of public policy as well as product and economic cycles that can affect the spending decisions of these entities. As a result, any revenue, earnings or financial guidance or outlook which we have given or might give may turn out to be inaccurate. Though we will endeavor to give reasonable estimates of future revenues, earnings and financial information at the time we give such guidance, based on then-current conditions, there is a significant risk that such guidance or outlook will turn out to be incorrect. Historically, companies that have overstated their operating guidance have suffered significant declines in their stock price when such results are announced to the public.

There are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance with United States Generally Accepted Accounting Principles (“GAAP”). Furthermore, portions of GAAP require the use of fair value models which are variable in application and methodology from appraiser to appraiser. Any changes in estimates, judgments and assumptions used could have a material adverse effect on our business, financial position and operating results.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such assumptions and estimates include those related to revenue recognition, accruals for product returns, valuation of inventory, impairment of intangibles and long-lived assets, accounting for income taxes and stock-based compensation and allowances for uncertainties. These factors are also influenced by regular changes to GAAP, some of which are material to most companies, such as recent changes to revenue recognition. These changes introduce risk to our financial reporting processes due to implementation and internal control implications.

We base the aforementioned estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, as discussed in greater detail in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Our actual operating results may differ and fall below our assumptions and the financial forecasts of securities analysts and investors, resulting in a significant decline in our stock price.

Our adoption and implementation of the new revenue accounting standard on January 1, 2018 included management’s judgments and assumptions based on our interpretation of the new standard. The new revenue standard is principle based and interpretation of those principles may vary from company to company based on their unique circumstances. If our initial judgments and assumptions require change or if actual circumstances differ from our assumptions, our operating results may be adversely affected and could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our common stock.

Table of Contents

Changes in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our results.

On December 22, 2017, President Trump signed into law new legislation that significantly revised the Internal Revenue Code of 1986, as amended. The newly enacted federal income tax law, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of adjusted earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year taxable income and elimination of net operating loss carrybacks, one time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits. Notwithstanding the reduction in the corporate income tax rate, the overall impact of the new federal tax law, including potential U.S. state and foreign tax jurisdiction responses, is uncertain and our business and financial condition could be adversely affected.

In addition, we are subject to the continuous examination of our income tax returns by the Internal Revenue Service, or IRS, and other tax authorities. It is possible that tax authorities may disagree with certain positions we have taken, and any adverse outcome of such a review or audit could have a negative effect on our financial position and operating results. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes, but the determination of our provision for income taxes and other tax liabilities requires significant judgment by management, and there are transactions where the ultimate tax determination is uncertain. Although we believe that our estimates are reasonable, the ultimate tax outcome may differ from the amounts recorded in our financial statements and may materially affect our financial results in the period or periods for which such determination is made. There can be no assurance that the outcomes from continuous examinations will not have an adverse effect on our business, financial condition, and results of operations.

We are subject to various privacy and consumer protection laws.

Our privacy policy is posted on our website, and any failure by us or our vendor or other business partners to comply with it or with federal, state or international privacy, data protection or security laws or regulations could result in regulatory or litigation-related actions against us, legal liability, fines, damages and other costs. Substantial expenses and operational changes may be required in connection with maintaining compliance with such laws, and in particular certain emerging privacy laws are still subject to a high degree of uncertainty as to their interpretation and application. For example, in May 2018, the General Data Protection Regulation (the “GDPR”) began to fully apply to the processing of personal information collected from individuals located in the European Union. The GDPR has created new compliance obligations and has significantly increased fines for noncompliance. Although we take steps to protect the security of our customers’ personal information, we may be required to expend significant resources to comply with data breach requirements if third parties improperly obtain and use the personal information of our customers or we otherwise experience a data loss with respect to customers’ personal information. A breach of our network security and systems could have negative consequences for our business and future prospects, including possible fines, penalties and damages, reduced customer demand for our products, and harm to our reputation and brand.

Political and economic uncertainty arising from the outcome of the United Kingdom’s referendum on its membership in the European Union could adversely affect our business and results of operations.

On June 23, 2016, the United Kingdom (UK) held a referendum in which voters approved a withdrawal from the European Union (EU), commonly referred to as “Brexit.” The timing of the UK’s exit from the EU remains uncertain; the EU has extended the deadline for the UK to exit the EU until October 31, 2019. The terms of the withdrawal are subject to ongoing negotiation that has created significant uncertainty about the future relationship between the UK and the EU. It is possible that the level of economic activity in this region will be adversely impacted and that there will be increased regulatory and legal complexities, including those relating to tax, trade, security and employees. In addition, Brexit could lead to economic uncertainty, including significant volatility in global stock markets and currency exchange rates, which may adversely impact our business. Although the specific terms and the timeframe of the negotiations are unknown, it is possible that these changes could adversely affect our business and results of operations. To attempt to reduce the impact of a potential Brexit on our ability to sell our products in the EU, we have changed from a UK-based notified body, UL International Ltd. (“UL”), to the Polish Center for Testing and Certification (Polskie Centrum Badań i Certyfikacji S.A.) based in Warsaw, Poland.

Table of Contents

Risks Related to Our Industry

We are subject to substantial government regulation that is subject to change and could force us to make modifications to how we develop, manufacture, market and price our products.

The medical device industry is regulated extensively by governmental authorities, principally the FDA in the U.S. and corresponding state and foreign regulatory agencies. The majority of our manufacturing processes are required to comply with quality systems regulations, including current good manufacturing practice requirements that cover the methods and documentation of the design, testing, production, control, quality assurance, labeling, packaging and shipping of our products. Failure to comply with applicable medical device regulatory requirements could result in, among other things, warning letters, fines, injunctions, civil penalties, repairs, replacements, refunds, recalls or seizures of products, total or partial suspensions of production, refusal of the FDA or other regulatory agencies to grant pre-market clearances or approvals for our products, withdrawals or suspensions of future or current clearances or approvals and criminal prosecution.

In addition, our products are subject to pre-clearance requirements by the FDA and similar international agencies that govern a wide variety of product activities from design and development to labeling, manufacturing, promotion, sales and distribution. Compliance with these regulations may be time consuming, burdensome and expensive for us. The failure to obtain, or the loss or suspension of any such pre-approval, would negatively affect our ability to sell our products and harm our anticipated revenues.

Foreign governmental authorities that regulate the manufacture and sale of medical devices have become increasingly stringent and, to the extent we sell our products in foreign countries, we may be subject to rigorous regulation in the future. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated revenue.

On January 16, 2019, we were notified by the U.K. Notified Body, UL International Ltd. (“UL”) that their recent technical file review of our 3880 MRI compatible patient vital signs monitoring system could not be completed as aspects of clinical evaluation reporting, as required by newly issued guidance from the European Union, was not acceptable, resulting in a technical non-conformity. Accordingly, UL issued a temporary EC Certificate that excludes our 3880 patient vital signs monitoring system. This temporary EC Certificate extends through July 27, 2019. We immediately suspended shipments of our 3880 patient vital signs monitor to all markets requiring a CE Mark. We are addressing the technical non-conformity and plan to be permitted to use the CE Mark on our 3880 patient vital signs monitoring system, but there can be no assurance that these efforts will be successful.

If we fail to obtain, or experience significant delays in obtaining, FDA clearances or other necessary approvals to commercially distribute new products, our ability to maintain profitability or grow will suffer.

Our current products are Class II medical devices and hence require regulatory pre-market approval by the FDA and other federal and state authorities prior to their sale in the U.S. Similar approvals are required by foreign governmental authorities for sale of our products outside of the U.S., including the EU. We are responsible for obtaining the applicable regulatory approval for the commercial distribution of our products. As part of our strategy, we plan to seek approvals for new MRI compatible products. The process of obtaining approvals, particularly from the FDA, is costly and time consuming, and there can be no assurance that we will obtain the required approvals on a timely basis, or at all. Failure to receive approvals for new products will hurt our ability to grow.

We are subject to risks associated with doing business outside of the U.S.

Sales to customers outside of the U.S. have historically comprised of approximately one-tenth to one-third of our net revenues and we expect that non-U.S. sales will contribute to future growth. A majority of our international sales originate from Europe and Japan, and we also make sales in Canada, Hong Kong, Australia, Mexico and certain parts of the Middle East. The risks associated with operations outside the U.S. include:

· foreign regulatory and governmental requirements that could change and restrict our ability to manufacture and sell our products;

· possible failure to comply with anti-bribery laws such as the U.S. Foreign Corrupt Practices Act and similar anti-bribery laws in other jurisdictions;

· foreign currency fluctuations that can impact our financial statements when foreign denominations are translated into U.S. dollars;

· different local product preferences and product requirements, which might increase with increasing nationalism;

Table of Contents

· trade protection and restriction measures under international trade treaties and via tariffs, and import or export licensing requirements;

· difficulty in establishing, staffing and managing non-U.S. operations;

· failure to maintain relationships with distributors, especially those who have assisted with foreign regulatory or government clearances;

· changes in labor, environmental, health and safety laws;

· potentially negative consequences from changes in or interpretations of tax laws, including U.S. state and foreign tax jurisdiction responses to recent changes in U.S. federal tax laws;

· political instability and actual or anticipated military or political conflicts, including instability related to war and terrorist attacks and to political matters such as Brexit;

· economic instability, inflation, deflation, recession or interest rate fluctuations;

· uncertainties regarding judicial systems and procedures; and

· minimal or diminished protection of intellectual property.

These risks, individually or in the aggregate, could have an adverse effect on our results of operations and financial condition.

We may incur product liability losses, or become subject to other lawsuits related to our products, business, and insurance coverage could be inadequate or unavailable to cover these losses.

Our business is subject to potential product liability risks that are inherent in the design, development, manufacture and marketing of our medical devices and consumable products. We carry third-party product liability insurance coverage to protect against such risks, but there can be no assurance that our policy is adequate. In the ordinary course of business, we may become the subject of product liability claims and lawsuits alleging that our products have resulted or could result in an unsafe condition or injury to patients. Any product liability claim brought against us, with or without merit, could be costly to defend and could result in settlement payments and adjustments not covered by or in excess of our product liability insurance. We currently have third-party product liability insurance with maximum coverage of $5,000,000; however, such coverage requires a substantial deductible that we must pay before becoming eligible to receive any insurance proceeds. The deductible amount is currently equal to $25,000 per occurrence and $125,000 in the aggregate. We will have to pay for defending product liability or other claims that are not covered by our insurance. These payments could have a material adverse effect on our profitability and financial condition. Product liability claims and lawsuits, safety alerts, recalls or corrective actions, regardless of their ultimate outcome, could have a material adverse effect on our business, financial condition, reputation and on our ability to attract and retain customers. In addition, we may not be able to obtain insurance in the future on terms acceptable to us or at all.

Defects or failures associated with our products and/or our quality control systems could lead to the filing of adverse event reports, recalls or safety alerts and negative publicity and could subject us to regulatory actions.

Safety problems associated with our products could lead to a product recall or the issuance of a safety alert relating to such products and result in significant costs and negative publicity. An adverse event involving one of our products could require us to file an adverse event report with the FDA. Such disclosure could result in reduced market acceptance and demand for all our products, and could harm our reputation and our ability to market our products in the future. In some circumstances, adverse events arising from or associated with the design, manufacture or marketing of our products could result in the suspension or delay of regulatory reviews of our applications for new product approvals or clearances.

We may also voluntarily undertake a recall of our products or temporarily shut down production lines based on internal safety, quality monitoring and testing data. To avoid future product recalls we have made and continue to invest in our quality systems, processes and procedures. We will continue to make improvements to our products and systems to further reduce issues related to patient safety.

Table of Contents

However, there can be no assurance our efforts or systems will be sufficient. Future quality concerns, whether real or perceived, could adversely affect our operating results.

Our products or product types, or MR imaging could be subject to negative publicity, which could have a material adverse effect on our financial position and results of operations and could cause the market value of our common stock to decline.

The market’s perception of our products could be harmed if any of our products or similar products offered by others in our industry become the subject of negative publicity due to a product safety issue, withdrawal, recall, or are proven or are claimed to be harmful to patients. The harm to market perception may have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

Our products are designed for use around MRI scanners. MRI has been an important imaging diagnostic for some time now, however should MRI technology change materially or decline in usage due to new technologies or concerns about costs or efficacy of MR imaging, our products would suffer as MRI usage and installations declined. Such a matter may also have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

U.S. healthcare policy and changes thereto, including the Affordable Care Act and PPACA, may have a material adverse effect on our financial condition and results of operations.

The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively, the “PPACA”), enacted in 2010, implemented changes that significantly impacted the medical device industry. Beginning on January 1, 2013, the Affordable Care Act imposed a 2.3 percent excise tax on sales of products defined as “medical devices” by the regulations of the FDA. We believe that all our current products are “medical devices” within the meaning of the FDA regulations. On December 18, 2015, under the Consolidated Appropriations Act of 2015, the medical device excise tax was suspended for two years beginning on January 1, 2016. New legislation passed in January 2018 further suspended the medical device excise tax through December 31, 2019. While this tax was suspended by legislation for 2018 and 2019, its return beginning on January 1, 2020 and potential increases from the 2.3 percent level in future years would negatively impact our operating results. We cannot currently foresee that the suspension will be reinstated.

Other significant measures contained in the PPACA include research on the comparative clinical effectiveness of different technologies and procedures, initiatives to revise Medicare payment methodologies, such as bundling of payments across the continuum of care by providers and physicians, and initiatives to promote quality indicators in payment methodologies. The PPACA also includes significant new fraud and abuse measures, including required disclosures of financial payments to and arrangements with physician customers, lower thresholds for violations and increasing potential penalties for such violations.

Since its enactment, there have been judicial and Congressional challenges to certain aspects of PPACA. In January 2017, Congress voted to adopt a budget resolution for fiscal year 2017, or the Budget Resolution, that authorizes the implementation of legislation that would repeal portions of PPACA. The Budget Resolution is not a law; however, it was widely viewed as the first step toward the passage of legislation that would repeal certain aspects of PPACA. Further, on January 20, 2017, President Trump signed an Executive Order directing federal agencies with authorities and responsibilities under PPACA to waive, defer, grant exemptions from, or delay the implementation of any provision of PPACA that would impose a fiscal or regulatory burden on states, individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. In addition, with enactment of the Tax Cuts and Jobs Act of 2017, in December 2017, Congress repealed the “individual mandate” portion of PPACA. The repeal of this provision, which requires most Americans to carry a minimal level of health insurance, became effective in January 2019. The potential impact of these efforts to repeal or defer and delay enforcement of PPACA on our business remains unclear. Congress also could consider subsequent legislation to replace elements of PPACA that are repealed. Because of the continued uncertainty about the implementation of the PPACA, including the potential for further legal challenges or repeal of PPACA, we cannot quantify or predict with any certainty the likely impact of the PPACA or its repeal on our business, prospects, financial condition or results of operations.

We are subject to healthcare fraud and abuse regulations that could result in significant liability, require us to change our business practices and restrict our operations in the future.

We and our customers are subject to various U.S. federal, state and local laws targeting fraud and abuse in the healthcare industry, including anti-kickback and false claims laws. Violations of these laws are punishable by criminal or civil sanctions, including substantial fines, imprisonment and exclusion from participation in healthcare programs such as Medicare and Medicaid, and Veterans’ Administration health programs and health programs outside the U.S. These laws and regulations are broad in scope and are subject to evolving interpretations, which could require us to alter one or more of our sales or marketing practices. In addition, violations of these laws, or allegations of such violations, could disrupt our business and result in a material adverse effect on our sales, profitability and financial condition. Furthermore, since many of our customers rely on reimbursement from Medicare, Medicaid and other governmental programs to cover a substantial portion of their expenditures, if we or our customers are excluded from such programs as a result of a violation of these laws, it could have an adverse effect on our results of operations and financial condition.

Table of Contents

We have developed and implemented business practices and processes to train our personnel to perform their duties in compliance with healthcare fraud and abuse laws and conduct informal oversight to detect and prevent these types of fraud and abuse. However, we lack formal written policies and procedures at this time. If we are unable to formally document and implement the controls and procedures required in a timely manner or we are otherwise found to be in violation of such laws, we might suffer adverse regulatory consequences or face criminal sanctions, which could harm our operations, financial reporting or financial results.

We could be adversely affected by violations of the U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws.

The U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws generally prohibit companies and their intermediaries from making improper payments to non-U.S. officials for the purpose of obtaining or retaining business. We intend to adopt policies for compliance with these anti-bribery laws, which often carry substantial penalties.

We cannot assure you that our internal control policies and procedures always will protect us from reckless or other inappropriate acts committed by our affiliates, employees or agents. Violations of these laws, or allegations of such violations, could have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

We and our suppliers and customers are required to obtain regulatory approvals to comply with regulations applicable to medical devices and infusion pumps, and these approvals could result in delays or increased costs in developing new products.

In December 2014, the FDA issued guidance entitled “Infusion Pumps Total Product Life Cycle.” This guidance established substantial additional pre-market requirements for new and modified infusion pumps. Through this guidance, the FDA indicated more data demonstrating product safety will be required for future 510(k) submissions for infusion pumps, including the potential for more clinical and human factors data. The process for obtaining regulatory approvals to market infusion pumps and related accessories have become more costly and time consuming. The impact of this guidance is likely to result in a more time consuming and costly process to obtain regulatory clearance to market infusion pumps. In addition, new requirements could result in longer delays for the clearance of new products, modification of existing infusion pump products or remediation of existing products in the market. Future delays in the receipt of, or failure to obtain, approvals could result in delayed or no realization of product revenues.

We and our suppliers and customers are required to maintain compliance with regulations applicable to medical devices and infusion pumps, and it could be costly to comply with these regulations and to develop compliant products and processes. Failure to comply with these regulations could subject us to sanctions and could adversely affect our business.

Even if we are able to obtain approval for introducing new products to the market, we and our suppliers may not be able to remain in compliance with applicable FDA and other material regulatory requirements once clearance or approval has been obtained for a product. These requirements include, among other things, regulations regarding manufacturing practices, product labeling, off-label marketing, advertising and post-marketing reporting, adverse event reports and field alerts. Compliance with these FDA requirements is subject to continual review and is monitored through periodic inspections by the FDA. For example, the FDA conducted routine inspections of our facility in Winter Springs, Florida in July 2016. The FDA issued a Form 483 on July 18, 2016 resulting from an inspection of our facility between July 11 and July 18, 2016 that identified three observations. These observations were related to procedural and documentation issues associated with the CAPA system, vendor requirements and complaint investigation. This was the first FDA inspection of our facility since the receipt of the Warning Letter.

We submitted responses to the Form 483 in August 2016 and October 2016 in which we described our proposed corrective and preventative actions to address each of the observations. As part of our response, on October 13, 2016 we initiated a customer follow up to our August 2012 Safety Alert, and made available an updated instruction card for customers. As of March 31, 2019, the Safety Alert remains open.

During the July 2016 inspection, updated documents and actions implemented in response to the Warning Letter findings were reviewed, and the FDA determined that no further actions were necessary in response to the Warning Letter. As of March 31, 2019, the Warning Letter remains open.

In addition, manufacturing flaws, component failures, design defects, off-label uses or inadequate disclosure of product related information could result in an unsafe condition or the injury or death of a patient. All of these events could harm our sales, margins and profitability in the affected periods and may have a material adverse effect on our business. Any adverse regulatory action or action taken by us to maintain appropriate regulatory compliance, with respect to these laws and regulations could disrupt our business and have a material adverse effect on our sales, profitability and financial condition. Furthermore, an adverse regulatory action with respect to any of our products or operating procedure or to our, or our suppliers’ manufacturing facility could materially harm our reputation in the marketplace.

Table of Contents

Our operations are subject to environmental laws and regulations, with which compliance is costly and which exposes us to penalties for non-compliance.

Our business, products, and product candidates are subject to federal, state, and local laws and regulations relating to the protection of the environment, worker health and safety and the use, management, storage, and disposal of hazardous substances, waste, and other regulated materials. These environmental laws and regulations could require us to pay for environmental remediation and response costs at third-party locations where we dispose of or recycle hazardous substances. The costs of complying with these various environmental requirements, as they now exist or as may be altered in the future, could adversely affect our financial condition and results of operations.

Risks Relating to our Intellectual Property

Our success depends on our ability to protect our intellectual property.

We intend to rely on a combination of patents, trademarks, trade secrets, know-how, license agreements and contractual provisions to establish and protect our proprietary rights to our technologies and products. We cannot guarantee that the steps we have taken or will take to protect our intellectual property rights will be adequate or that they will deter infringement, misappropriation or violation of our intellectual property. We may fail to secure patents that are important to our business, and we cannot guarantee that any pending U.S. trademark or patent application, if ultimately issued, will provide us some relative competitive advantage. Litigation may be necessary to enforce our intellectual property rights and to determine the validity and scope of our proprietary rights.

Any litigation could result in substantial expenses and may not adequately protect our intellectual property rights. In addition, the laws of some of the countries in which our products may in the future be sold may not protect our products and intellectual property to the same extent as U.S. laws, or at all. We may be unable to protect our rights in trade secrets and unpatented proprietary technology in these countries. If our trade secrets become known, we may lose our competitive advantages.

Even if we are able to secure necessary patents in the U.S., we may not be able to secure necessary patents and trademarks in foreign countries in which we sell our products or plan to sell our products. In 2013, the U.S. transitioned to a “first inventor to file” system for patents in which, assuming the other requirements for patentability are met, the first inventor to file a patent application is entitled to a patent. We may be subject to a third-party pre-issuance submission of prior art to the U.S. Patent and Trademark Office, or become involved in opposition, derivation, reexamination, inter parties review or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate our patent rights, allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third party patent rights.

Our unpatented trade secrets, know-how, confidential and proprietary information, and technology may be inadequately protected.

We rely on unpatented trade secrets, know-how and technology. This intellectual property is difficult to protect, especially in the medical device industry, where much of the information about a product must be submitted to regulatory authorities during the regulatory approval process. We seek to protect trade secrets, confidential information and proprietary information, in part, by entering into confidentiality and invention assignment agreements with employees, consultants, and others. These parties may breach or terminate these agreements, and we may not have adequate remedies for such breaches. Furthermore, these agreements may not provide meaningful protection for our trade secrets or other confidential or proprietary information or result in the effective assignment to us of intellectual property, and may not provide an adequate remedy in the event of unauthorized use or disclosure of confidential information or other breaches of the agreements. Despite our efforts to protect our trade secrets and our other confidential and proprietary information, we or our collaboration partners, board members, employees, consultants, contractors, or scientific and other advisors may unintentionally or willfully disclose our proprietary information to competitors.

There is a risk that our trade secrets and other confidential and proprietary information could have been, or could, in the future, be shared by any of our former employees with, and be used to the benefit of, any company that competes with us.

If we fail to maintain trade secret protection or fail to protect the confidentiality of our other confidential and proprietary information, our competitive position may be adversely affected. Competitors may also independently discover our trade secrets. Enforcement of claims that a third party has illegally obtained and is using trade secrets is expensive, time consuming and uncertain. If our competitors independently develop equivalent knowledge, methods and know-how, we would not be able to effectively assert our trade secret protections against them, which could have a material adverse effect on our business.

Table of Contents

There can be no assurance of timely patent review and approval to minimize competition and generate sufficient revenues.

There can be no assurance that the Patent and Trademark Office will have sufficient resources to review our patent applications in a timely manner. Consequently, even if our patent applications are ultimately successful, our patent applications may be delayed, which would prevent intellectual property protection for our products. If we fail to successfully commercialize our products due to the lack of intellectual property protection, we may be unable to generate sufficient revenues to meet or grow our business according to our expected goals and this may have a materially adverse effect on our profitability, financial condition, and operations.

We may become involved in patent litigation or other intellectual property proceedings relating to our future product approvals, which could result in liability for damages or delay or stop our development and commercialization efforts.

The medical device industry has been characterized by significant litigation and other proceedings regarding patents, patent applications, and other intellectual property rights. The situations in which we may become parties to such litigation or proceedings may include any third parties (which may have substantially greater resources than we have) initiating litigation claiming that our products infringe their patent or other intellectual property rights; in such case, we will need to defend against such proceedings.

The large number of patents, the rapid rate of new patent applications and issuances, the complexities of the technologies involved and the uncertainty of litigation significantly increase the risks related to any patent litigation. Any potential intellectual property litigation also could force us to do one or more of the following:

· stop selling, making, or using products that use the disputed intellectual property;

· obtain a license from the intellectual property owner to continue selling, making, licensing, or using products, which license may require substantial royalty payments and may not be available on reasonable terms, or at all;

· pay substantial damages or royalties to the party whose intellectual property rights we may be found to be infringing;

· pay the attorney fees and costs of litigation to the party whose intellectual property rights we may be found to be infringing; or

· redesign those products that contain the allegedly infringing intellectual property, which could be costly, disruptive and/or infeasible.

If any of the foregoing events occur, we may have to withdraw existing products from the market or may be unable to commercialize one or more of our products, all of which could have a material adverse effect on our business, results of operations and financial condition. As the number of participants in our industry grows, the possibility of intellectual property infringement claims against us increases.

Furthermore, the costs of resolving any patent litigation or other intellectual property proceeding, even if resolved in our favor, could be substantial. Uncertainties resulting from the initiation and continuation of patent litigation or other intellectual property proceedings could have a material adverse effect on our ability to compete in the marketplace. Patent litigation and other intellectual property proceedings may also consume significant management time.

In the event that a competitor infringes upon our patent or other intellectual property rights, enforcing those rights may be costly, difficult, and time-consuming. Even if successful, litigation to enforce our intellectual property rights or to defend our patents against challenge could be expensive and time-consuming and could divert our management’s attention. We may not have sufficient resources to enforce our intellectual property rights or to defend our patent or other intellectual property rights against a challenge. If we are unsuccessful in enforcing and protecting our intellectual property rights and protecting our products, it could materially harm our business.

There may also be situations where we use our business judgment and decide to market and sell products, notwithstanding the fact that allegations of patent infringement(s) have not been finally resolved by the courts (i.e., an “at-risk launch”). The risk involved in doing so can be substantial because the remedies available to the owner of a patent for infringement may include, among other things, damages measured by the profits lost by the patent owner and not necessarily by the profits earned by the infringer. In the case of a willful infringement, the definition of which is subjective, such damages may be increased up to three times. An adverse decision could have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

Table of Contents

In addition, we may indemnify our customers and distributors with respect to infringement by our products of the proprietary rights of third parties. Third parties may assert infringement claims against our customers or distributors. These claims may require us to initiate or defend protracted and costly litigation on behalf of our customers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers or distributors or may be required to obtain licenses for the products they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using our products.

We may be subject to claims that we, our board members, employees or consultants have used or disclosed alleged trade secrets or other proprietary information belonging to third parties and any such individuals who are currently affiliated with one of our competitors may disclose our proprietary technology or information.

As is commonplace in the medical device industry, some of our board members, employees and consultants are or have been associated with other medical device companies that compete with us. For example, Mr. Susi and a number of our other employees are former employees of Invivo Corporation and/or other medical device firms. While associated with such other companies, these individuals may have been exposed to research and technology similar to the areas of research, technology, sales methodology, pricing models and other such matters in which we are engaged. We may become subject to future claims that we, our employees, board members, or consultants have inadvertently or otherwise used or disclosed alleged trade secrets or other proprietary information of those companies. Litigation may be necessary to defend against such claims.

We have entered into confidentiality agreements with our executives and key consultants. However, we do not have, and are not planning to enter into, any confidentiality agreements with our non-executive directors because they have a fiduciary duty of confidentiality as directors.

There is the possibility that any of our former board members, employees, or consultants who are currently or who may be employed at, or associated with, one of our competitors may unintentionally or willfully disclose our proprietary technology or information.

Risks Related to Ownership of Our Common Stock

Our common stock price has been and will likely continue to be subject to significant fluctuations and volatility, and you may be unable to sell your shares at a fair price, or at all.

Our stock could be subject to wide fluctuations in price in response to various factors, including the following:

· a lack of liquidity in the public trading of our common stock;

· the commercial success or failure of our key products;

· delayed or reduced orders from our customers;

· manufacturing or supply interruptions;

· changes or developments in laws or regulations applicable to our products and product candidates;

· introduction of competitive products or technologies;

· poorly executed acquisitions or acquisitions whose projected potential is not realized;

· actual or anticipated variations in quarterly operating results;

· failure to meet or exceed our own estimates and projections or the estimates and projections of securities analysts or investors;

· new or revised earnings estimates or guidance by us or securities analysts or investors;

Table of Contents

· varying economic and market conditions in the U.S.;

· negative developments impacting the medical device industry in general and changes in the market valuations of companies deemed similar to us;

· negative developments concerning our sources of manufacturing supply;

· disputes or other developments relating to patents, trademarks or other proprietary rights;

· litigation or investigations involving us, our industry, or both;

· issuances of debt, equity or convertible securities at terms deemed unfavorable by the market;

· major catastrophic events;

· sales of large blocks of our stock;

· exercise of the underwriter’s warrant that may lead to sales that put downward pressure on our stock price;

· changes in our Board of Directors, management or key personnel; or

· the other factors described in this “Risk Factors” section.

Any one of the factors above, or the cumulative effect of some of the factors referred to above, may result in significant fluctuations in our quarterly or annual operating results, fluctuations in our share price and investors’ perception of our business. If we fail to meet or exceed such expectations, our business and stock price could be materially adversely affected.

Any use of capital to repurchase shares of our common stock could have a material adverse effect on our stock price and our business.

Since we announced stock repurchase programs in 2016 and 2017, we have used a significant amount of cash to repurchase shares of common stock of our company. Historically, we have opportunistically repurchased additional shares of common stock from time to time at prices that we believe are attractive. While our stock repurchase program has expired, should our Board of Directors authorize another stock repurchase program, there can be no assurance that we will be able to repurchase shares on favorable terms or, if we do repurchase shares, that such repurchases will increase shareholder value. Additionally, if we use a significant portion of our capital to repurchase shares, our financial flexibility will be reduced and we may not be able to execute on other strategic initiatives or tolerate periods of operating losses. If we repurchase shares on unfavorable terms or if our use of capital to repurchase shares inhibits our ability to pursue other strategic initiatives or tolerate periods of operating losses, it could have a material adverse effect on our stock price and our business.

Future sales of our common stock may cause our stock price to decline.

On September 26, 2014, we filed a registration statement under Form S-8 to register all of the shares issuable upon exercise of options outstanding or reserved for future issuance under our equity compensation plans. If any of the foregoing shares are sold or if there is another future offering by the Company, or if it is perceived that they will be sold or there will be another future offering, the trading price of our common stock could decline.

We may need or choose to raise additional capital in the future, which could result in dilution to our stockholders and adversely affect stock price.

While we believe that our cash and investment balances and prospective cash flow from our operations will provide us with adequate capital to fund operations for at least the next 12 months, we may need or choose to raise additional funds prior to that time. We may seek to sell additional equity or debt securities or to obtain a credit facility, which we may not be able to do on favorable terms, or at all. The sale of additional equity or convertible debt securities could result in additional dilution to our stockholders. If additional funds are raised through the issuance of debt securities or preferred stock, these securities could have rights that are senior to holders of common stock and any debt securities could contain covenants that would restrict our operations. The sale of such securities could hurt demand for our common stock and lead our share price to decline.

Table of Contents

Roger Susi, who serves as our Chairman of the Board of Directors and an executive officer, owns a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.

Mr. Susi, our founder, who serves as our Chairman of the Board of Directors, President and Chief Executive Officer, and his affiliates, beneficially owns a majority of our outstanding common stock. Mr. Susi is able to influence or control matters requiring approval by our stockholders, including the election of directors and the approval of mergers, acquisitions or other extraordinary transactions. He may also have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. This concentration of ownership may have the effect of delaying, preventing or deterring a change of control of our company, could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of our company and might ultimately affect the market price of our common stock.

Mr. Susi’s majority ownership also qualifies our company as a “controlled company” and allows us to opt out of compliance with numerous corporate governance listing requirements.

In addition, we qualify for the “controlled company” exemption under the corporate governance rules of the NASDAQ Stock Market until such a time as Mr. Susi does not control a majority of our outstanding common stock. As a “controlled company,” we would be permitted to opt out of compliance with the requirements that a majority of our Board of Directors consist of independent directors, that our Board of Directors’ compensation committee be comprised solely of independent directors, and that director nominees be selected or recommended to the Board of Directors for selection by independent directors. Notwithstanding the availability of these exemptions, we have elected not to rely upon any of the exemptions afforded to a “controlled company” under NASDAQ rules. A majority of our Board of Directors is comprised of independent directors, our compensation committee is comprised solely of independent directors, and our director nominees are recommended for selection to our Board of Directors by a majority of our independent directors in a vote in which only independent directors may participate. Our compliance is voluntary, however, and there can be no assurance that we will continue to comply with these standards in the future. We do not currently require that our Chairman of the Board be an independent director.

We do not intend to pay dividends for the foreseeable future.

We do not anticipate that we will pay any cash dividends on shares of our common stock for the foreseeable future. Any determination to pay dividends in the future will be at the discretion of our Board of Directors and will depend upon results of operations, financial condition, contractual restrictions, restrictions imposed by applicable law and other factors our Board of Directors deems relevant. Investors seeking cash dividends should not purchase our common stock.

Accordingly, if you purchase shares, realization of a gain on your investment will depend solely on the appreciation of the price of our common stock, which may never occur.

The requirements of being a public company may strain our resources, divert management’s attention and affect our ability to attract and retain executive management and qualified board members.

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (“Exchange Act”), the Sarbanes-Oxley Act, the Dodd-Frank Act, the listing requirements of the NASDAQ Stock Market and other applicable securities rules and regulations. Compliance with these rules and regulations will increase our legal and financial compliance costs, make some activities more difficult, time-consuming or costly and increase demand on our systems and resources. The Exchange Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and operating results. As a result, management’s attention may be diverted from other business concerns, which could adversely affect our business and operating results. We may need to hire more employees in the future or engage outside consultants to monitor and advise us regarding compliance, which will increase our costs and expenses.

In addition, changing laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs and making some activities more time consuming. These laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We are investing additional resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us, and our business may be adversely affected. These compliance requirements and costs will increase once we are no longer an “emerging growth company” as defined in the JOBS Act, which we anticipate will occur on December 31, 2019.

Table of Contents

We believe that being a public company and compliant with these new rules and regulations has made it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified members of our Board of Directors, particularly to serve on our audit committee and compensation committee, and qualified executive officers.

As a result of being a public company, we are obligated to establish and maintain adequate internal controls. Failure to develop and maintain adequate internal controls or to implement new or improved controls could have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

Ensuring that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort. Our internal controls over financial reporting are designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP. We are developing the system and processing documentation necessary to perform the evaluation needed to comply with Section 404 of the Sarbanes-Oxley Act of 2002. We may not be able to complete our evaluation, testing and any required remediation in a timely fashion. During the evaluation and testing process, if we identify one or more material weaknesses in our internal controls over financial reporting, we will be unable to assert that our internal controls are effective.

We will be required to disclose changes made in our internal controls and procedures on a quarterly basis. However, our independent registered public accounting firm will not be required to report on the effectiveness of our internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act until we file our first Form 10-K following the date we are no longer an “emerging growth company” as defined in the JOBS Act. At such time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our controls are documented, designed or operating. Our remediation efforts may not enable us to avoid a material weakness in the future.

Our business practices have become more visible as a public company, and this could impact our competitive environment and our risk of potential litigation.

As a result of disclosure of information in filings required of a public company, our business and financial condition have become more visible potentially exposing us to new competition and threatened or actual litigation, including by competitors and other third parties. New competition could result in reduced sales of our products and adversely impact our profitability. If lawsuits prevail against us, our business and operating results could be adversely affected, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and adversely affect our business and operating results.

We may and have become involved in securities class action litigation that could divert management’s attention from our business and adversely affect our business and could subject us to significant liabilities.

The stock markets have from time to time experienced significant price and volume fluctuations that have affected the market prices of small capitalization medical device companies. These broad market fluctuations as well a broad range of other factors, including the realization of any of the risks described in this “Risk Factors” section, may cause the market price of our common stock to decline. In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. We have become, and may in the future, become involved in this type of litigation. Litigation is expensive and could divert management’s attention and resources from our primary business, which could adversely affect our operating results. Any adverse determination in any such litigation or any amounts paid to settle any such actual or threatened litigation could require us to make significant payments. Such payment could have a material impact on how investors view our company and result in a decline in our stock price.

We are an “emerging growth company,” and we are not certain if the reduced reporting requirements applicable to emerging growth companies has made our common stock less attractive to investors.

We are an “emerging growth company,” as defined in the JOBS Act, and intend to take advantage of certain exemptions from various reporting requirements. We cannot predict if investors will respond negatively to our reliance on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile.

Table of Contents

As an “emerging growth company” we have also chosen to take advantage of certain provisions of the JOBS Act that allow us to provide you with less information in our public filings than would otherwise be required. As a result it may be more difficult for you to evaluate an investment in our company. We anticipate that starting December 31, 2019, we will no longer be an emerging growth company and after that date we will no longer be able to avail ourselves of these exemptions.

If securities or industry analysts fail to initiate research coverage of our stock, downgrade our stock, or discontinue coverage, our trading volume might be reduced and our stock price could decline.

The trading market for our common stock depends, in part, on the research reports that securities or industry analysts publish about our business. If securities or industry analysts do not commence or continue coverage of our company, the trading market for our stock may not be robust and the price of our stock could likely be negatively impacted. In the event securities or industry analysts initiate coverage, and later downgrade our stock or discontinue such coverage, our stock price could decline.

Our charter documents and Delaware law have provisions that may discourage an acquisition of us by others and may prevent attempts by our stockholders to replace or remove our current management.

Provisions in our charter documents, as well as provisions of the Delaware General Corporation Law (“DGCL”), could depress the trading price of our common stock by making it more difficult for a third party to acquire us at a price favorable to our shareholders. These provisions include:

· authorizing the issuance of “blank check” preferred stock, the terms of which may be established and shares of which may be issued without stockholder approval to defend against a takeover attempt; and

· establishing advance notice requirements for nominations for election to our Board of Directors or for proposing matters that can be acted upon at stockholder meetings.

In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our Board of Directors. We are subject to Section 203 of the DGCL, which generally prohibits a Delaware corporation from engaging in any of a broad range of business combinations with an interested stockholder for a period of three years following the date on which the stockholder became an interested stockholder, unless such transactions are approved by our Board of Directors. This provision could have the effect of delaying or preventing a change of control, whether or not it is desired by or beneficial to our stockholders, which could also affect the price that some investors are willing to pay for our common stock.

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds

Not Applicable.

Item 3. Default Upon Senior Securities

Not Applicable.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information

Not Applicable.

Table of Contents

Item 6. Exhibits

(a) Exhibits

Exhibit Number		Description of Document
10.1 †		Amendment Agreement to Supply Agreement between the Registant and Fukoku Co., Ltd. entered into on March 26, 2019
31.1		Certification of Chief Executive Officer pursuant to Exchange Act Rule, 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Chief Financial Officer pursuant to Exchange Act Rule, 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 I.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

† Certain confidential information contained in the Amendment Agreement to Supply Agreement, marked by asterisks, has been omitted because the information is (i) not material and (ii) would be competitively harmful if disclosed.

* This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

Table of Contents

IRADIMED CORPORATION

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IRADIMED CORPORATION


Dated: May 8, 2019	/s/ Roger Susi
	By:	Roger Susi
	Its:	Chief Executive Officer and President (Principal Executive Officer and Authorized Officer)

	/s/ Chris Scott
	By:	Chris Scott
	Its:	Chief Financial Officer and Secretary (Principal Financial and Accounting Officer)

EX-10.1 2 a19-7721_1ex10d1.htm EX-10.1

Exhibit 10.1

Amendment Agreement to Supply Agreement

This Amendment Agreement (hereinafter referred to as this “Amendment”) is made and entered into as of February 26th, 2019 between Iradimed Corporation, having its principal place of business at 1025 Willa Springs Drive. Winter Springs, FL 32708 USA (hereinafter referred to as “Iradimed”) and FUKOKU CO., LTD,, having its principal place of business at 3-105, Sugaya, Ageo-shi, Saitama, 362-8561, Japan (hereinafter referred to as “Supplier”) regarding the Supply Agreement executed between Iradimed and Supplier as of January 26, 2014 (hereinafter referred to as the “Original Agreement”)

Article 1

Article 1 of the Original Agreement shall be amended in its entirety to read as follows:

ARTICLE 1. TERM

1.1 Unless earlier terminated as provided herein, this Agreement shall have a term of ten (10) years from the effective date of this Agreement.

1.2 Unless terminated earlier in accordance with article 13, this Agreement shall remain in effect until February 25, 2024, and thereafter may be further renewed with mutual written consent of Iradimed and Supplier six (6) months before from expiry date of this Agreement.

Article 2.

Article 2 of the Original Agreement shall be amended in its entirety to read as follows:

ARTICLE 1. SUPPLY OF THE PRODUCTS

For purpose of this Agreement, the “Products” mean the specified Ultra Sonic motors as described in Exhibit A and Exhibit B and its modified version agreed in writing by the Parties. Subject to the terms and conditions herein contained, Supplier agrees to sell the Products and its control device to Iradimed, Iradimed agrees to purchase the Products and its control device from the Supplier. Supplier further agrees to not sell the Products to any other third party.

Also, the Parties confirmed and agreed that the Products have been or will be designed and manufactured by Supplier with Iradimed specification and requirements input, Ultra sonic motors as Exhibit A have been modified and. improved from prototype as follows; (i) ****, (ii) ****, (iii) ****, (iv) ****, and (v) ****.

Therefore, the Parties confirmed that the Ultra sonic motors described in Exhibit A and B may be, from time to time, modified thereafter. Provided, however, that,

such modifications shall be valid only by an Agreement in writing signed by the Parties.

Article 3.

Article 3 and 13.2 of the Original Agreement shall be deleted.

Article 4.

Exhibit A to the Original Agreement shall be deleted in its entirety and replaced in its entirety with Exhibit A and B attached to this Amendment.

Article 5.

AU other terms and. conditions of the Original Agreement shall continue unchanged and remain in full force and effect.

Article 6.

This Amendment shall take effect on February 26, 2019.

IN WITNESS WHEREOF, the parties have caused this Amendment to be executed by their duly authorized representatives as of the date first above written.

IRADIMED CORP	FUKOKU CO., Ltd.
Winter Park, FL. USA	Saitama, Japan

Signature:	Signature:
Name: Roger Susi	Name:	Daisuke Takahata
Title: President	Title:	New Business Division Managing Director, New Business Division

Exhibit A

****

Exhibit B

****

EX-31.1 3 a19-7721_1ex31d1.htm EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Roger Susi, certify that:

1. I have reviewed this quarterly report on Form 10-Q of IRADIMED CORPORATION;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2019


/s/ Roger Susi
By: Roger Susi
Chief Executive Officer and President
(Principal Executive Officer)

EX-31.2 4 a19-7721_1ex31d2.htm EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Chris Scott, certify that:

1. I have reviewed this quarterly report on Form 10-Q of IRADIMED CORPORATION;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2019


/s/ Chris Scott
By: Chris Scott
Chief Financial Officer and Secretary
(Principal Financial and Accounting Officer)

EX-32.1 5 a19-7721_1ex32d1.htm EX-32.1

Exhibit 32.1

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of IRADIMED CORPORATION (the “Company”) on Form 10-Q for the quarter ending March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Roger Susi
By: Roger Susi
Chief Executive Officer and President
(Principal Executive Officer)
May 8, 2019


/s/ Chris Scott
By: Chris Scott
Chief Financial Officer and Secretary
(Principal Financial and Accounting Officer)
May 8, 2019

EX-101.INS 6 irmd-20190331.xml XBRL INSTANCE DOCUMENT 0001325618 us-gaap:RetainedEarningsMember 2019-03-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001325618 us-gaap:RetainedEarningsMember 2018-12-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001325618 us-gaap:RetainedEarningsMember 2018-03-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001325618 us-gaap:RetainedEarningsMember 2017-12-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001325618 us-gaap:CommonStockMember 2019-03-31 0001325618 us-gaap:CommonStockMember 2018-12-31 0001325618 us-gaap:CommonStockMember 2018-03-31 0001325618 us-gaap:CommonStockMember 2017-12-31 0001325618 us-gaap:EmployeeStockOptionMember 2018-12-31 0001325618 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001325618 irmd:InternationalMember 2019-01-01 2019-03-31 0001325618 country:US 2019-01-01 2019-03-31 0001325618 irmd:InternationalMember 2018-01-01 2018-12-31 0001325618 country:US 2018-01-01 2018-12-31 0001325618 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001325618 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001325618 irmd:InternationalMember 2019-03-31 0001325618 country:US 2019-03-31 0001325618 irmd:InternationalMember 2018-12-31 0001325618 country:US 2018-12-31 0001325618 us-gaap:MachineryAndEquipmentMember 2019-03-31 0001325618 us-gaap:LeaseholdImprovementsMember 2019-03-31 0001325618 us-gaap:FurnitureAndFixturesMember 2019-03-31 0001325618 irmd:ToolingInProcessMember 2019-03-31 0001325618 irmd:ComputerSoftwareAndHardwareMember 2019-03-31 0001325618 us-gaap:MachineryAndEquipmentMember 2018-12-31 0001325618 us-gaap:LeaseholdImprovementsMember 2018-12-31 0001325618 us-gaap:FurnitureAndFixturesMember 2018-12-31 0001325618 irmd:ToolingInProcessMember 2018-12-31 0001325618 irmd:ComputerSoftwareAndHardwareMember 2018-12-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001325618 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001325618 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001325618 2019-01-01 0001325618 2019-01-01 2019-01-01 0001325618 us-gaap:TrademarksMember 2019-03-31 0001325618 irmd:SoftwareDevelopmentInUseMember 2019-03-31 0001325618 irmd:SoftwareDevelopmentInProcessMember 2019-03-31 0001325618 irmd:PatentsInUseMember 2019-03-31 0001325618 irmd:PatentsInProcessMember 2019-03-31 0001325618 us-gaap:TrademarksMember 2018-12-31 0001325618 irmd:SoftwareDevelopmentInUseMember 2018-12-31 0001325618 irmd:SoftwareDevelopmentInProcessMember 2018-12-31 0001325618 irmd:PatentsInUseMember 2018-12-31 0001325618 irmd:PatentsInProcessMember 2018-12-31 0001325618 us-gaap:RestrictedStockUnitsRSUMember 2019-03-31 0001325618 us-gaap:EmployeeStockOptionMember 2019-03-31 0001325618 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0001325618 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0001325618 us-gaap:DomesticCorporateDebtSecuritiesMember 2018-01-01 2018-12-31 0001325618 us-gaap:ForeignCorporateDebtSecuritiesMember 2019-01-01 2019-03-31 0001325618 us-gaap:DomesticCorporateDebtSecuritiesMember 2019-01-01 2019-03-31 0001325618 us-gaap:ForeignCorporateDebtSecuritiesMember 2018-01-01 2018-12-31 0001325618 2018-01-01 2018-12-31 0001325618 irmd:DomesticCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-03-31 0001325618 us-gaap:ForeignCorporateDebtSecuritiesMember 2019-03-31 0001325618 us-gaap:DomesticCorporateDebtSecuritiesMember 2019-03-31 0001325618 us-gaap:ForeignCorporateDebtSecuritiesMember 2018-12-31 0001325618 us-gaap:DomesticCorporateDebtSecuritiesMember 2018-12-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignCorporateDebtSecuritiesMember 2019-03-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DomesticCorporateDebtSecuritiesMember 2019-03-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignCorporateDebtSecuritiesMember 2019-03-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DomesticCorporateDebtSecuritiesMember 2019-03-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignCorporateDebtSecuritiesMember 2018-12-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DomesticCorporateDebtSecuritiesMember 2018-12-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignCorporateDebtSecuritiesMember 2018-12-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DomesticCorporateDebtSecuritiesMember 2018-12-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001325618 us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-03-31 0001325618 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-03-31 0001325618 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-03-31 0001325618 us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0001325618 us-gaap:SellingAndMarketingExpenseMember 2018-01-01 2018-03-31 0001325618 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-03-31 0001325618 us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-03-31 0001325618 us-gaap:CostOfSalesMember 2018-01-01 2018-03-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001325618 2018-03-31 0001325618 2017-12-31 0001325618 2014-04-16 0001325618 2014-09-02 0001325618 irmd:MriCompatiblePatientVitalSignsMonitoringSystemsMember 2019-01-01 2019-03-31 0001325618 irmd:MRICompatibleIVInfusionPumpsMember 2019-01-01 2019-03-31 0001325618 irmd:MriCompatiblePatientVitalSignsMonitoringSystemsMember 2018-01-01 2018-03-31 0001325618 irmd:MRICompatibleIVInfusionPumpsMember 2018-01-01 2018-03-31 0001325618 irmd:DomesticCustomerMember 2019-01-01 2019-03-31 0001325618 irmd:WinterSpringsFloridaFacilityMember irmd:SusiLLCMember 2014-01-31 0001325618 irmd:WinterSpringsFloridaFacilityMember irmd:SusiLLCMember 2019-01-01 2019-03-31 0001325618 irmd:WinterSpringsFloridaFacilityMember irmd:SusiLLCMember 2014-01-01 2014-01-31 0001325618 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0001325618 2018-01-01 2018-03-31 0001325618 2019-03-31 0001325618 2018-12-31 0001325618 2019-04-30 0001325618 2019-01-01 2019-03-31 irmd:segment iso4217:USD xbrli:shares irmd:item xbrli:pure iso4217:USD xbrli:shares false --12-31 Q1 2019 2019-03-31 10-Q 0001325618 11157222 Yes true true Non-accelerated Filer IRADIMED CORP true IRMD 180425 51991 339582 441557 <div> <div> CE Mark for 3880 Patient Vital Signs Monitoring System   On January 16, 2019, we were notified by the U.K. Notified Body, UL International Ltd. (“UL”) that their recent technical file review of our 3880 MRI compatible patient vital signs monitoring system could not be completed as aspects of clinical evaluation reporting, as required by newly issued guidance from the European Union, was not acceptable, resulting in a technical non-conformity. Accordingly, UL issued a temporary EC Certificate that excludes our 3880 patient vital signs monitoring system. This temporary EC Certificate extends through July 27, 2019. We immediately suspended shipments of our 3880 patient vital signs monitor to all markets requiring a CE Mark. We are addressing the technical non-conformity, but there can be no assurance that these efforts will be successful. <div /></div> </div> 591376 -652564 549032 813298 -10496 10496 -10496 0 0 0 0 <div> <div> FDA Warning Letter   The FDA conducted a routine inspection of our prior facility between April 7 and April 16, 2014. This was the first FDA inspection of our facility since the voluntary product recall in August 2012 of certain infusion sets and the voluntary recall in July 2013 of our DERS software. The FDA issued a Form 483 on April 16, 2014 that identified eight observations. Most of the observations related to procedural and documentation issues associated with the design, development, validation testing and documentation of software used in certain of our products. Other observations were related to the design validation of pump labeling, design analysis of tube stretching, procedures for post-market design review, and control and procedures related to handling certain reported complaints. We submitted responses to the Form 483 in May 2014 and June 2014 in which we described our proposed corrective and preventative actions to address each of the FDA’s observations.   On September 2, 2014, we received a warning letter from the FDA relating to this inspection (the “Warning Letter”). The Warning Letter states that the FDA accepted as adequate several of our responses to Form 483 observations, identified two responses whose accuracy will be determined in the next scheduled inspection of our facility and identified issues for which our response was determined to be inadequate. The issues identified as inadequate concern our procedures for validating device design primarily related to software quality assurance.   Also, the Warning Letter raised a new issue. The Warning Letter states that modifications made to software on our previously cleared infusion pumps, the MRidium 3860 and MRidium 3850, were “significant” and required submission of new premarket notifications under Section 510(k) (a “510(k) submission”) of the FDC Act. These modifications had been made over time. We believed they were insignificant and did not require premarket notification submissions. However, the FDA indicated that the modifications of the software for the MRidium 3860 and the software for the MRidium 3850 were “significant” modifications because they could significantly affect the safety or effectiveness of these devices. As a result, the Warning Letter states that the products being sold by us are “adulterated” and “misbranded” under the FDC Act. The Warning Letter also indicates that the MRidium 3860+ infusion pump requires separate FDA clearance from the MRidium 3860 and MRidium 3850.   The Warning Letter requested that we immediately cease activities that result in the misbranding or adulteration of the MRidium 3860 MRI infusion pump, MRidium 3850 MRI infusion pump, and the MRidium 3860+ MRI infusion pump, including the commercial distribution of the devices. We immediately complied with the Warning Letter and ceased sale and distribution of the identified products in the United States.   On September 4, 2014, we submitted to the FDA our initial response to the Warning Letter and on September 17, 2014 we sent an additional response that included supplemental information related to the Form 483 inspection observations for which the FDA considered our initial responses inadequate.   On November 25, 2014, we announced that we filed the 510(k) submission related to our MRidium 3860+ MRI IV infusion pumps and on December 12, 2014 we were notified that our 510(k) submission had been formally accepted for review by the FDA. On December 22, 2014, under FDA enforcement discretion, we announced that we resumed domestic distribution of our MRI compatible MRidium 3860+ MRI IV infusion pump systems, without the DERS option. On January 28, 2015, under FDA enforcement discretion, we announced that we resumed domestic distribution of our DERS option. On December 9, 2015, we met with the FDA to review responses to the agency’s additional information letter.   Between July 11 and July 18, 2016, the FDA conducted a routine inspection of our facility. This was the first FDA inspection of our facility since the receipt of the Warning Letter.  During this inspection, the updated documents and actions implemented in response to the Warning Letter findings were reviewed, and the FDA determined that no further actions were necessary.   On December 15, 2016, we received FDA 510(k) clearance for our MRidium 3860+ MRI IV infusion pump system, including the DERS software feature. As of March 31, 2019, the Warning Letter remains open. <div /></div> </div> 88439 10414 -341 62360 101940 P5Y P5Y P1Y P10Y2M12D 34133 1 2 95924 456739 4829478 3625622 1203856 5959362 4192754 1766608 1939091 2036674 9582 177344 2 8

772470

1180598

4209992

5328550

133000

86168

2031450

2155791

-48909

-102485

-42192

-3998

15317335

16133905

416327

382353

416327

68259

226771

37681

83616

382353

62524

219705

17993

82131

42443

63894

21860

22491

64382

7123

48442258

54413215

44541717

47440555

6349915

5429336

920579

5429336

920579

5746888

4820552

926336

4820552

926336

6349915

5429336

920579

5746888

4820552

926336

181248

186140

28027688

29684457

18205976

20093133

28027688

29684457

1887157

1656769

<div> <div> 13 — Commitments and Contingencies   Purchase commitments. We had various purchase orders for goods or services totaling $2,920,468 and $2,674,691 as of March 31, 2019 and December 31, 2018, respectively. No amounts related to these purchase orders have been recognized in our balance sheet.   Legal matters. We may from time to time become party to various legal proceedings or claims that arise in the ordinary course of business.   <div /></div> </div>

0.0001

31500000

10989111

11144196

10989111

11144196

1099

1114

798116

1883759

<div> <div> 9 — Accumulated Other Comprehensive Loss   The components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2019 and 2018 are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized (Losses)  </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains on </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Available-For-Sale </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Securities </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at December 31, 2018 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (42,192) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gains on available-for-sale securities, net </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 35,317 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Reclassification realized in net earnings </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,877 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at March 31, 2019 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (3,998) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at December 31, 2017 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (48,909) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Losses on available-for-sale securities, net </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (42,651) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Reclassification realized in net earnings </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (429) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Cumulative effect from adoption of accounting standard update </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (10,496) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at March 31, 2018 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (102,485) </td> </tr> </table></div>   <div /></div> </div>

<div> <div> Certain Significant Risks and Uncertainties   We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses. As of March 31, 2019, one domestic customer accounted for approximately 16.2% of accounts receivable. <div /></div> </div>

0.162

<div> <div> Our contract liabilities consist of:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Advance payments from customers </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 51,991 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 180,425 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Shipments in-transit </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 177,344 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 9,582 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Extended warranty agreements </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,537,188 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,415,782 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,766,523 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,605,789 </td> </tr> </table></div>   Changes in the contract liabilities during the periods presented are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Deferred </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Revenue </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Contract liabilities, December 31, 2018 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,605,789 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Increases due to cash received from customers </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 813,298 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Decreases due to recognition of revenue </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (652,564) </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Contract liabilities, March 31, 2019 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,766,523 </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Deferred  </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Revenue </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Contract liabilities, December 31, 2017 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,621,256 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Increases due to cash received from customers </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 549,032 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Decreases due to recognition of revenue </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (591,376) </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Contract liabilities, March 31, 2018 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,578,912 </td> </tr> </table></div>   <div /></div> </div>

3621256

3578912

3605789

3766523

1798784

1902175

1807005

1864348

1691535

2047827

<div> <div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="10" valign="bottom" style="width:50.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2019 </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Losses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,833,819 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,100 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 14,367 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,820,552 </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 918,417 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,919 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 926,336 </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,752,236 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 9,019 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 14,367 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,746,888 </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="10" valign="bottom" style="width:51.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31, 2018 </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Losses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,487,645 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 58,309 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,429,336 </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 918,417 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,162 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 920,579 </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,406,062 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,162 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 58,309 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,349,915 </td> </tr> </table></div>   <div /></div> </div>

6349915

5746888

2162

9019

1100

7919

58309

14367

1088702

1017049

109371

124341

427747

387081

<div> <div>   Revenue information by geographic region is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> United States </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,073,735 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,977,107 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> International </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,363,858 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,131,044 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,437,593 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,108,151 </td> </tr> </table></div>   Revenue information by type is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Devices: </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> MRI compatible IV infusion pump system </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,192,754 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,625,622 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> MRI compatible patient vital signs monitoring systems </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,766,608 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,203,856 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total Devices revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,959,362 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,829,478 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Disposables and services </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,036,674 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,939,091 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Amortization of extended warranty agreements </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 441,557 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 339,582 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,437,593 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,108,151 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> 10 — Stock-Based Compensation   Stock-based compensation was recognized as follows in the Condensed Statements of Operations:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:70.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:70.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:24.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:70.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:24.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:70.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> </tr> <tr> <td valign="bottom" style="width:70.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:24.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:70.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Cost of revenue </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 62,524 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 68,259 </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:70.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> General and administrative </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 219,705 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 226,771 </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:70.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Sales and marketing </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 82,131 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 83,616 </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:70.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Research and development </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 17,993 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 37,681 </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:70.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 382,353 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 416,327 </td> <td valign="bottom" style="width:02.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> </table></div>   As of March 31, 2019, we had $35,611 of unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted-average period of 0.6 years. As of March 31, 2019, we had $2,870,751 of unrecognized compensation cost related to unvested restricted stock units, which is expected to be recognized over a weighted-average period of 2.6 years.   The following table presents a summary of our stock-based compensation activity for the three months ended March 31, 2019 (shares):   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Stock </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Restricted </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Stock Units </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding beginning of period </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,129,463 </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 226,501 </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Awards granted </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,592 </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Awards exercised/vested </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (150,763) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (5,200) </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Awards canceled </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (750) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (11,270) </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding end of period </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 977,950 </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 213,623 </td> </tr> </table></div>     <div /></div> </div>

0.08

0.17

0.07

0.15

<div> <div> 3 — Basic and Diluted Net Income per Share   Basic net income per share is based upon the weighted-average number of common shares outstanding during the period. Diluted net income per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. The underwriters’ warrants, stock options and restricted stock units granted by us represent the only dilutive effect reflected in diluted weighted-average shares outstanding.   The following table presents the computation of basic and diluted net income per share:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:28.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended March 31, </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:28.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Net income </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,845,565 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 841,196 </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Weighted-average shares outstanding — Basic </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 11,029,639 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 10,608,387 </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Effect of dilutive securities: </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Underwriters' warrants </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 99,814 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 53,434 </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Stock options </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 996,303 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,155,708 </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Restricted stock units </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 101,940 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 62,360 </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Weighted-average shares outstanding — Diluted </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 12,227,696 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 11,879,889 </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Basic net income per share </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 0.17 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 0.08 </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Diluted net income per share </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 0.15 </td> <td valign="bottom" style="width:02.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 0.07 </td> <td valign="bottom" style="width:01.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> </table></div>   Stock options and warrants to purchase shares of our common stock and restricted stock units excluded from the calculation of diluted net income per share because the effect would have been anti-dilutive are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:68.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:68.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:25.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:68.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:25.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:68.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> </tr> <tr> <td valign="bottom" style="width:68.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:25.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:68.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Anti-dilutive stock options, restricted stock units and warrants </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,123 </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 64,382 </td> <td valign="bottom" style="width:02.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> </table></div>   <div /></div> </div>

0.254

-0.149

1802321

1423967

P7M6D

P2Y7M6D

35611

2870751

3415782

3537188

<div> <div> 8 — Fair Value Measurements   The fair value of our assets and liabilities subject to recurring fair value measurements are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="11" valign="bottom" style="width:58.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair Value at March 31, 2019 </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Quoted Prices </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> in Active </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Other </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Market for </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Observable </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unobservable </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Identical Assets </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 1) </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 2) </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,820,552 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,820,552 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 926,336 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 926,336 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,746,888 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,746,888 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="11" valign="bottom" style="width:58.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair Value at December 31, 2018 </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Quoted Prices </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> in Active </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Other </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Market for </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Observable </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unobservable </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Identical Assets </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 1) </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 2) </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,429,336 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,429,336 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 920,579 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 920,579 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,349,915 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,349,915 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> </table></div>   Our corporate bonds are valued by a third-party custodian at closing prices from secondary exchanges or pricing vendors on the valuation date.   There were no transfers into or out of any Levels during the three months ended March 31, 2019 or the year ended December 31, 2018. <div /></div> </div>

449224

471715

67472

88740

89392

89963

1281743

73164

304270

13723

867569

23017

1291467

76990

304270

19621

867569

23017

832519

819752

2303532

2412696

5416616

6389766

1127394

1606419

<div> <div> 11 — Income Taxes   For the three months ended March 31, 2019, we recorded a provision for income tax benefit of $(239,146). Our effective tax rate was (14.9) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation, partially offset by U.S. state tax expense.   For the three months ended March 31, 2018, we recorded a provision for income tax expense of $286,198. Our effective tax rate was 25.4 percent and differed from the U.S. Federal statutory rate primarily due to research and development credits, partially offset by U.S. state tax expense.   As of March 31, 2019 and December 31, 2018, we had not identified or accrued for any uncertain tax positions. We are currently unaware of any uncertain tax positions that could result in significant payments, accruals or other material deviations in this estimate over the next 12 months. We believe that our tax positions comply in all material respects with applicable tax law. However, tax law is subject to interpretation, and interpretations by taxing authorities could be different from ours, which could result in the imposition of additional taxes and penalties.   We file tax returns in the United States Federal jurisdiction and many U.S. state jurisdictions. The Company is subject to income tax examinations for our United States Federal and certain U.S. state income taxes for 2015 and subsequent years and various other U.S. state income taxes for 2014 and subsequent years.   <div /></div> </div>

286198

-239146

-80631

375202

-490147

1140008

410045

-298094

-42344

338078

123689

-59048

-331790

-378354

155234

333546

18185

4891

254051

665862

-75365

-46832

53434

99814

1155708

996303

<div> <div> 6 — Intangible Assets   The following table summarizes the components of intangible asset balances:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Patents — in use </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 304,270 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 304,270 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Patents — in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 76,990 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 73,164 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Internally developed software — in use </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 867,569 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 867,569 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Internally developed software — in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 19,621 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 13,723 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Trademarks </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 23,017 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 23,017 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,291,467 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,281,743 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accumulated amortization </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (471,715) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (449,224) </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 819,752 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 832,519 </td> </tr> </table></div>   Amortization expense of intangible assets was $22,491 and $21,860 for the three months ended March 31, 2019 and 2018, respectively.   Expected annual amortization expense for the remaining portion of 2019 and the next five years related to intangible assets is as follows (excludes in process intangible assets):   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Nine months ending December 31, 2019 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">      </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 67,472 </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 89,963 </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 89,963 </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2022 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 89,392 </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2023 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 88,740 </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2024 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 88,439 </td> </tr> </table></div>   <div /></div> </div>

211843

245077

<div> <div> 4 — Inventory   Inventory consists of:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Raw materials </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,570,874 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,408,158 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Work in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 252,829 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 305,562 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Finished goods </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 652,878 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 557,566 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Inventory before allowance for excess and obsolete </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,476,581 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,271,286 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Allowance for excess and obsolete </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (245,077) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (211,843) </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,231,504 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,059,443 </td> </tr> </table></div>   <div /></div> </div>

557566

652878

4271286

4476581

4059443

4231504

3408158

3570874

305562

252829

61011

120529

<div> <div> 7 — Investments   Our investments consist of corporate bonds that we have classified as available-for-sale and are summarized in the following tables:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="10" valign="bottom" style="width:50.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2019 </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Losses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,833,819 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,100 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 14,367 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,820,552 </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 918,417 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,919 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 926,336 </td> </tr> <tr> <td valign="bottom" style="width:46.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,752,236 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 9,019 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 14,367 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,746,888 </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="10" valign="bottom" style="width:51.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31, 2018 </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:09.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Losses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,487,645 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 58,309 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,429,336 </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 918,417 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,162 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 920,579 </td> </tr> <tr> <td valign="bottom" style="width:44.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,406,062 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,162 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 58,309 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,349,915 </td> </tr> </table></div>   Unrealized losses from the above investments for all periods presented are attributable to changes in interest rates. We do not believe any of these unrealized losses represent other-than-temporary impairments based on our evaluation of available evidence as of March 31, 2019. <div /></div> </div>

true

0.060

true

false

4164227

2218646

409596

307197

1036949

<div> <div> 12 — Leases   Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate, unless the rate implicit in the lease is readily determinable. Lease assets also include any upfront lease payments made and exclude lease incentives. Lease terms include options to extend or terminate leases when it is reasonably certain that those options will be exercised.   Variable lease payments are expensed as incurred and include annual rent adjustments based on the consumer price index. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.   Lease agreements with lease and nonlease components are combined as a single lease component. The depreciable life of lease assets and leasehold improvements is limited by the expected lease term.   We have only one material lease contract outstanding. In January 2014, we entered into a non-cancelable operating lease, commencing July 1, 2014, for our manufacturing and headquarters facility in Winter Springs, Florida owned by Susi, LLC, an entity controlled by our President and CEO, Roger Susi. Pursuant to the terms of our lease for this property, the monthly base rent is $34,133, adjusted annually for changes in the consumer price index. Under the terms of the lease, we are responsible for property taxes, insurance and maintenance expenses. The initial term of the lease expires on May 31, 2019. Unless advance written notice of termination is timely provided, the lease will automatically renew for two successive terms of five years each beginning in 2019 and again in 2024, and thereafter, will be renewed for successive terms of one year each. For purposes of Topic 842, we concluded that we will exercise both of the five year options, resulting in a remaining lease term of 10.2 years as of March 31, 2019. This lease agreement does not contain any residual value guarantee or material restrictive convenants.   Operating lease cost recognized for the three months ended March 31, 2019 is follows in the Condensed Statements of Operations:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Cost of revenue </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">      </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 46,535 </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> General and administrative </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 46,044 </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Sales and marketing </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,605 </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Research and development </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 7,215 </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 102,399 </td> </tr> </table></div>   Lease costs for short-term leases were immaterial for the three months ended March 31, 2019.   Maturity of Operating Lease Liability as of March 31, 2019 is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:83.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:83.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Nine months ending December 31, 2019 </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">      </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 307,197 </td> </tr> <tr> <td valign="bottom" style="width:83.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 409,596 </td> </tr> <tr> <td valign="bottom" style="width:83.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 409,596 </td> </tr> <tr> <td valign="bottom" style="width:83.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2022 </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 409,596 </td> </tr> <tr> <td valign="bottom" style="width:83.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2023 </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 409,596 </td> </tr> <tr> <td valign="bottom" style="width:83.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Thereafter </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,218,646 </td> </tr> <tr> <td valign="bottom" style="width:83.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total lease payments </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4,164,227 </td> </tr> <tr> <td valign="bottom" style="width:83.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Imputed interest </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (1,036,949) </td> </tr> <tr> <td valign="bottom" style="width:83.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Present value of lease liability </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,127,278 </td> </tr> </table></div>   We used a discount rate of 6.0% to determine the present value of the operating lease liability on January 1, 2019.   Undiscounted future minimum lease payments under noncancelable operating leases as of December 31, 2018 as determined prior to the adoption of ASC 842 are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">      </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 170,664 </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2022 </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2023 </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Thereafter </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total minimum lease payments </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 170,664 </td> </tr> </table></div>   <div /></div> </div>

6496525

9767138

48442258

54413215

4689520

5005783

<div> <div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> United States </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,474,529 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,439,545 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> International </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 427,516 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 430,016 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total property and equipment, net </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,902,045 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,869,561 </td> </tr> </table></div>   <div /></div> </div>

91548

434232

211719

557333

1583890

665204

841196

1845565

40072

92574

4329294

4875921

1087322

1513845

102399

46535

46044

7215

2605

3127278

226852

230271

2955872

2897007

101505

106659

3182724

3127278

170664

<div> <div>   1 — Basis of Presentation   The accompanying interim condensed financial statements of IRADIMED CORPORATION (“IRADIMED”, the “Company”, “we”, “our”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally presented in annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The interim financial information is unaudited, but reflects all normal adjustments that are, in the opinion of management, necessary for the fair presentation of our financial position, results of operations and cash flows for the interim periods presented. Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019.   These accompanying interim condensed financial statements should be read with the financial statements and related footnotes to financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018. The accounting policies followed in the preparation of these interim condensed financial statements, except as described in Note 1, are consistent in all material respects with those described in Note 1 of our Form 10-K.   We operate in one reportable segment which is the development, manufacture and sale of MRI compatible medical devices, related accessories, disposables and services for use by hospitals and acute care facilities during MRI procedures.   FDA Warning Letter   The FDA conducted a routine inspection of our prior facility between April 7 and April 16, 2014. This was the first FDA inspection of our facility since the voluntary product recall in August 2012 of certain infusion sets and the voluntary recall in July 2013 of our DERS software. The FDA issued a Form 483 on April 16, 2014 that identified eight observations. Most of the observations related to procedural and documentation issues associated with the design, development, validation testing and documentation of software used in certain of our products. Other observations were related to the design validation of pump labeling, design analysis of tube stretching, procedures for post-market design review, and control and procedures related to handling certain reported complaints. We submitted responses to the Form 483 in May 2014 and June 2014 in which we described our proposed corrective and preventative actions to address each of the FDA’s observations.   On September 2, 2014, we received a warning letter from the FDA relating to this inspection (the “Warning Letter”). The Warning Letter states that the FDA accepted as adequate several of our responses to Form 483 observations, identified two responses whose accuracy will be determined in the next scheduled inspection of our facility and identified issues for which our response was determined to be inadequate. The issues identified as inadequate concern our procedures for validating device design primarily related to software quality assurance.   Also, the Warning Letter raised a new issue. The Warning Letter states that modifications made to software on our previously cleared infusion pumps, the MRidium 3860 and MRidium 3850, were “significant” and required submission of new premarket notifications under Section 510(k) (a “510(k) submission”) of the FDC Act. These modifications had been made over time. We believed they were insignificant and did not require premarket notification submissions. However, the FDA indicated that the modifications of the software for the MRidium 3860 and the software for the MRidium 3850 were “significant” modifications because they could significantly affect the safety or effectiveness of these devices. As a result, the Warning Letter states that the products being sold by us are “adulterated” and “misbranded” under the FDC Act. The Warning Letter also indicates that the MRidium 3860+ infusion pump requires separate FDA clearance from the MRidium 3860 and MRidium 3850.   The Warning Letter requested that we immediately cease activities that result in the misbranding or adulteration of the MRidium 3860 MRI infusion pump, MRidium 3850 MRI infusion pump, and the MRidium 3860+ MRI infusion pump, including the commercial distribution of the devices. We immediately complied with the Warning Letter and ceased sale and distribution of the identified products in the United States.   On September 4, 2014, we submitted to the FDA our initial response to the Warning Letter and on September 17, 2014 we sent an additional response that included supplemental information related to the Form 483 inspection observations for which the FDA considered our initial responses inadequate.   On November 25, 2014, we announced that we filed the 510(k) submission related to our MRidium 3860+ MRI IV infusion pumps and on December 12, 2014 we were notified that our 510(k) submission had been formally accepted for review by the FDA. On December 22, 2014, under FDA enforcement discretion, we announced that we resumed domestic distribution of our MRI compatible MRidium 3860+ MRI IV infusion pump systems, without the DERS option. On January 28, 2015, under FDA enforcement discretion, we announced that we resumed domestic distribution of our DERS option. On December 9, 2015, we met with the FDA to review responses to the agency’s additional information letter.   Between July 11 and July 18, 2016, the FDA conducted a routine inspection of our facility. This was the first FDA inspection of our facility since the receipt of the Warning Letter.  During this inspection, the updated documents and actions implemented in response to the Warning Letter findings were reviewed, and the FDA determined that no further actions were necessary.   On December 15, 2016, we received FDA 510(k) clearance for our MRidium 3860+ MRI IV infusion pump system, including the DERS software feature. As of March 31, 2019, the Warning Letter remains open.   CE Mark for 3880 Patient Vital Signs Monitoring System   On January 16, 2019, we were notified by the U.K. Notified Body, UL International Ltd. (“UL”) that their recent technical file review of our 3880 MRI compatible patient vital signs monitoring system could not be completed as aspects of clinical evaluation reporting, as required by newly issued guidance from the European Union, was not acceptable, resulting in a technical non-conformity. Accordingly, UL issued a temporary EC Certificate that excludes our 3880 patient vital signs monitoring system. This temporary EC Certificate extends through July 27, 2019. We immediately suspended shipments of our 3880 patient vital signs monitor to all markets requiring a CE Mark. We are addressing the technical non-conformity, but there can be no assurance that these efforts will be successful.     Certain Significant Risks and Uncertainties   We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses. As of March 31, 2019, one domestic customer accounted for approximately 16.2% of accounts receivable.   Recent Accounting Pronouncements   Accounting Pronouncements Implemented in 2019   In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842). This update requires lessees to recognize, on the balance sheet, assets and liabilities for the rights and obligations created by all leases not considered short-term leases. For short-term leases, lessees may elect an accounting policy by class of underlying assets under which right-of-use assets and lease liabilities are not recognized and lease payments are generally recognized as expense over the lease term on a straight-line basis.   We adopted this update on January 1, 2019 and, as part of that process, made the following elections:   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> We elected to use the hindsight practical expedient.</td></tr></table></div>   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> We elected the package of practical expedients in transition for leases that commenced prior to January 1, 2019 whereby contracts were not reassessed or reclassified from their previous assessment as of December 31, 2018.</td></tr></table></div>   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> In March 2018, the FASB approved an optional transition method that allows companies to use the effective date as the date of initial application on transition. We elected this transition method, and as a result, did not adjust comparative period financial information or make the newly required lease disclosures for periods before the effective date.</td></tr></table></div>   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> We elected to make the accounting policy election for short-term leases resulting in lease payments being recorded as an expense on a straight-line basis over the lease term.</td></tr></table></div>   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> We elected to not separate lease and nonlease components, for all leases.</td></tr></table></div>   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> We did not elect the land easement practical expedient.</td></tr></table></div>   The impact of Topic 842 on our Balance Sheet beginning January 1, 2019 was through the recognition of an operating lease right-of-use asset and operating lease liability. Amounts recognized at January 1, 2109 for operating leases were as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:84.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:84.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> January 1, </td> </tr> <tr> <td valign="bottom" style="width:84.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:84.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Operating lease right-of-use asset </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,182,724 </td> </tr> <tr> <td valign="bottom" style="width:84.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Current portion of operating lease liability </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 226,852 </td> </tr> <tr> <td valign="bottom" style="width:84.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Operating lease liability, less current portion </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,955,872 </td> </tr> </table></div>   There was no impact to our Condensed Statements of Operations, Condensed Statements of Cash Flows or beginning retained earnings related to the adoption of Topic 842.   Recently Issued Accounting Pronouncements to be Implemented   In August 2018, the FASB issued ASU 2018-03, Fair Value Measurement (Topic 820). This update modifies disclosure requirements related to fair value measurements. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2019. Implementation on a prospective or retrospective basis varies by specific disclosure requirement. Early adoption is permitted. The ASU also allows for early adoption of any removed or modified disclosures upon issuance of this ASU, while delaying adoption of the additional disclosures until their effective date. We do not expect the adoption of this guidance will have a material impact upon our footnote disclosures.   In June 2016, the FASB issued 2016-03, Financial Instruments – Credit Losses (Topic 326). This update requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. In addition, for available-for-sale debt securities, this ASU replaces the other-than-temporary impairment model and requires the recognition of an allowance for reductions in a security’s fair value attributable to declines in credit quality, instead of a direct writedown of the security, when a valuation decline is determined to be other-than-temporary. The ASU requires a cumulative-effect adjustment to retained earnings as of the beginning of the reporting period of adoption. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019 and for interim periods therein. Companies may choose to adopt this ASU as of its fiscal year beginning after December 15, 2018. We did not early adopt this standard. We do not believe this ASU will have a material impact on our financial condition or statements of operations.   <div /></div> </div>

109759

106536

-42651

35317

-14128

11656

-43080

38194

-43080

38194

429

-2877

-86

949

108421

-250000

-650000

4376

22507

298

9724

37983

82943

526787

783170

1367892

1665986

74524

74183

841196

1845565

<div> <div> 5 — Property and Equipment   Property and equipment consist of:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Computer software and hardware </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 593,347 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 555,292 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Furniture and fixtures </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 978,152 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 901,415 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Leasehold improvements </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 209,226 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 202,026 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Machinery and equipment </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,193,486 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,184,015 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Tooling in-process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 83,625 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 58,263 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,057,836 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,901,011 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accumulated depreciation </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (2,155,791) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (2,031,450) </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,902,045 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,869,561 </td> </tr> </table></div>   Depreciation expense of property and equipment was $124,341 and $109,371 for the three months ended March 31, 2019 and 2018, respectively.   Property and equipment, net, information by geographic region is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> United States </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,474,529 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,439,545 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> International </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 427,516 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 430,016 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total property and equipment, net </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,902,045 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,869,561 </td> </tr> </table></div>   Long-lived assets held outside of the United States consist principally of tooling and machinery and equipment, which are components of property and equipment, net. <div /></div> </div>

3901011

555292

58263

901415

202026

2184015

4057836

593347

83625

978152

209226

2193486

1869561

1439545

430016

1902045

1474529

427516

8842

21450

2674691

2920468

550

-3826

-429

2877

379826

352573

3163

4322

-4376

-22507

26669491

28515056

7108151

5977107

1131044

8437593

7073735

1363858

<div> <div> 2 — Revenue Recognition   Disaggregation of Revenue   We disaggregate revenue from contracts with customers by geographic region and revenue type as we believe it best depicts the nature, amount, timing and uncertainty of our revenue and cash flow.   Revenue information by geographic region is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> United States </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,073,735 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,977,107 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> International </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,363,858 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,131,044 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,437,593 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,108,151 </td> </tr> </table></div>   Revenue information by type is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Devices: </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> MRI compatible IV infusion pump system </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,192,754 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,625,622 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> MRI compatible patient vital signs monitoring systems </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,766,608 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,203,856 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total Devices revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,959,362 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,829,478 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Disposables and services </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,036,674 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,939,091 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Amortization of extended warranty agreements </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 441,557 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 339,582 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,437,593 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,108,151 </td> </tr> </table></div>   Contract Liabilities   Our contract liabilities consist of:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Advance payments from customers </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 51,991 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 180,425 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Shipments in-transit </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 177,344 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 9,582 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Extended warranty agreements </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,537,188 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,415,782 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,766,523 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,605,789 </td> </tr> </table></div>   Changes in the contract liabilities during the periods presented are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Deferred </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Revenue </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Contract liabilities, December 31, 2018 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,605,789 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Increases due to cash received from customers </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 813,298 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Decreases due to recognition of revenue </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (652,564) </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Contract liabilities, March 31, 2019 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,766,523 </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Deferred  </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Revenue </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Contract liabilities, December 31, 2017 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,621,256 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Increases due to cash received from customers </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 549,032 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Decreases due to recognition of revenue </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (591,376) </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Contract liabilities, March 31, 2018 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,578,912 </td> </tr> </table></div>   Capitalized Contract Costs   Our capitalized contract costs consist of:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:64.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:64.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31, </td> </tr> <tr> <td valign="bottom" style="width:64.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:64.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:64.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Capitalized contract costs </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 186,140 </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 181,248 </td> </tr> </table></div>   Expense for the three months ended March 31, 2019 and 2018 related to the amortization of capitalized contract costs were immaterial to our financial statements.   <div /></div> </div>

7108151

8437593

3182724

<div> <div>     The components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2019 and 2018 are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized (Losses)  </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains on </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Available-For-Sale </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Securities </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at December 31, 2018 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (42,192) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gains on available-for-sale securities, net </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 35,317 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Reclassification realized in net earnings </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,877 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at March 31, 2019 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (3,998) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at December 31, 2017 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (48,909) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Losses on available-for-sale securities, net </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (42,651) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Reclassification realized in net earnings </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (429) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Cumulative effect from adoption of accounting standard update </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (10,496) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at March 31, 2018 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (102,485) </td> </tr> </table></div>   <div /></div> </div>

<div> <div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="11" valign="bottom" style="width:58.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair Value at March 31, 2019 </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Quoted Prices </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> in Active </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Other </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Market for </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Observable </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unobservable </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Identical Assets </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 1) </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 2) </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,820,552 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,820,552 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 926,336 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 926,336 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,746,888 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,746,888 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="11" valign="bottom" style="width:58.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair Value at December 31, 2018 </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Quoted Prices </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> in Active </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Other </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Market for </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Observable </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unobservable </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Identical Assets </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 1) </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 2) </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,429,336 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,429,336 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 920,579 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 920,579 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:39.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,349,915 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,349,915 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> </table></div>   <div /></div> </div>

<div> <div> <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Patents — in use </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 304,270 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 304,270 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Patents — in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 76,990 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 73,164 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Internally developed software — in use </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 867,569 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 867,569 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Internally developed software — in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 19,621 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 13,723 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Trademarks </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 23,017 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 23,017 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,291,467 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,281,743 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accumulated amortization </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (471,715) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (449,224) </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 819,752 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 832,519 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">      </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 170,664 </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2022 </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2023 </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Thereafter </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:84.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total minimum lease payments </td> <td valign="bottom" style="width:02.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 170,664 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2018 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Raw materials </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,570,874 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,408,158 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Work in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 252,829 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 305,562 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Finished goods </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 652,878 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 557,566 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Inventory before allowance for excess and obsolete </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,476,581 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,271,286 </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Allowance for excess and obsolete </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (245,077) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (211,843) </td> </tr> <tr> <td valign="bottom" style="width:65.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,231,504 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,059,443 </td> </tr> </table></div>   <div /></div> </div>

<div> <div>   The following table presents a summary of our stock-based compensation activity for the three months ended March 31, 2019 (shares):   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Stock </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Restricted </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Stock Units </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding beginning of period </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,129,463 </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 226,501 </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Awards granted </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,592 </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Awards exercised/vested </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (150,763) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (5,200) </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Awards canceled </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (750) </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (11,270) </td> </tr> <tr> <td valign="bottom" style="width:73.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding end of period </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 977,950 </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 213,623 </td> </tr> </table></div>   <div /></div> </div>

1645936

2110652

416327

382353

11270

3592

226501

213623

5200

750

1129463

977950

10596566

10622042

10989111

11144196

32930877

-48909

12623181

1060

20355545

34236868

-102485

13131054

1062

21207237

41945733

-42192

15317335

1099

26669491

44646077

-3998

16133905

1114

28515056

22313

150763

95924

95922

456739

456724

6406062

5487645

918417

5752236

4833819

918417

11879889

12227696

10608387

11029639

EX-101.SCH 7 irmd-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00100 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONDENSED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Revenue Recognition - Information by Type (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - Revenue Recognition - Contract Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Basic and Diluted Net Income per Share (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 41203 - Disclosure - Leases - Maturity of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 41203 - Disclosure - Leases - Maturity of lease liabilities (Details) Calc 2 link:presentationLink link:calculationLink link:definitionLink 41204 - Disclosure - Leases - Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Basic and Diluted Net Income per Share link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Basic and Diluted Net Income per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Basis of Presentation - FDA Warning Letter (Details) link:presentationLink link:calculationLink link:definitionLink 40103 - Disclosure - Basis of Presentation - Certain Significant Risks and Uncertainties (Details) link:presentationLink link:calculationLink link:definitionLink 40104 - Disclosure - Basis of Presentation - Recent Accounting Pronouncements (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Revenue Recognition - Information by Geographic Region (Details) link:presentationLink link:calculationLink link:definitionLink 40204 - Disclosure - Revenue Recognition - Capitalized Contract Costs (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Property and Equipment - Geographic information (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Investments (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Stock-Based Compensation - Stock Options and Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 41202 - Disclosure - Leases - Operating Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 30103 - Disclosure - Basis of Presentation (Tables) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 irmd-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 irmd-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 irmd-20190331_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Document and Entity Information Statement [Table] Statement [Line Items] Basis of Presentation Statement Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Filer Category Trading Symbol Entity Common Stock, Shares Outstanding Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Document Fiscal Year Focus Document Fiscal Period Focus CONDENSED BALANCE SHEETS Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Accounts Receivable, Net, Current Accounts receivable, net of allowance for doubtful accounts of $63,894 as of March 31, 2019 and $42,443 as of December 31, 2018 Debt Securities, Current Investments Inventory, Net Inventory, net Total Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Prepaid Taxes Prepaid income taxes Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Total Finite-Lived Intangible Assets, Net Intangible assets, net Total Operating Lease, Right-of-Use Asset Operating lease right-of-use asset Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Deferred income taxes, net Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Employee-related Liabilities, Current Accrued payroll and benefits Accrual for Taxes Other than Income Taxes, Current Other accrued taxes Product Warranty Accrual, Current Warranty reserve Contract with Customer, Liability, Current Deferred revenue Operating Lease, Liability, Current Current portion of operating lease liability Other Liabilities, Current Other current liability Liabilities, Current Total current liabilities Contract with Customer, Liability, Noncurrent Deferred revenue Operating Lease, Liability, Noncurrent Operating lease liability, less current portion Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Common Stock, Value, Issued Common stock; $0.0001 par value; 31,500,000 shares authorized; 11,144,196 shares issued and outstanding as of March 31, 2019 and 10,989,111 shares issued and outstanding as of December 31, 2018 Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Retained earnings Accumulated Other Comprehensive Income (Loss), Net of Tax Balance at the end Balance at the beginning Accumulated other comprehensive loss Stockholders' Equity Attributable to Parent Balances Balances Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Allowance for Doubtful Accounts Receivable, Current Accounts receivable, allowance for doubtful accounts Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding CONDENSED STATEMENTS OF OPERATIONS Revenues Revenue Cost of Revenue. Cost of revenue Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses: General and Administrative Expense General and administrative Selling and Marketing Expense Sales and marketing Research and Development Expense Research and development Operating Expenses Total operating expenses Operating Income (Loss) Income from operations Nonoperating Income (Expense) Other income, net Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Income before provision for income taxes Income Tax Expense (Benefit) Provision for income tax (benefit) expense Provision for income tax (benefit) expense Net Income (Loss) Attributable to Parent Net income Net income Earnings Per Share, Basic [Abstract] Net income per share: Earnings Per Share, Basic Basic net income per share (in dollars per share) Basic (in dollars per share) Earnings Per Share, Diluted Diluted net income per share (in dollars per share) Diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Basic Weighted-average shares outstanding - Basic (in shares) Basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average shares outstanding - Diluted (in shares) Diluted (in shares) CONDENSED STATEMENTS OF COMPREHENSIVE INCOME Accumulated Other Comprehensive Loss Other comprehensive income (loss): Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Change in fair value of available-for-sale securities, , net of tax expense (benefit) of $11,656 and $(14,128), , respectively Gains (Losses) on available-for-sale securities, net Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Realized loss on available-for-sale securities reclassified to net income, net of tax (benefit) expense of $(949) and $86, respectively Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent Change in fair value of available-for-sale securities, tax benefit Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax Reclassification to net income, tax benefit CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY Increase (Decrease) in Stockholders' Equity Shares, Outstanding Balance (in shares) Balance (in shares) Other Comprehensive Income (Loss), Net of Tax Other comprehensive income (loss) Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation Restricted Stock, Value, Shares Issued Net of Tax Withholdings Net share settlement of restricted stock units Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Net share settlement of restricted stock units (in shares) Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Awards exercised/vested (in shares) Exercise of stock options (in shares) Amount after tax of cumulative effect adjustment on equity or net assets for prospective application of a new accounting principle. Cumulative Effect Of Prospective Application Of New Accounting Principle, Net Of Tax Cumulative effect from adoption of accounting standard update CONDENSED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net income Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Provision for Doubtful Accounts Change in allowance for doubtful accounts Inventory Write-down Change in provision for excess and obsolete inventory Depreciation, Depletion and Amortization Depreciation and amortization Share-based Compensation Stock-based compensation Increase (Decrease) in Deferred Income Taxes Deferred income taxes, net Realized Investment Gains (Losses) Loss (gain) on maturities of investments Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Other Operating Assets Other assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Employee Related Liabilities Accrued payroll and benefits Increase (Decrease) in Property and Other Taxes Payable Other accrued taxes Represents the increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to warranty reserve. Increase Decrease in Warranty Reserve Warranty reserve Increase (Decrease) in Contract with Customer, Liability Deferred revenue Increase (Decrease) in Income Taxes Payable Prepaid income taxes, net of accrued income taxes Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash provided by operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Investing activities: Payments for (Proceeds from) Investments Proceeds from maturity of investments Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Payments to Acquire Other Productive Assets Capitalized intangible assets Net Cash Provided by (Used in) Investing Activities Net cash provided by investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Financing activities: The cash inflow associated with the amount received from holders exercising their stock options or from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Proceeds from Issuance of Stock Option and Warrants exercised Proceeds from exercises of stock options and underwriters' warrants Payments Related to Tax Withholding for Share-based Compensation Taxes paid related to the net share settlement of equity awards Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-use asset recognized in exchange for new lease obligation Operating Lease, Payments Operating and short-term lease payments recorded within cash flow from operating activities Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Basis of Presentation Revenue Recognition Revenue from Contract with Customer [Text Block] Revenue Recognition Basic and Diluted Net Income per Share Earnings Per Share [Text Block] Basic and Diluted Net Income per Share Inventory Inventory Disclosure [Text Block] Inventory Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Property and Equipment Intangible Assets Intangible Assets Disclosure [Text Block] Intangible Assets Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Investments Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Comprehensive Income (Loss) Note [Text Block] Accumulated Other Comprehensive Loss Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-Based Compensation Income Taxes Income Tax Disclosure [Text Block] Income Taxes Leases Lessee, Operating Leases [Text Block] Leases Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies FDA matters policy text block FDA Matters [Policy Text Block] FDA Warning Letter CE Mark for 3880 Patient Vital Signs Monitoring System policy text block. CE Mark for 3880 Patient Vital Signs Monitoring System [Policy Text Block] CE Mark for 3880 Patient Vital Signs Monitoring System Concentration Risk, Credit Risk, Policy [Policy Text Block] Certain Significant Risks and Uncertainties New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Schedule of new accounting pronouncements and changes in accounting principles Disaggregation of Revenue [Table Text Block] Schedule of disaggregation of revenue by geographic region and type Contract with Customer, Asset and Liability [Table Text Block] Schedule of deferred revenue and changes in the contract liabilities Capitalized Contract Cost [Table Text Block] Schedule of capitalized contract costs Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of basic and diluted net income per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of stock options and warrants to purchase shares of our commons stock and restricted stock units excluded from the calculation of diluted net income per share Schedule of Inventory, Current [Table Text Block] Schedule of inventory Property, Plant and Equipment [Table Text Block] Schedule of property and equipment Long-lived Assets by Geographic Areas [Table Text Block] Schedule of property and equipment, net, information by geographic region Schedule of Finite-Lived Intangible Assets [Table Text Block] Summary of the components of intangible asset balances Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of expected annual amortization expense related to intangible assets (excludes in process intangible assets) Debt Securities, Available-for-sale [Table Text Block] Summary of available-for-sale securities Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of the fair value of assets and liabilities subject to recurring fair value measurements Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of components of accumulated other comprehensive loss, net of tax Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of stock-based compensation Schedule of Share-based Compensation, Activity [Table Text Block] Summary of stock options and restricted stock units activity Lease, Cost [Table Text Block] Schedule of lease cost Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of maturity of lease liabilities Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of future minimum operating lease payments Number of Reportable Segments Number of reportable segment Concentration Risk [Table] n/a FDA Warning Letter [Abstract] FDA Warning Letter Represents information pertaining to the number of observations identified in the warning letter issued by FDA. Warning Letter Number of Observations Number of observations Represents the number of responses whose accuracy will be determined by the FDA. Warning Letter Number of Identified Responses Number of identified responses whose accuracy will be determined Risks and Uncertainties [Abstract] Certain Significant Risks and Uncertainties Represents the number of customers of the entity. Number of Customers Number of customers Concentration Risk, Percentage Concentration risk (as a percent) New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Lease, Practical Expedient, Use of Hindsight [true false] Lease, practical expedient, use of hindsight Lease, Practical Expedients, Package [true false] Lease, practical expedients, package EX-101.PRE 11 irmd-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2019	Apr. 30, 2019
Document and Entity Information
Entity Registrant Name	IRADIMED CORP
Entity Central Index Key	0001325618
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Trading Symbol	IRMD
Entity Common Stock, Shares Outstanding		11,157,222
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 29,684,457	$ 28,027,688
Accounts receivable, net of allowance for doubtful accounts of $63,894 as of March 31, 2019 and $42,443 as of December 31, 2018	5,328,550	4,209,992
Investments	5,746,888	6,349,915
Inventory, net	4,231,504	4,059,443
Prepaid expenses and other current assets	783,170	526,787
Prepaid income taxes	1,665,986	1,367,892
Total current assets	47,440,555	44,541,717
Property and equipment, net	1,902,045	1,869,561
Intangible assets, net	819,752	832,519
Operating lease right-of-use asset	3,127,278
Deferred income taxes, net	1,017,049	1,088,702
Other assets	106,536	109,759
Total assets	54,413,215	48,442,258
Current liabilities:
Accounts payable	1,180,598	772,470
Accrued payroll and benefits	1,423,967	1,802,321
Other accrued taxes	86,168	133,000
Warranty reserve	74,183	74,524
Deferred revenue	1,902,175	1,798,784
Current portion of operating lease liability	230,271
Other current liability	108,421	108,421
Total current liabilities	5,005,783	4,689,520
Deferred revenue	1,864,348	1,807,005
Operating lease liability, less current portion	2,897,007
Total liabilities	9,767,138	6,496,525
Stockholders' equity:
Common stock; $0.0001 par value; 31,500,000 shares authorized; 11,144,196 shares issued and outstanding as of March 31, 2019 and 10,989,111 shares issued and outstanding as of December 31, 2018	1,114	1,099
Additional paid-in capital	16,133,905	15,317,335
Retained earnings	28,515,056	26,669,491
Accumulated other comprehensive loss	(3,998)	(42,192)
Total stockholders' equity	44,646,077	41,945,733
Total liabilities and stockholders' equity	$ 54,413,215	$ 48,442,258

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
CONDENSED BALANCE SHEETS
Accounts receivable, allowance for doubtful accounts	$ 63,894	$ 42,443
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	31,500,000	31,500,000
Common stock, shares issued	11,144,196	10,989,111
Common stock, shares outstanding	11,144,196	10,989,111

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Mar. 31, 2019	Mar. 31, 2018
CONDENSED STATEMENTS OF OPERATIONS
Revenue	$ 8,437,593	$ 7,108,151
Cost of revenue	2,047,827	1,691,535
Gross profit	6,389,766	5,416,616
Operating expenses:
General and administrative	2,412,696	2,303,532
Sales and marketing	2,110,652	1,645,936
Research and development	352,573	379,826
Total operating expenses	4,875,921	4,329,294
Income from operations	1,513,845	1,087,322
Other income, net	92,574	40,072
Income before provision for income taxes	1,606,419	1,127,394
Provision for income tax (benefit) expense	(239,146)	286,198
Net income	$ 1,845,565	$ 841,196
Net income per share:
Basic (in dollars per share)	$ 0.17	$ 0.08
Diluted (in dollars per share)	$ 0.15	$ 0.07
Weighted average shares outstanding:
Basic (in shares)	11,029,639	10,608,387
Diluted (in shares)	12,227,696	11,879,889

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)	Mar. 31, 2019	Mar. 31, 2018
CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
Net income	$ 1,845,565	$ 841,196
Other comprehensive income (loss):
Change in fair value of available-for-sale securities, , net of tax expense (benefit) of $11,656 and $(14,128), , respectively	35,317	(42,651)
Realized loss on available-for-sale securities reclassified to net income, net of tax (benefit) expense of $(949) and $86, respectively	2,877	(429)
Other comprehensive income (loss)	38,194	(43,080)
Comprehensive income	$ 1,883,759	$ 798,116

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
Change in fair value of available-for-sale securities, tax benefit	$ 11,656	$ (14,128)
Reclassification to net income, tax benefit	$ (949)	$ 86

XML 18 R7.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Total
Balances at Dec. 31, 2017	$ 1,060	$ 12,623,181	$ 20,355,545	$ (48,909)	$ 32,930,877
Balance (in shares) at Dec. 31, 2017	10,596,566
Increase (Decrease) in Stockholders' Equity
Net income			841,196		841,196
Other comprehensive income (loss)				(43,080)	(43,080)
Stock-based compensation		416,327			416,327
Net share settlement of restricted stock units		(4,376)			(4,376)
Net share settlement of restricted stock units (in shares)	3,163
Exercise of stock options	$ 2	95,922			95,924
Exercise of stock options (in shares)	22,313
Cumulative effect from adoption of accounting standard update			10,496	(10,496)
Balances at Mar. 31, 2018	$ 1,062	13,131,054	21,207,237	(102,485)	34,236,868
Balance (in shares) at Mar. 31, 2018	10,622,042
Balances at Dec. 31, 2018	$ 1,099	15,317,335	26,669,491	(42,192)	41,945,733
Balance (in shares) at Dec. 31, 2018	10,989,111
Increase (Decrease) in Stockholders' Equity
Net income			1,845,565		1,845,565
Other comprehensive income (loss)				38,194	38,194
Stock-based compensation		382,353			382,353
Net share settlement of restricted stock units		(22,507)			(22,507)
Net share settlement of restricted stock units (in shares)	4,322
Exercise of stock options	$ 15	456,724			456,739
Exercise of stock options (in shares)	150,763
Balances at Mar. 31, 2019	$ 1,114	$ 16,133,905	$ 28,515,056	$ (3,998)	$ 44,646,077
Balance (in shares) at Mar. 31, 2019	11,144,196

XML 19 R8.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	Mar. 31, 2019	Mar. 31, 2018
Operating activities:
Net income	$ 1,845,565	$ 841,196
Adjustments to reconcile net income to net cash provided by operating activities:
Change in allowance for doubtful accounts	21,450	8,842
Change in provision for excess and obsolete inventory	120,529	61,011
Depreciation and amortization	387,081	427,747
Stock-based compensation	382,353	416,327
Deferred income taxes, net	59,048	(123,689)
Loss (gain) on maturities of investments	3,826	(550)
Changes in operating assets and liabilities:
Accounts receivable	(1,140,008)	490,147
Inventory	(333,546)	(155,234)
Prepaid expenses and other current assets	(665,862)	(254,051)
Other assets	(4,891)	(18,185)
Accounts payable	375,202	(80,631)
Accrued payroll and benefits	(378,354)	(331,790)
Other accrued taxes	(46,832)	(75,365)
Warranty reserve	(341)	10,414
Deferred revenue	338,078	(42,344)
Prepaid income taxes, net of accrued income taxes	(298,094)	410,045
Net cash provided by operating activities	665,204	1,583,890
Investing activities:
Proceeds from maturity of investments	650,000	250,000
Purchases of property and equipment	(82,943)	(37,983)
Capitalized intangible assets	(9,724)	(298)
Net cash provided by investing activities	557,333	211,719
Financing activities:
Proceeds from exercises of stock options and underwriters' warrants	456,739	95,924
Taxes paid related to the net share settlement of equity awards	(22,507)	(4,376)
Net cash provided by financing activities	434,232	91,548
Net increase in cash and cash equivalents	1,656,769	1,887,157
Cash and cash equivalents, beginning of period	28,027,688	18,205,976
Cash and cash equivalents, end of period	29,684,457	20,093,133
Supplemental disclosure of cash flow information:
Right-of-use asset recognized in exchange for new lease obligation	3,182,724
Operating and short-term lease payments recorded within cash flow from operating activities	$ 106,659	$ 101,505

XML 20 R9.htm IDEA: XBRL DOCUMENT

Basis of Presentation

3 Months Ended

Mar. 31, 2019

Basis of Presentation

Basis of Presentation

1 — Basis of Presentation

FDA Warning Letter

On December 15, 2016, we received FDA 510(k) clearance for our MRidium 3860+ MRI IV infusion pump system, including the DERS software feature. As of March 31, 2019, the Warning Letter remains open.

CE Mark for 3880 Patient Vital Signs Monitoring System

Certain Significant Risks and Uncertainties

We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses. As of March 31, 2019, one domestic customer accounted for approximately 16.2% of accounts receivable.

Recent Accounting Pronouncements

Accounting Pronouncements Implemented in 2019

We adopted this update on January 1, 2019 and, as part of that process, made the following elections:

We elected to use the hindsight practical expedient.

We elected the package of practical expedients in transition for leases that commenced prior to January 1, 2019 whereby contracts were not reassessed or reclassified from their previous assessment as of December 31, 2018.

In March 2018, the FASB approved an optional transition method that allows companies to use the effective date as the date of initial application on transition. We elected this transition method, and as a result, did not adjust comparative period financial information or make the newly required lease disclosures for periods before the effective date.

We elected to make the accounting policy election for short-term leases resulting in lease payments being recorded as an expense on a straight-line basis over the lease term.

We elected to not separate lease and nonlease components, for all leases.

We did not elect the land easement practical expedient.


	January 1,
	2019
Operating lease right-of-use asset	$	3,182,724
Current portion of operating lease liability	$	226,852
Operating lease liability, less current portion	$	2,955,872

There was no impact to our Condensed Statements of Operations, Condensed Statements of Cash Flows or beginning retained earnings related to the adoption of Topic 842.

Recently Issued Accounting Pronouncements to be Implemented

In June 2016, the FASB issued 2016-03, Financial Instruments – Credit Losses (Topic 326). This update requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. In addition, for available-for-sale debt securities, this ASU replaces the other-than-temporary impairment model and requires the recognition of an allowance for reductions in a security’s fair value attributable to declines in credit quality, instead of a direct writedown of the security, when a valuation decline is determined to be other-than-temporary. The ASU requires a cumulative-effect adjustment to retained earnings as of the beginning of the reporting period of adoption. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019 and for interim periods therein. Companies may choose to adopt this ASU as of its fiscal year beginning after December 15, 2018. We did not early adopt this standard. We do not believe this ASU will have a material impact on our financial condition or statements of operations.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Revenue Recognition

3 Months Ended

Mar. 31, 2019

Revenue Recognition

Revenue Recognition

2 — Revenue Recognition

Disaggregation of Revenue

We disaggregate revenue from contracts with customers by geographic region and revenue type as we believe it best depicts the nature, amount, timing and uncertainty of our revenue and cash flow.

Revenue information by geographic region is as follows:


	Three Months Ended
	March 31,
	2019		2018
	(unaudited)
United States	$	7,073,735	$	5,977,107
International		1,363,858		1,131,044
Total revenue	$	8,437,593	$	7,108,151

Revenue information by type is as follows:


	Three Months Ended
	March 31,
	2019		2018
	(unaudited)
Devices:
MRI compatible IV infusion pump system	$	4,192,754	$	3,625,622
MRI compatible patient vital signs monitoring systems		1,766,608		1,203,856
Total Devices revenue		5,959,362		4,829,478
Disposables and services		2,036,674		1,939,091
Amortization of extended warranty agreements		441,557		339,582
Total revenue	$	8,437,593	$	7,108,151

Contract Liabilities

Our contract liabilities consist of:


	March 31,		December 31,
	2019		2018
	(unaudited)
Advance payments from customers	$	51,991	$	180,425
Shipments in-transit		177,344		9,582
Extended warranty agreements		3,537,188		3,415,782
Total	$	3,766,523	$	3,605,789

Changes in the contract liabilities during the periods presented are as follows:


	Deferred
	Revenue
Contract liabilities, December 31, 2018	$	3,605,789
Increases due to cash received from customers		813,298
Decreases due to recognition of revenue		(652,564)
Contract liabilities, March 31, 2019	$	3,766,523


	Deferred
	Revenue
Contract liabilities, December 31, 2017	$	3,621,256
Increases due to cash received from customers		549,032
Decreases due to recognition of revenue		(591,376)
Contract liabilities, March 31, 2018	$	3,578,912

Capitalized Contract Costs

Our capitalized contract costs consist of:

Expense for the three months ended March 31, 2019 and 2018 related to the amortization of capitalized contract costs were immaterial to our financial statements.

XML 22 R11.htm IDEA: XBRL DOCUMENT

Basic and Diluted Net Income per Share

3 Months Ended

Mar. 31, 2019

Basic and Diluted Net Income per Share

Basic and Diluted Net Income per Share

3 — Basic and Diluted Net Income per Share

The following table presents the computation of basic and diluted net income per share:


	Three Months Ended March 31,
	2019		2018
	(unaudited)
Net income	$	1,845,565	$	841,196
Weighted-average shares outstanding — Basic		11,029,639		10,608,387
Effect of dilutive securities:
Underwriters' warrants		99,814		53,434
Stock options		996,303		1,155,708
Restricted stock units		101,940		62,360
Weighted-average shares outstanding — Diluted		12,227,696		11,879,889
Basic net income per share	$	0.17	$	0.08
Diluted net income per share	$	0.15	$	0.07


	Three Months Ended
	March 31,
	2019	2018
	(unaudited)
Anti-dilutive stock options, restricted stock units and warrants	7,123	64,382

XML 23 R12.htm IDEA: XBRL DOCUMENT

Inventory

3 Months Ended

Mar. 31, 2019

Inventory

Inventory

4 — Inventory

Inventory consists of:


	March 31,		December 31,
	2019		2018
	(unaudited)
Raw materials	$	3,570,874	$	3,408,158
Work in process		252,829		305,562
Finished goods		652,878		557,566
Inventory before allowance for excess and obsolete		4,476,581		4,271,286
Allowance for excess and obsolete		(245,077)		(211,843)
Total	$	4,231,504	$	4,059,443

XML 24 R13.htm IDEA: XBRL DOCUMENT

Property and Equipment

3 Months Ended

Mar. 31, 2019

Property and Equipment

Property and Equipment

5 — Property and Equipment

Property and equipment consist of:


	March 31,		December 31,
	2019		2018
	(unaudited)
Computer software and hardware	$	593,347	$	555,292
Furniture and fixtures		978,152		901,415
Leasehold improvements		209,226		202,026
Machinery and equipment		2,193,486		2,184,015
Tooling in-process		83,625		58,263
		4,057,836		3,901,011
Accumulated depreciation		(2,155,791)		(2,031,450)
Total	$	1,902,045	$	1,869,561

Depreciation expense of property and equipment was $124,341 and $109,371 for the three months ended March 31, 2019 and 2018, respectively.

Property and equipment, net, information by geographic region is as follows:


	March 31,		December 31,
	2019		2018
	(unaudited)
United States	$	1,474,529	$	1,439,545
International		427,516		430,016
Total property and equipment, net	$	1,902,045	$	1,869,561

Long-lived assets held outside of the United States consist principally of tooling and machinery and equipment, which are components of property and equipment, net.

XML 25 R14.htm IDEA: XBRL DOCUMENT

Intangible Assets

3 Months Ended

Mar. 31, 2019

Intangible Assets

Intangible Assets

6 — Intangible Assets

The following table summarizes the components of intangible asset balances:


	March 31,		December 31,
	2019		2018
	(unaudited)
Patents — in use	$	304,270	$	304,270
Patents — in process		76,990		73,164
Internally developed software — in use		867,569		867,569
Internally developed software — in process		19,621		13,723
Trademarks		23,017		23,017
		1,291,467		1,281,743
Accumulated amortization		(471,715)		(449,224)
Total	$	819,752	$	832,519

Amortization expense of intangible assets was $22,491 and $21,860 for the three months ended March 31, 2019 and 2018, respectively.

Expected annual amortization expense for the remaining portion of 2019 and the next five years related to intangible assets is as follows (excludes in process intangible assets):


Nine months ending December 31, 2019	$	67,472
2020		89,963
2021		89,963
2022		89,392
2023		88,740
2024		88,439

XML 26 R15.htm IDEA: XBRL DOCUMENT

Investments

3 Months Ended

Mar. 31, 2019

Investments

Investments

7 — Investments

Our investments consist of corporate bonds that we have classified as available-for-sale and are summarized in the following tables:


		March 31, 2019
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
Corporate bonds:
U.S. corporations	$	4,833,819	$	1,100	$	14,367	$	4,820,552
International corporations		918,417		7,919		—		926,336
Total	$	5,752,236	$	9,019	$	14,367	$	5,746,888


		December 31, 2018
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
Corporate bonds:
U.S. corporations	$	5,487,645	$	—	$	58,309	$	5,429,336
International corporations		918,417		2,162		—		920,579
Total	$	6,406,062	$	2,162	$	58,309	$	6,349,915

XML 27 R16.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Mar. 31, 2019

Fair Value Measurements

Fair Value Measurements

8 — Fair Value Measurements

The fair value of our assets and liabilities subject to recurring fair value measurements are as follows:


	Fair Value at March 31, 2019
			Quoted Prices		Significant
			in Active		Other		Significant
			Market for		Observable		Unobservable
	Fair		Identical Assets		Inputs		Inputs
	Value		(Level 1)		(Level 2)		(Level 3)
Corporate bonds:
U.S. corporations	$	4,820,552	$	—	$	4,820,552	$	—
International corporations		926,336		—		926,336		—
Total	$	5,746,888	$	—	$	5,746,888	$	—


	Fair Value at December 31, 2018
			Quoted Prices		Significant
			in Active		Other		Significant
			Market for		Observable		Unobservable
	Fair		Identical Assets		Inputs		Inputs
	Value		(Level 1)		(Level 2)		(Level 3)
Corporate bonds:
U.S. corporations	$	5,429,336	$	—	$	5,429,336	$	—
International corporations		920,579		—		920,579		—
Total	$	6,349,915	$	—	$	6,349,915	$	—

Our corporate bonds are valued by a third-party custodian at closing prices from secondary exchanges or pricing vendors on the valuation date.

There were no transfers into or out of any Levels during the three months ended March 31, 2019 or the year ended December 31, 2018.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 28 R17.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Loss

3 Months Ended

Mar. 31, 2019

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Loss

9 — Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2019 and 2018 are as follows:


	Unrealized (Losses)
	Gains on
	Available-For-Sale
	Securities
Balance at December 31, 2018	$	(42,192)
Gains on available-for-sale securities, net		35,317
Reclassification realized in net earnings		2,877
Balance at March 31, 2019	$	(3,998)

Balance at December 31, 2017	$	(48,909)
Losses on available-for-sale securities, net		(42,651)
Reclassification realized in net earnings		(429)
Cumulative effect from adoption of accounting standard update		(10,496)
Balance at March 31, 2018	$	(102,485)

XML 29 R18.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation

3 Months Ended

Mar. 31, 2019

Stock-Based Compensation

Stock-Based Compensation

10 — Stock-Based Compensation

Stock-based compensation was recognized as follows in the Condensed Statements of Operations:


	Three Months Ended
	March 31,
	2019		2018
	(unaudited)
Cost of revenue	$	62,524	$	68,259
General and administrative		219,705		226,771
Sales and marketing		82,131		83,616
Research and development		17,993		37,681
Total	$	382,353	$	416,327

The following table presents a summary of our stock-based compensation activity for the three months ended March 31, 2019 (shares):


	Stock	Restricted
	Options	Stock Units
Outstanding beginning of period	1,129,463	226,501
Awards granted	—	3,592
Awards exercised/vested	(150,763)	(5,200)
Awards canceled	(750)	(11,270)
Outstanding end of period	977,950	213,623

XML 30 R19.htm IDEA: XBRL DOCUMENT

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2019
Income Taxes
Income Taxes	11 — Income Taxes For the three months ended March 31, 2019, we recorded a provision for income tax benefit of $(239,146). Our effective tax rate was (14.9) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation, partially offset by U.S. state tax expense. For the three months ended March 31, 2018, we recorded a provision for income tax expense of $286,198. Our effective tax rate was 25.4 percent and differed from the U.S. Federal statutory rate primarily due to research and development credits, partially offset by U.S. state tax expense. As of March 31, 2019 and December 31, 2018, we had not identified or accrued for any uncertain tax positions. We are currently unaware of any uncertain tax positions that could result in significant payments, accruals or other material deviations in this estimate over the next 12 months. We believe that our tax positions comply in all material respects with applicable tax law. However, tax law is subject to interpretation, and interpretations by taxing authorities could be different from ours, which could result in the imposition of additional taxes and penalties. We file tax returns in the United States Federal jurisdiction and many U.S. state jurisdictions. The Company is subject to income tax examinations for our United States Federal and certain U.S. state income taxes for 2015 and subsequent years and various other U.S. state income taxes for 2014 and subsequent years.

XML 31 R20.htm IDEA: XBRL DOCUMENT

Leases

3 Months Ended

Mar. 31, 2019

Leases

Leases

12 — Leases

Lease agreements with lease and nonlease components are combined as a single lease component. The depreciable life of lease assets and leasehold improvements is limited by the expected lease term.

Operating lease cost recognized for the three months ended March 31, 2019 is follows in the Condensed Statements of Operations:


Cost of revenue	$	46,535
General and administrative		46,044
Sales and marketing		2,605
Research and development		7,215
Total	$	102,399

Lease costs for short-term leases were immaterial for the three months ended March 31, 2019.

Maturity of Operating Lease Liability as of March 31, 2019 is as follows:


Nine months ending December 31, 2019	$	307,197
2020		409,596
2021		409,596
2022		409,596
2023		409,596
Thereafter		2,218,646
Total lease payments		4,164,227
Imputed interest		(1,036,949)
Present value of lease liability	$	3,127,278

We used a discount rate of 6.0% to determine the present value of the operating lease liability on January 1, 2019.

Undiscounted future minimum lease payments under noncancelable operating leases as of December 31, 2018 as determined prior to the adoption of ASC 842 are as follows:


2019	$	170,664
2020		—
2021		—
2022		—
2023		—
Thereafter		—
Total minimum lease payments	$	170,664

XML 32 R21.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2019
Commitments and Contingencies
Commitments and Contingencies	13 — Commitments and Contingencies Purchase commitments. We had various purchase orders for goods or services totaling $2,920,468 and $2,674,691 as of March 31, 2019 and December 31, 2018, respectively. No amounts related to these purchase orders have been recognized in our balance sheet. Legal matters. We may from time to time become party to various legal proceedings or claims that arise in the ordinary course of business.

XML 33 R22.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2019

Basis of Presentation

FDA Warning Letter

On December 15, 2016, we received FDA 510(k) clearance for our MRidium 3860+ MRI IV infusion pump system, including the DERS software feature. As of March 31, 2019, the Warning Letter remains open.

CE Mark for 3880 Patient Vital Signs Monitoring System

Certain Significant Risks and Uncertainties

We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses. As of March 31, 2019, one domestic customer accounted for approximately 16.2% of accounts receivable.

Recent Accounting Pronouncements

Accounting Pronouncements Implemented in 2019

We adopted this update on January 1, 2019 and, as part of that process, made the following elections:

We elected to use the hindsight practical expedient.

We elected to make the accounting policy election for short-term leases resulting in lease payments being recorded as an expense on a straight-line basis over the lease term.

We elected to not separate lease and nonlease components, for all leases.

We did not elect the land easement practical expedient.


	January 1,
	2019
Operating lease right-of-use asset	$	3,182,724
Current portion of operating lease liability	$	226,852
Operating lease liability, less current portion	$	2,955,872

There was no impact to our Condensed Statements of Operations, Condensed Statements of Cash Flows or beginning retained earnings related to the adoption of Topic 842.

Recently Issued Accounting Pronouncements to be Implemented

XML 34 R23.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2019

Basis of Presentation

Schedule of new accounting pronouncements and changes in accounting principles


	January 1,
	2019
Operating lease right-of-use asset	$	3,182,724
Current portion of operating lease liability	$	226,852
Operating lease liability, less current portion	$	2,955,872

XML 35 R24.htm IDEA: XBRL DOCUMENT

Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2019

Revenue Recognition

Schedule of disaggregation of revenue by geographic region and type

Revenue information by geographic region is as follows:


	Three Months Ended
	March 31,
	2019		2018
	(unaudited)
United States	$	7,073,735	$	5,977,107
International		1,363,858		1,131,044
Total revenue	$	8,437,593	$	7,108,151

Revenue information by type is as follows:


	Three Months Ended
	March 31,
	2019		2018
	(unaudited)
Devices:
MRI compatible IV infusion pump system	$	4,192,754	$	3,625,622
MRI compatible patient vital signs monitoring systems		1,766,608		1,203,856
Total Devices revenue		5,959,362		4,829,478
Disposables and services		2,036,674		1,939,091
Amortization of extended warranty agreements		441,557		339,582
Total revenue	$	8,437,593	$	7,108,151

Schedule of deferred revenue and changes in the contract liabilities

Our contract liabilities consist of:


	March 31,		December 31,
	2019		2018
	(unaudited)
Advance payments from customers	$	51,991	$	180,425
Shipments in-transit		177,344		9,582
Extended warranty agreements		3,537,188		3,415,782
Total	$	3,766,523	$	3,605,789

Changes in the contract liabilities during the periods presented are as follows:


	Deferred
	Revenue
Contract liabilities, December 31, 2018	$	3,605,789
Increases due to cash received from customers		813,298
Decreases due to recognition of revenue		(652,564)
Contract liabilities, March 31, 2019	$	3,766,523


	Deferred
	Revenue
Contract liabilities, December 31, 2017	$	3,621,256
Increases due to cash received from customers		549,032
Decreases due to recognition of revenue		(591,376)
Contract liabilities, March 31, 2018	$	3,578,912

Schedule of capitalized contract costs

XML 36 R25.htm IDEA: XBRL DOCUMENT

Basic and Diluted Net Income per Share (Tables)

3 Months Ended

Mar. 31, 2019

Basic and Diluted Net Income per Share

Schedule of computation of basic and diluted net income per share


	Three Months Ended March 31,
	2019		2018
	(unaudited)
Net income	$	1,845,565	$	841,196
Weighted-average shares outstanding — Basic		11,029,639		10,608,387
Effect of dilutive securities:
Underwriters' warrants		99,814		53,434
Stock options		996,303		1,155,708
Restricted stock units		101,940		62,360
Weighted-average shares outstanding — Diluted		12,227,696		11,879,889
Basic net income per share	$	0.17	$	0.08
Diluted net income per share	$	0.15	$	0.07

Schedule of stock options and warrants to purchase shares of our commons stock and restricted stock units excluded from the calculation of diluted net income per share


	Three Months Ended
	March 31,
	2019	2018
	(unaudited)
Anti-dilutive stock options, restricted stock units and warrants	7,123	64,382

XML 37 R26.htm IDEA: XBRL DOCUMENT

Inventory (Tables)

3 Months Ended

Mar. 31, 2019

Inventory

Schedule of inventory


	March 31,		December 31,
	2019		2018
	(unaudited)
Raw materials	$	3,570,874	$	3,408,158
Work in process		252,829		305,562
Finished goods		652,878		557,566
Inventory before allowance for excess and obsolete		4,476,581		4,271,286
Allowance for excess and obsolete		(245,077)		(211,843)
Total	$	4,231,504	$	4,059,443

XML 38 R27.htm IDEA: XBRL DOCUMENT

Property and Equipment (Tables)

3 Months Ended

Mar. 31, 2019

Property and Equipment

Schedule of property and equipment


	March 31,		December 31,
	2019		2018
	(unaudited)
Computer software and hardware	$	593,347	$	555,292
Furniture and fixtures		978,152		901,415
Leasehold improvements		209,226		202,026
Machinery and equipment		2,193,486		2,184,015
Tooling in-process		83,625		58,263
		4,057,836		3,901,011
Accumulated depreciation		(2,155,791)		(2,031,450)
Total	$	1,902,045	$	1,869,561

Schedule of property and equipment, net, information by geographic region


	March 31,		December 31,
	2019		2018
	(unaudited)
United States	$	1,474,529	$	1,439,545
International		427,516		430,016
Total property and equipment, net	$	1,902,045	$	1,869,561

XML 39 R28.htm IDEA: XBRL DOCUMENT

Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2019

Intangible Assets

Summary of the components of intangible asset balances


	March 31,		December 31,
	2019		2018
	(unaudited)
Patents — in use	$	304,270	$	304,270
Patents — in process		76,990		73,164
Internally developed software — in use		867,569		867,569
Internally developed software — in process		19,621		13,723
Trademarks		23,017		23,017
		1,291,467		1,281,743
Accumulated amortization		(471,715)		(449,224)
Total	$	819,752	$	832,519

Schedule of expected annual amortization expense related to intangible assets (excludes in process intangible assets)


Nine months ending December 31, 2019	$	67,472
2020		89,963
2021		89,963
2022		89,392
2023		88,740
2024		88,439

XML 40 R29.htm IDEA: XBRL DOCUMENT

Investments (Tables)

3 Months Ended

Mar. 31, 2019

Investments

Summary of available-for-sale securities


		March 31, 2019
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
Corporate bonds:
U.S. corporations	$	4,833,819	$	1,100	$	14,367	$	4,820,552
International corporations		918,417		7,919		—		926,336
Total	$	5,752,236	$	9,019	$	14,367	$	5,746,888


		December 31, 2018
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
Corporate bonds:
U.S. corporations	$	5,487,645	$	—	$	58,309	$	5,429,336
International corporations		918,417		2,162		—		920,579
Total	$	6,406,062	$	2,162	$	58,309	$	6,349,915

XML 41 R30.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2019

Fair Value Measurements

Schedule of the fair value of assets and liabilities subject to recurring fair value measurements


	Fair Value at March 31, 2019
			Quoted Prices		Significant
			in Active		Other		Significant
			Market for		Observable		Unobservable
	Fair		Identical Assets		Inputs		Inputs
	Value		(Level 1)		(Level 2)		(Level 3)
Corporate bonds:
U.S. corporations	$	4,820,552	$	—	$	4,820,552	$	—
International corporations		926,336		—		926,336		—
Total	$	5,746,888	$	—	$	5,746,888	$	—


	Fair Value at December 31, 2018
			Quoted Prices		Significant
			in Active		Other		Significant
			Market for		Observable		Unobservable
	Fair		Identical Assets		Inputs		Inputs
	Value		(Level 1)		(Level 2)		(Level 3)
Corporate bonds:
U.S. corporations	$	5,429,336	$	—	$	5,429,336	$	—
International corporations		920,579		—		920,579		—
Total	$	6,349,915	$	—	$	6,349,915	$	—

XML 42 R31.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Mar. 31, 2019

Accumulated Other Comprehensive Loss

Schedule of components of accumulated other comprehensive loss, net of tax

The components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2019 and 2018 are as follows:


	Unrealized (Losses)
	Gains on
	Available-For-Sale
	Securities
Balance at December 31, 2018	$	(42,192)
Gains on available-for-sale securities, net		35,317
Reclassification realized in net earnings		2,877
Balance at March 31, 2019	$	(3,998)

Balance at December 31, 2017	$	(48,909)
Losses on available-for-sale securities, net		(42,651)
Reclassification realized in net earnings		(429)
Cumulative effect from adoption of accounting standard update		(10,496)
Balance at March 31, 2018	$	(102,485)

XML 43 R32.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2019

Stock-Based Compensation

Schedule of stock-based compensation


	Three Months Ended
	March 31,
	2019		2018
	(unaudited)
Cost of revenue	$	62,524	$	68,259
General and administrative		219,705		226,771
Sales and marketing		82,131		83,616
Research and development		17,993		37,681
Total	$	382,353	$	416,327

Summary of stock options and restricted stock units activity

The following table presents a summary of our stock-based compensation activity for the three months ended March 31, 2019 (shares):


	Stock	Restricted
	Options	Stock Units
Outstanding beginning of period	1,129,463	226,501
Awards granted	—	3,592
Awards exercised/vested	(150,763)	(5,200)
Awards canceled	(750)	(11,270)
Outstanding end of period	977,950	213,623

XML 44 R33.htm IDEA: XBRL DOCUMENT

Leases (Tables)

3 Months Ended

Mar. 31, 2019

Leases

Schedule of lease cost


Cost of revenue	$	46,535
General and administrative		46,044
Sales and marketing		2,605
Research and development		7,215
Total	$	102,399

Schedule of maturity of lease liabilities


Nine months ending December 31, 2019	$	307,197
2020		409,596
2021		409,596
2022		409,596
2023		409,596
Thereafter		2,218,646
Total lease payments		4,164,227
Imputed interest		(1,036,949)
Present value of lease liability	$	3,127,278

Schedule of future minimum operating lease payments


2019	$	170,664
2020		—
2021		—
2022		—
2023		—
Thereafter		—
Total minimum lease payments	$	170,664

XML 45 R34.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Details)	3 Months Ended
Basis of Presentation (Details)	Mar. 31, 2019 segment
Basis of Presentation
Number of reportable segment	1

XML 46 R35.htm IDEA: XBRL DOCUMENT

Basis of Presentation - FDA Warning Letter (Details) - item	Sep. 02, 2014	Apr. 16, 2014
FDA Warning Letter
Number of observations		8
Number of identified responses whose accuracy will be determined	2

XML 47 R36.htm IDEA: XBRL DOCUMENT

Basis of Presentation - Certain Significant Risks and Uncertainties (Details) - Domestic customer	3 Months Ended
	Mar. 31, 2019
Certain Significant Risks and Uncertainties
Number of customers	1
Accounts receivable \| Customer concentration risk
Certain Significant Risks and Uncertainties
Concentration risk (as a percent)	16.20%

XML 48 R37.htm IDEA: XBRL DOCUMENT

Basis of Presentation - Recent Accounting Pronouncements (Details) - USD ($)	Jan. 01, 2019	Mar. 31, 2019
Leases
Lease, practical expedient, use of hindsight	true
Lease, practical expedients, package	true
Operating lease right-of-use asset		$ 3,127,278
Current portion of operating lease liability		230,271
Operating lease liability, less current portion		$ 2,897,007
ASU 2016-02
Leases
Operating lease right-of-use asset	$ 3,182,724
Current portion of operating lease liability	226,852
Operating lease liability, less current portion	$ 2,955,872

XML 49 R38.htm IDEA: XBRL DOCUMENT

Revenue Recognition - Information by Geographic Region (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Contract Liabilities
Total revenue	$ 8,437,593	$ 7,108,151	$ 7,108,151
United States
Contract Liabilities
Total revenue	7,073,735		5,977,107
International
Contract Liabilities
Total revenue	$ 1,363,858		$ 1,131,044

XML 50 R39.htm IDEA: XBRL DOCUMENT

Revenue Recognition - Information by Type (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Disaggregation of Revenue
Total Devices Revenue	$ 5,959,362	$ 4,829,478
Disposables and Services	2,036,674	1,939,091
Amortization of extended warranty agreements	441,557	339,582
Total revenue	8,437,593	7,108,151	$ 7,108,151
MRI Compatible IV Infusion Pump Systems
Disaggregation of Revenue
Total Devices Revenue	4,192,754	3,625,622
MRI Compatible Patient Vital Signs Monitoring Systems
Disaggregation of Revenue
Total Devices Revenue	$ 1,766,608	$ 1,203,856

XML 51 R40.htm IDEA: XBRL DOCUMENT

Revenue Recognition - Contract Liabilities (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2019	Dec. 31, 2018
Deferred revenue
Advance payments from customers			$ 51,991	$ 180,425
Shipments in-transit			177,344	9,582
Extended warranty agreements			3,537,188	3,415,782
Total	$ 3,605,789	$ 3,621,256	$ 3,766,523	$ 3,605,789
Changes in contract liabilities
Contract liabilities at beginning of the year	3,605,789	3,621,256
Increases due to cash received from customers	813,298	549,032
Decreases due to recognition of revenue	652,564	(591,376)
Contract liabilities at end of the year	$ 3,766,523	$ 3,578,912

XML 52 R41.htm IDEA: XBRL DOCUMENT

Revenue Recognition - Capitalized Contract Costs (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Revenue Recognition
Capitalized contract costs	$ 186,140	$ 181,248

XML 53 R42.htm IDEA: XBRL DOCUMENT

Basic and Diluted Net Income per Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Basic and Diluted Net Income per Share
Net income	$ 1,845,565	$ 841,196
Weighted-average shares outstanding - Basic (in shares)	11,029,639	10,608,387
Effect of dilutive securities:
Underwriters' warrants	99,814	53,434
Stock options	996,303	1,155,708
Restricted stock units	101,940	62,360
Weighted-average shares outstanding - Diluted (in shares)	12,227,696	11,879,889
Basic net income per share (in dollars per share)	$ 0.17	$ 0.08
Diluted net income per share (in dollars per share)	$ 0.15	$ 0.07
Anti-dilutive stock
Anti-dilutive stock options, restricted stock units and warrants	7,123	64,382

XML 54 R43.htm IDEA: XBRL DOCUMENT

Inventory (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Inventory
Raw materials	$ 3,570,874	$ 3,408,158
Work in process	252,829	305,562
Finished goods	652,878	557,566
Inventory before allowance for excess and obsolete	4,476,581	4,271,286
Allowance for excess and obsolete	(245,077)	(211,843)
Total	$ 4,231,504	$ 4,059,443

XML 55 R44.htm IDEA: XBRL DOCUMENT

Property and Equipment (Details) - USD ($)	3 Months Ended
Property and Equipment (Details) - USD ($)	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Property and equipment
Property and equipment, gross	$ 4,057,836		$ 3,901,011
Accumulated depreciation	(2,155,791)		(2,031,450)
Total	1,902,045		1,869,561
Depreciation expense of property and equipment	124,341	$ 109,371
Computer software and hardware
Property and equipment
Property and equipment, gross	593,347		555,292
Furniture and fixtures
Property and equipment
Property and equipment, gross	978,152		901,415
Leasehold improvements
Property and equipment
Property and equipment, gross	209,226		202,026
Machinery and equipment
Property and equipment
Property and equipment, gross	2,193,486		2,184,015
Tooling in-process
Property and equipment
Property and equipment, gross	$ 83,625		$ 58,263

XML 56 R45.htm IDEA: XBRL DOCUMENT

Property and Equipment - Geographic information (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Property and equipment
Property and equipment, net	$ 1,902,045	$ 1,869,561
United States
Property and equipment
Property and equipment, net	1,474,529	1,439,545
International
Property and equipment
Property and equipment, net	$ 427,516	$ 430,016

XML 57 R46.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details) - USD ($)	3 Months Ended
Intangible Assets (Details) - USD ($)	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Intangible assets
Intangible Assets, gross	$ 1,291,467		$ 1,281,743
Accumulated amortization	(471,715)		(449,224)
Total	819,752		832,519
Amortization expense of intangible assets	22,491	$ 21,860
Expected annual amortization expense
Nine months ending December 31, 2019	67,472
2020	89,963
2021	89,963
2022	89,392
2023	88,740
2024	88,439
Patents - in use
Intangible assets
Intangible Assets, gross	304,270		304,270
Patents - in process
Intangible assets
Intangible Assets, gross	76,990		73,164
Internally developed software - in use
Intangible assets
Intangible Assets, gross	867,569		867,569
Internally developed software - in process
Intangible assets
Intangible Assets, gross	19,621		13,723
Trademarks
Intangible assets
Intangible Assets, gross	$ 23,017		$ 23,017

XML 58 R47.htm IDEA: XBRL DOCUMENT

Investments (Details) - USD ($)	3 Months Ended	12 Months Ended
Investments (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Investments
Cost	$ 5,752,236	$ 6,406,062
Gross Unrealized Gains	9,019	2,162
Gross Unrealized Losses	14,367	58,309
Fair Value	5,746,888	6,349,915
U.S. corporations
Investments
Cost	4,833,819	5,487,645
Gross Unrealized Gains	1,100
Gross Unrealized Losses	14,367	58,309
Fair Value	4,820,552	5,429,336
International corporations
Investments
Cost	918,417	918,417
Gross Unrealized Gains	7,919	2,162
Fair Value	$ 926,336	$ 920,579

XML 59 R48.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Fair Value Measurements
Fair value assets, amount transferred between measurement levels	$ 0	$ 0
Fair value liabilities, amount transferred between measurement levels	0	0
Recurring
Fair Value Measurements
Total	5,746,888	6,349,915
Recurring \| U.S. corporations
Fair Value Measurements
Total	4,820,552	5,429,336
Recurring \| International corporations
Fair Value Measurements
Total	926,336	920,579
Recurring \| Significant Other Observable Inputs (Level 2)
Fair Value Measurements
Total	5,746,888	6,349,915
Recurring \| Significant Other Observable Inputs (Level 2) \| U.S. corporations
Fair Value Measurements
Total	4,820,552	5,429,336
Recurring \| Significant Other Observable Inputs (Level 2) \| International corporations
Fair Value Measurements
Total	$ 926,336	$ 920,579

XML 60 R49.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Loss (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Component of accumulated other comprehensive loss
Balance at the beginning	$ (42,192)	$ (48,909)
Gains (Losses) on available-for-sale securities, net	35,317	(42,651)
Reclassification realized in net earnings	(2,877)	429
Cumulative effect from adoption of accounting standard update		(10,496)
Balance at the end	$ (3,998)	$ (102,485)

XML 61 R50.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Details) - USD ($)	3 Months Ended
Stock-Based Compensation (Details) - USD ($)	Mar. 31, 2019	Mar. 31, 2018
Stock-Based Compensation
Total stock-based compensation expense	$ 382,353	$ 416,327
Cost of revenue
Stock-Based Compensation
Total stock-based compensation expense	62,524	68,259
General and administrative
Stock-Based Compensation
Total stock-based compensation expense	219,705	226,771
Sales and marketing
Stock-Based Compensation
Total stock-based compensation expense	82,131	83,616
Research and development
Stock-Based Compensation
Total stock-based compensation expense	$ 17,993	$ 37,681

XML 62 R51.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation - Stock Options and Restricted Stock Units Activity (Details)	3 Months Ended
	Mar. 31, 2019 USD ($) shares
Stock Options
Stock-Based Compensation
Total unrecognized compensation expense \| $	$ 35,611
Weighted-average period expected to be recognized	7 months 6 days
Stock Options
Outstanding beginning of period (in shares)	1,129,463
Awards exercised/vested (in shares)	(150,763)
Awards cancelled (in shares)	(750)
Outstanding end of period (in shares)	977,950
Restricted Stock Units
Stock-Based Compensation
Total unrecognized compensation expense \| $	$ 2,870,751
Weighted-average period expected to be recognized	2 years 7 months 6 days
Restricted Stock Units
Outstanding beginning of period (in shares)	226,501
Awards granted (in shares)	3,592
Awards exercised/vested (in shares)	(5,200)
Awards cancelled (in shares)	(11,270)
Outstanding end of period (in shares)	213,623

XML 63 R52.htm IDEA: XBRL DOCUMENT

Income Taxes (Details) - USD ($)	3 Months Ended
Income Taxes (Details) - USD ($)	Mar. 31, 2019	Mar. 31, 2018
Reconciliation of the statutory U.S. federal tax rate to effective rate
Provision for income tax (benefit) expense	$ (239,146)	$ 286,198
Effective tax rate (as a percent)	(14.90%)	25.40%

XML 64 R53.htm IDEA: XBRL DOCUMENT

Leases (Details)	1 Months Ended	3 Months Ended
Leases (Details)	Jan. 31, 2014 USD ($)	Mar. 31, 2019
Lessee, Lease, Description [Line Items]
Lessee, operating lease, existence of option to extend		true
Lessee, operating lease, existence of option to terminate		true
Lessee, operating lease, existence of residual value guarantee		false
Susi, LLC \| Winter Springs, Florida Facility
Lessee, Lease, Description [Line Items]
Monthly base rent	$ 34,133
Number of successive renewal terms of lease	2
Renewal term of lease beginning in 2019	5 years
Renewal term of lease beginning in 2024	5 years
Renewal term lease thereafter	1 year
Remaining lease term (in years)		10 years 2 months 12 days

XML 65 R54.htm IDEA: XBRL DOCUMENT

Leases - Operating Lease Cost (Details)	3 Months Ended
Leases - Operating Lease Cost (Details)	Mar. 31, 2019 USD ($)
Leases
Operating lease cost	$ 102,399
Cost of revenue
Leases
Operating lease cost	46,535
General and administrative
Leases
Operating lease cost	46,044
Sales and marketing
Leases
Operating lease cost	2,605
Research and development
Leases
Operating lease cost	$ 7,215

XML 66 R55.htm IDEA: XBRL DOCUMENT

Leases - Maturity of Lease Liabilities (Details) - USD ($)	Mar. 31, 2019	Jan. 01, 2019
Operating leases
Nine months ending December 31, 2019	$ 307,197
2020	409,596
2021	409,596
2022	409,596
2023	409,596
Thereafter	2,218,646
Total lease payments	4,164,227
Imputed interest	(1,036,949)
Present value of lease liability	$ 3,127,278
Discount rate		6.00%

XML 67 R56.htm IDEA: XBRL DOCUMENT

Leases - Future Minimum Lease Payments (Details)	Dec. 31, 2018 USD ($)
Operating leases, future minimum payments due, fiscal year maturity
2019	$ 170,664
Total minimum lease payments	$ 170,664

XML 68 R57.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Purchase commitments
Purchase commitments	$ 2,920,468	$ 2,674,691

EXCEL 69 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 71 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 72 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 108 226 1 false 34 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.iradimed.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED BALANCE SHEETS Sheet http://www.iradimed.com/role/StatementCondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.iradimed.com/role/StatementCondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.iradimed.com/role/StatementCondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - CONDENSED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.iradimed.com/role/StatementCondensedStatementsOfComprehensiveIncome CONDENSED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 00305 - Statement - CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Sheet http://www.iradimed.com/role/StatementCondensedStatementsOfComprehensiveIncomeParenthetical CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.iradimed.com/role/StatementCondensedStatementsOfStockholdersEquity CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 7 false false R8.htm 00500 - Statement - CONDENSED STATEMENTS OF CASH FLOWS Sheet http://www.iradimed.com/role/StatementCondensedStatementsOfCashFlows CONDENSED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 10101 - Disclosure - Basis of Presentation Sheet http://www.iradimed.com/role/DisclosureBasisOfPresentation Basis of Presentation Notes 9 false false R10.htm 10201 - Disclosure - Revenue Recognition Sheet http://www.iradimed.com/role/DisclosureRevenueRecognition Revenue Recognition Notes 10 false false R11.htm 10301 - Disclosure - Basic and Diluted Net Income per Share Sheet http://www.iradimed.com/role/DisclosureBasicAndDilutedNetIncomePerShare Basic and Diluted Net Income per Share Notes 11 false false R12.htm 10401 - Disclosure - Inventory Sheet http://www.iradimed.com/role/DisclosureInventory Inventory Notes 12 false false R13.htm 10501 - Disclosure - Property and Equipment Sheet http://www.iradimed.com/role/DisclosurePropertyAndEquipment Property and Equipment Notes 13 false false R14.htm 10601 - Disclosure - Intangible Assets Sheet http://www.iradimed.com/role/DisclosureIntangibleAssets Intangible Assets Notes 14 false false R15.htm 10701 - Disclosure - Investments Sheet http://www.iradimed.com/role/DisclosureInvestments Investments Notes 15 false false R16.htm 10801 - Disclosure - Fair Value Measurements Sheet http://www.iradimed.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 10901 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.iradimed.com/role/DisclosureAccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 17 false false R18.htm 11001 - Disclosure - Stock-Based Compensation Sheet http://www.iradimed.com/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 18 false false R19.htm 11101 - Disclosure - Income Taxes Sheet http://www.iradimed.com/role/DisclosureIncomeTaxes Income Taxes Notes 19 false false R20.htm 11201 - Disclosure - Leases Sheet http://www.iradimed.com/role/DisclosureLeases Leases Notes 20 false false R21.htm 11301 - Disclosure - Commitments and Contingencies Sheet http://www.iradimed.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 20102 - Disclosure - Basis of Presentation (Policies) Sheet http://www.iradimed.com/role/DisclosureBasisOfPresentationPolicies Basis of Presentation (Policies) Policies 22 false false R23.htm 30103 - Disclosure - Basis of Presentation (Tables) Sheet http://www.iradimed.com/role/DisclosureBasisOfPresentationTables Basis of Presentation (Tables) Tables http://www.iradimed.com/role/DisclosureBasisOfPresentation 23 false false R24.htm 30203 - Disclosure - Revenue Recognition (Tables) Sheet http://www.iradimed.com/role/DisclosureRevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.iradimed.com/role/DisclosureRevenueRecognition 24 false false R25.htm 30303 - Disclosure - Basic and Diluted Net Income per Share (Tables) Sheet http://www.iradimed.com/role/DisclosureBasicAndDilutedNetIncomePerShareTables Basic and Diluted Net Income per Share (Tables) Tables http://www.iradimed.com/role/DisclosureBasicAndDilutedNetIncomePerShare 25 false false R26.htm 30403 - Disclosure - Inventory (Tables) Sheet http://www.iradimed.com/role/DisclosureInventoryTables Inventory (Tables) Tables http://www.iradimed.com/role/DisclosureInventory 26 false false R27.htm 30503 - Disclosure - Property and Equipment (Tables) Sheet http://www.iradimed.com/role/DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) Tables http://www.iradimed.com/role/DisclosurePropertyAndEquipment 27 false false R28.htm 30603 - Disclosure - Intangible Assets (Tables) Sheet http://www.iradimed.com/role/DisclosureIntangibleAssetsTables Intangible Assets (Tables) Tables http://www.iradimed.com/role/DisclosureIntangibleAssets 28 false false R29.htm 30703 - Disclosure - Investments (Tables) Sheet http://www.iradimed.com/role/DisclosureInvestmentsTables Investments (Tables) Tables http://www.iradimed.com/role/DisclosureInvestments 29 false false R30.htm 30803 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.iradimed.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.iradimed.com/role/DisclosureFairValueMeasurements 30 false false R31.htm 30903 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.iradimed.com/role/DisclosureAccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.iradimed.com/role/DisclosureAccumulatedOtherComprehensiveLoss 31 false false R32.htm 31003 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.iradimed.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.iradimed.com/role/DisclosureStockBasedCompensation 32 false false R33.htm 31203 - Disclosure - Leases (Tables) Sheet http://www.iradimed.com/role/DisclosureLeasesTables Leases (Tables) Tables http://www.iradimed.com/role/DisclosureLeases 33 false false R34.htm 40101 - Disclosure - Basis of Presentation (Details) Sheet http://www.iradimed.com/role/DisclosureBasisOfPresentationDetails Basis of Presentation (Details) Details http://www.iradimed.com/role/DisclosureBasisOfPresentationTables 34 false false R35.htm 40102 - Disclosure - Basis of Presentation - FDA Warning Letter (Details) Sheet http://www.iradimed.com/role/DisclosureBasisOfPresentationFdaWarningLetterDetails Basis of Presentation - FDA Warning Letter (Details) Details 35 false false R36.htm 40103 - Disclosure - Basis of Presentation - Certain Significant Risks and Uncertainties (Details) Sheet http://www.iradimed.com/role/DisclosureBasisOfPresentationCertainSignificantRisksAndUncertaintiesDetails Basis of Presentation - Certain Significant Risks and Uncertainties (Details) Details 36 false false R37.htm 40104 - Disclosure - Basis of Presentation - Recent Accounting Pronouncements (Details) Sheet http://www.iradimed.com/role/DisclosureBasisOfPresentationRecentAccountingPronouncementsDetails Basis of Presentation - Recent Accounting Pronouncements (Details) Details 37 false false R38.htm 40201 - Disclosure - Revenue Recognition - Information by Geographic Region (Details) Sheet http://www.iradimed.com/role/DisclosureRevenueRecognitionInformationByGeographicRegionDetails Revenue Recognition - Information by Geographic Region (Details) Details 38 false false R39.htm 40202 - Disclosure - Revenue Recognition - Information by Type (Details) Sheet http://www.iradimed.com/role/DisclosureRevenueRecognitionInformationByTypeDetails Revenue Recognition - Information by Type (Details) Details 39 false false R40.htm 40203 - Disclosure - Revenue Recognition - Contract Liabilities (Details) Sheet http://www.iradimed.com/role/DisclosureRevenueRecognitionContractLiabilitiesDetails Revenue Recognition - Contract Liabilities (Details) Details 40 false false R41.htm 40204 - Disclosure - Revenue Recognition - Capitalized Contract Costs (Details) Sheet http://www.iradimed.com/role/DisclosureRevenueRecognitionCapitalizedContractCostsDetails Revenue Recognition - Capitalized Contract Costs (Details) Details 41 false false R42.htm 40301 - Disclosure - Basic and Diluted Net Income per Share (Details) Sheet http://www.iradimed.com/role/DisclosureBasicAndDilutedNetIncomePerShareDetails Basic and Diluted Net Income per Share (Details) Details http://www.iradimed.com/role/DisclosureBasicAndDilutedNetIncomePerShareTables 42 false false R43.htm 40401 - Disclosure - Inventory (Details) Sheet http://www.iradimed.com/role/DisclosureInventoryDetails Inventory (Details) Details http://www.iradimed.com/role/DisclosureInventoryTables 43 false false R44.htm 40501 - Disclosure - Property and Equipment (Details) Sheet http://www.iradimed.com/role/DisclosurePropertyAndEquipmentDetails Property and Equipment (Details) Details http://www.iradimed.com/role/DisclosurePropertyAndEquipmentTables 44 false false R45.htm 40502 - Disclosure - Property and Equipment - Geographic information (Details) Sheet http://www.iradimed.com/role/DisclosurePropertyAndEquipmentGeographicInformationDetails Property and Equipment - Geographic information (Details) Details 45 false false R46.htm 40601 - Disclosure - Intangible Assets (Details) Sheet http://www.iradimed.com/role/DisclosureIntangibleAssetsDetails Intangible Assets (Details) Details http://www.iradimed.com/role/DisclosureIntangibleAssetsTables 46 false false R47.htm 40701 - Disclosure - Investments (Details) Sheet http://www.iradimed.com/role/DisclosureInvestmentsDetails Investments (Details) Details http://www.iradimed.com/role/DisclosureInvestmentsTables 47 false false R48.htm 40801 - Disclosure - Fair Value Measurements (Details) Sheet http://www.iradimed.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.iradimed.com/role/DisclosureFairValueMeasurementsTables 48 false false R49.htm 40901 - Disclosure - Accumulated Other Comprehensive Loss (Details) Sheet http://www.iradimed.com/role/DisclosureAccumulatedOtherComprehensiveLossDetails Accumulated Other Comprehensive Loss (Details) Details http://www.iradimed.com/role/DisclosureAccumulatedOtherComprehensiveLossTables 49 false false R50.htm 41001 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.iradimed.com/role/DisclosureStockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.iradimed.com/role/DisclosureStockBasedCompensationTables 50 false false R51.htm 41002 - Disclosure - Stock-Based Compensation - Stock Options and Restricted Stock Units Activity (Details) Sheet http://www.iradimed.com/role/DisclosureStockBasedCompensationStockOptionsAndRestrictedStockUnitsActivityDetails Stock-Based Compensation - Stock Options and Restricted Stock Units Activity (Details) Details 51 false false R52.htm 41101 - Disclosure - Income Taxes (Details) Sheet http://www.iradimed.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.iradimed.com/role/DisclosureIncomeTaxes 52 false false R53.htm 41201 - Disclosure - Leases (Details) Sheet http://www.iradimed.com/role/DisclosureLeasesDetails Leases (Details) Details http://www.iradimed.com/role/DisclosureLeasesTables 53 false false R54.htm 41202 - Disclosure - Leases - Operating Lease Cost (Details) Sheet http://www.iradimed.com/role/DisclosureLeasesOperatingLeaseCostDetails Leases - Operating Lease Cost (Details) Details 54 false false R55.htm 41203 - Disclosure - Leases - Maturity of Lease Liabilities (Details) Sheet http://www.iradimed.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesDetails Leases - Maturity of Lease Liabilities (Details) Details 55 false false R56.htm 41204 - Disclosure - Leases - Future Minimum Lease Payments (Details) Sheet http://www.iradimed.com/role/DisclosureLeasesFutureMinimumLeasePaymentsDetails Leases - Future Minimum Lease Payments (Details) Details 56 false false R57.htm 41301 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.iradimed.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.iradimed.com/role/DisclosureCommitmentsAndContingencies 57 false false All Reports Book All Reports irmd-20190331.xml irmd-20190331.xsd irmd-20190331_cal.xml irmd-20190331_def.xml irmd-20190331_lab.xml irmd-20190331_pre.xml http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 74 0001104659-19-027657-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-19-027657-xbrl.zip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�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end

December 31,

(unaudited)

Capitalized contract costs